Processing 00000000.tx.1: Bone Morphogenetic Protein 2Inhibits Platelet-derived Growth Factor-induced c-fos Gene Transcription and DNA Synthesis in Mesangial Cells INVOLVEMENT OF MITOGEN-ACTIVATED PROTEIN KINASE* Goutam Ghosh Choundhury, Yong-soo Kim, Matthias Simon, John Wozney, Stephen Harris, Nandini Ghosh-Choundhury**, and Hanna E. 

Phrase: "Bone Morphogenetic Protein 2Inhibits Platelet-derived Growth Factor-induced c-fos Gene Transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0040649:Gene Transcription [Genetic Function]
           Transcription
   720   C1332589:Bone Morphogenetic Protein Gene [Gene or Genome]

Phrase: "and"

Phrase: "DNA Synthesis in Mesangial Cells INVOLVEMENT OF MITOGEN-ACTIVATED PROTEIN KINASE"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   756   C0598312:DNA Synthesis [Genetic Function]
   756   C1328870:DNA synthesis [Laboratory Procedure]
   756   C1817262:DNA synthesis [Genetic Function]
   754   C0597295:Protein Synthesis [Molecular Function]
   738   C0220781:synthesis [Biologic Function]
   738   C1883254:Synthesis [Activity]
   718 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]
   718 E C0598279:synthetic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   718   C2936320:Synthetic Cells [Manufactured Object]

Phrase: "* Goutam Ghosh Choundhury,"

Phrase: "Yong-soo Kim,"

Phrase: "Matthias Simon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443058:Simon [Intellectual Product]

Phrase: "John Wozney,"

Phrase: "Stephen Harris,"

Phrase: "Nandini Ghosh-Choundhury"

Phrase: "*"

Phrase: "*,"

Phrase: "and"

Phrase: "Hanna E."
Processing 00000000.tx.2: Abboud From the Departments of **Medicine and Pathology, The University of Texas Health Science Center and Audie L.Murphy Memorial Veterans Affairs Medical Center, San Antonio, Texas 78284-7882and the Genetics Institute, Cambridge, Massachusetts 01810  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Bone morphogenetic proteins (BMPs) play an important role in nephrogenesis. 

Phrase: "Abboud From the Departments of **Medicine"

Phrase: "and"

Phrase: "Pathology,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "The University of Texas Health Science Center"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   839   C0475309:Health center [Health Care Related Organization,Manufactured Object]
   799   C0018684:Health [Idea or Concept]
   799   C0036397:Science [Occupation or Discipline]
   799   C0039711:Texas [Geographic Area]
   799   C0041740:University [Manufactured Object,Organization]
   799   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "Audie L.Murphy Memorial Veterans Affairs Medical Center,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   812   C1549054:Veterans Affairs [Organization]
   812   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   793   C0042610:Veterans [Population Group]
   793   C0205099:Center [Spatial Concept]
   793   C0205476:Medical [Functional Concept]
   760 E C3245459:veteran [Intellectual Product]

Phrase: "San Antonio,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "Texas 78284-7882and"

Phrase: "the Genetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017398:Genetics [Biomedical Occupation or Discipline]
  1000   C0017399:genetics [Biologic Function]

Phrase: "Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021622:institute [Organization]
  1000   C1272753:Institute [Idea or Concept]

Phrase: ","

Phrase: "Cambridge,"

Phrase: "Massachusetts 01810  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0557061:Discussion [Therapeutic or Preventive Procedure]
   790   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Bone morphogenetic proteins (BMPs)"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0053932:Bone Morphogenetic Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   865   C2610491:bone morphogenesis [Organism Function]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   827   C0391978:Bone [Tissue]
   827   C1266908:Bone [Body Part, Organ, or Organ Component]
   827   C1266909:Bone [Body System]
   755   C0026559:Morphogenesis [Organism Function]
   755 E C0443157:Bony [Functional Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in nephrogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.3: The biologic effect and mechanism of action of these proteins in the adult kidney has not yet been studied. 

Phrase: "The biologic effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "mechanism of action of these proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   855   C1537045:protein mechanism of action [Molecular Function]
   833   C0031327:mechanism of action [Physiologic Function]
   833   C1524059:mechanism of action [Functional Concept]
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "in the adult kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0022646:Kidney [Body Part, Organ, or Organ Component]
   861   C0227665:kidney [Body Part, Organ, or Organ Component]
   861   C1278978:Kidney [Body Part, Organ, or Organ Component]
   861   C1514845:KIDNEY [Tissue]
   768 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "has"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.4: We investigated the effect of BMP2, a member of these growth and differentiation factors, on mitogenic signal transduction pathways induced by platelet-derived growth factor (PDGF) in glomerular mesangial cells. 

Phrase: "We"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the effect of BMP2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "a member of these growth and differentiation factors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0680022:member [Population Group]
   744   C2698041:Member [Professional or Occupational Group]

Phrase: "on mitogenic signal transduction pathways"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0086982:Signal Transduction Pathways [Molecular Function]
   875   C0037080:Signal Pathways [Molecular Function]
   861   C0037083:Signal Transduction [Cell Function]
   812   C1160185:transduction [Organism Function]
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]
   812   C1710082:Signal [Phenomenon or Process]

Phrase: "induced by platelet-derived growth factor (PDGF)"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   882   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   753   C0005821:Platelet [Cell]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0205263:Induced [Functional Concept]
   753   C0220844:growth [Physiologic Function]
   753   C1441547:Derived [Qualitative Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   753   C3245521:derived [Idea or Concept]

Phrase: "in glomerular mesangial cells."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C1512199:Glomerular Mesangial Cells [Cell]
   966 E C0227651:Glomerular mesangial cell [Cell]
           Mesangial Cells
   865   C0017655:Glomerular Mesangium [Body Part, Organ, or Organ Component]
           Mesangium
   865   C1280212:Glomerular mesangium [Body Part, Organ, or Organ Component]
   827   C0007634:Cells [Cell]
   827   C0022663:Glomerular [Body Part, Organ, or Organ Component]
   827   C0268731:GLOMERULAR [Disease or Syndrome]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.5: PDGF is a growth and survival factor for these cells in vitro and in vivo. 

Phrase: "PDGF"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "is"

Phrase: "a growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "survival factor for these cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   781   C0007620:Cell Survival [Cell Function]
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]
   760   C1521761:Factor [Functional Concept]
   760   C2827422:Factor [Conceptual Entity]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.6: Incubation of mesangial cells with increasing concentrations of BMP2 inhibited PDGF-induced DNA synthesis in a dose-dependent manner with maximum inhibition at 250ng/ml. 

Phrase: "Incubation of mesangial cells"

Phrase: "with increasing concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "PDGF-induced DNA synthesis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C0598312:DNA Synthesis [Genetic Function]
   818   C1328870:DNA synthesis [Laboratory Procedure]
   818   C1817262:DNA synthesis [Genetic Function]
   795   C0220781:synthesis [Biologic Function]
   795   C1883254:Synthesis [Activity]
   710   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in a dose-dependent manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]

Phrase: "with maximum inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "at 250ng/ml."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.7: Immune complex tyrosine kinase assay of PDGF receptor immunoprecipitates from lysates of mesangial cells treated with PDGF showed no inhibitory effect of BMP2 on PDGF receptor tyrosine phosphorylation. 

Phrase: "Immune complex tyrosine kinase assay of PDGF receptor"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   854   C0390431:platelet-derived-growth factor receptor tyrosine kinase [Amino Acid, Peptide, or Protein,Receptor]
   809   C0206364:Tyrosine Kinase Growth Factor Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
           Receptor Tyrosine Kinase
   809   C1334306:TYROSINE KINASE GROWTH FACTOR RECEPTOR [Gene or Genome]
   772   C0072482:Tyrosine Kinase Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   772   C0919487:TYROSINE KINASE RECEPTOR [Gene or Genome]
   772   C1261356:Immune complex assay [Laboratory Procedure]
   756   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   754   C0255618:tyrosine receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C0005507:Assay [Laboratory Procedure]
   738   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   738   C0243073:assay [Qualitative Concept]
   738   C1510438:Assay [Laboratory Procedure]

Phrase: "immunoprecipitates from lysates of mesangial cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0227651:Mesangial Cells [Cell]
   753   C0007634:Cells [Cell]
   753   C0301871:Immunoprecipitate [Immunologic Factor]
   753   C3282337:Cells [Cell]
   750   C1881488:Cell Lysate [Physical Object]
           Lysate
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "treated with PDGF"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   882   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   783   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   753   C0005821:Platelet [Cell]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1441547:Derived [Qualitative Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1522326:Treated [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   753   C3245521:derived [Idea or Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no inhibitory effect of BMP2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on PDGF receptor tyrosine phosphorylation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C1519726:Tyrosine Phosphorylation [Molecular Function]
   795   C0031715:Phosphorylation [Molecular Function]
   795   C1158886:Phosphorylation [Molecular Function]
   747   C0071253:Platelet-Derived Growth Factor Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   710   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.8: This indicates that the inhibition of DNA synthesis is likely due to postreceptor events. 

Phrase: "This"

Phrase: "indicates"

Phrase: "that"

Phrase: "the inhibition of DNA synthesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C1511701:DNA Synthesis Inhibition [Genetic Function]
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "is"

Phrase: "likely due to postreceptor events."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0332148:Likely [Qualitative Concept]
   760   C0441471:Events [Event]
   760   C0750492:Likely [Idea or Concept]
   760   C3146286:Due [Idea or Concept]
   760   C3541888:Events [Classification]
Processing 00000000.tx.9: However, BMP2 significantly inhibited PDGF-stimulated mitogen-activated protein kinase (MAPK) activity that phosphorylates the Elk-1 transcription factor, a component of the ternary complex factor. 

Phrase: "However,"

Phrase: "BMP2 significantly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1332424:BMP2 [Gene or Genome]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "PDGF-stimulated mitogen-activated protein kinase (MAPK) activity"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   872   C1149472:growth factor activity [Molecular Function]
   861   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   821   C1150527:protein kinase activity [Molecular Function]
   813   C1537044:protein activity [Molecular Function]
   804   C1150423:kinase activity [Molecular Function]
   802 E C2261495:protein phosphokinase activity [Molecular Function]
   799   C1752930:mitogenic activity [Cell Function]
   790   C0205177:Activity [Functional Concept]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1561536:*Activity [Idea or Concept]

Phrase: "that"

Phrase: "phosphorylates"

Phrase: "the Elk-1 transcription factor,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0209089:Elk-1 Transcription Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0040649:Transcription [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "a component of the ternary complex factor."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]
Processing 00000000.tx.10: Using a fusion protein-based reporter assay, we also show that BMP2 blocks PDGF-induced Elk-1-mediated transcription. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a fusion protein-based reporter assay,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0005507:Assay [Laboratory Procedure]
   804   C0243073:assay [Qualitative Concept]
   804   C0335038:Reporter [Professional or Occupational Group]
   804   C1510438:Assay [Laboratory Procedure]
   804   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   804   C1705915:Reporter [Conceptual Entity]
   804   C1709908:Reporter [Group]

Phrase: "we also"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "PDGF-induced Elk-1-mediated transcription."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0040649:Transcription [Genetic Function]
   701   C0071241:platelet factor 1 [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.11: Furthermore, we demonstrate that BMP2 inhibits PDGF-induced transcription of c-fos gene, a natural target of Elk-1 that normally forms a ternary complex that activates the serum response element of the c-fos gene. 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "PDGF-induced transcription of c-fos gene,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   775   C0812327:Transcription Factor Gene [Gene or Genome]
   757   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0040649:Gene Transcription [Genetic Function]
           Transcription

Phrase: "a natural target of Elk-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1521840:Target [Functional Concept]
   753   C2986546:TARGET [Diagnostic Procedure]

Phrase: "that normally"

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a ternary complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the serum response element of the c-fos gene."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0969709:Serum Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   764   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0013879:Element [Element, Ion, or Isotope]
   742   C0229671:Serum [Body Substance]
   742   C0871261:Response [Organism Attribute]
   742   C1546774:Serum [Intellectual Product]
   742   C1550100:Serum [Body Substance]
   742   C1704632:Response [Finding]
   742   C1705248:Element [Conceptual Entity]
   742   C1706817:Response [Intellectual Product]
   742   C2911692:Response [Mental Process]
Processing 00000000.tx.12: These data provide the first evidence that in mesangial cells, BMP2 signaling cross-talks with MAPK-based transcriptional events to inhibit PDGF-induced DNA synthesis. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "the first evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that in mesangial cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0227651:Mesangial Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "BMP2 signaling cross-talks"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C2986468:Cross-talk [Cell Function]
   812   C0600118:Talks [Finding]
   812   C2828360:Cross [Conceptual Entity]
   779 E C0037817:Talk [Organism Function]
   779 E C0234856:talk [Daily or Recreational Activity]

Phrase: "with MAPK-based transcriptional events to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0441471:Events [Event]
   793   C3541888:Events [Classification]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "PDGF-induced DNA synthesis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C0598312:DNA Synthesis [Genetic Function]
   818   C1328870:DNA synthesis [Laboratory Procedure]
   818   C1817262:DNA synthesis [Genetic Function]
   795   C0220781:synthesis [Biologic Function]
   795   C1883254:Synthesis [Activity]
   710   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.13: One target for this inhibition is the early response gene c-fos.  

Phrase: "One target for this inhibition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1521840:Target [Functional Concept]
   760   C2986546:TARGET [Diagnostic Procedure]

Phrase: "is"

Phrase: "the early response gene c-fos."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0599295:early response gene [Gene or Genome]
   717   C1705964:Early Response Gene [Gene or Genome]
Processing 00000000.tx.14: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Bone morphogenetic proteins are a group of growth and differentiation factors that were originally identified by their ability to form ectopic bone (1, 2). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Bone morphogenetic proteins"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0053932:Bone Morphogenetic Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   865   C2610491:bone morphogenesis [Organism Function]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   827   C0391978:Bone [Tissue]
   827   C1266908:Bone [Body Part, Organ, or Organ Component]
   827   C1266909:Bone [Body System]
   755   C0026559:Morphogenesis [Organism Function]
   755 E C0443157:Bony [Functional Concept]

Phrase: "are"

Phrase: "a group of growth and differentiation factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0441835:a group [Classification]
   748   C0441833:Group [Idea or Concept]
   748   C0687744:group [Population Group]
   748   C1257890:Group [Population Group]
   748   C1552516:Group [Health Care Related Organization]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]

Phrase: "that"

Phrase: "were"

Phrase: "originally"

Phrase: "identified by their ability to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0085732:Ability [Organism Attribute]
   760   C0205396:Identified [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "ectopic bone"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   861   C0391978:Bone [Tissue]
   861   C1266908:Bone [Body Part, Organ, or Organ Component]
   861   C1266909:Bone [Body System]
   789 E C0443157:Bony [Functional Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.15: Recently several members of this family have been cloned. 

Phrase: "Recently several members of this family"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   783   C0086282:Family Members [Family Group]
   767 E C1611821:Family Member [Intellectual Product]
   753   C0680022:members [Population Group]
   719 E C2698041:Member [Professional or Occupational Group]

Phrase: "have"

Phrase: "been"

Phrase: "cloned."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]
Processing 00000000.tx.16: These proteins contain seven highly conserved cysteines in the C terminus that are characteristic of the TGF-1 family of proteins and thus fall into that broad superfamily (3-6). 

Phrase: "These proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "seven highly conserved cysteines in the C terminus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0010654:cysteines [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "are"

Phrase: "characteristic of the TGF-1 family of proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1521970:Characteristic [Qualitative Concept]

Phrase: "and"

Phrase: "thus"

Phrase: "fall into that broad superfamily (3-6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0085639:Fall [Finding]
   748   C0238715:Fall [Temporal Concept]
   748   C0332464:Broad [Spatial Concept]
   748   C1883220:Superfamily [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.17: BMPs play an important role in the development of many organs, including lung, heart, teeth, gut, skin, and particularly the kidney (4). 

Phrase: "BMPs"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0053932:Bone Morphogenetic Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   865   C2610491:bone morphogenesis [Organism Function]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   827   C0391978:Bone [Tissue]
   827   C1266908:Bone [Body Part, Organ, or Organ Component]
   827   C1266909:Bone [Body System]
   755   C0026559:Morphogenesis [Organism Function]
   755 E C0443157:Bony [Functional Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in the development of many organs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "lung,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0024109:Lung [Body Part, Organ, or Organ Component]
  1000   C0819757:LUNG [Tissue]
  1000   C1278908:Lung [Body Part, Organ, or Organ Component]
   944 E C2707265:Pulmonary [Clinical Attribute]
   944 E C2709248:Pulmonary [Qualitative Concept]
   907 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "heart,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018787:Heart [Body Part, Organ, or Organ Component]
  1000   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "teeth,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0040426:Teeth [Body Part, Organ, or Organ Component]
  1000   C1519551:Teeth [Tissue]
   966 E C1281562:Tooth [Body Part, Organ, or Organ Component]
   928 E C0226984:Dental [Qualitative Concept]

Phrase: "gut,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017189:Gut [Body System]
  1000   C0699819:Gut [Body Part, Organ, or Organ Component]

Phrase: "skin,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0444099:Skin [Body Substance]
  1000   C1123023:Skin [Body System]
  1000   C1278993:Skin [Body System]
   944 E C0221912:Cutaneous [Spatial Concept]
   944 E C0221928:Dermal [Qualitative Concept]
   944 E C1522447:Cutaneous [Functional Concept]
   877 E C0011646:Dermis [Tissue]

Phrase: "and"

Phrase: "particularly"

Phrase: "the kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.18: BMP7, a member of this large family, has been shown to be abundantly expressed in the ureteric bud epithelium before condensation of mesenchyme during nephrogenesis. 

Phrase: "BMP7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0083867:BMP-7 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332428:BMP7 [Gene or Genome]

Phrase: "a member of this large family,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   858   C0424972:Member of large family [Family Group]
   783   C0086282:Family member [Family Group]
   783   C1611821:Family Member [Intellectual Product]
   753   C0680022:member [Population Group]
   753   C2698041:Member [Professional or Occupational Group]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "abundantly"

Phrase: "expressed in the ureteric bud epithelium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1284058:Ureteric bud [Embryonic Structure]
   753   C0014609:Epithelium [Tissue]
   753   C0041951:Ureteric [Body Part, Organ, or Organ Component]
   753   C2700462:Bud [Plant]
   753   C2945744:bud [Anatomical Structure]

Phrase: "before condensation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0233656:Condensation [Mental or Behavioral Dysfunction]
  1000   C0598405:condensation [Natural Phenomenon or Process]

Phrase: "of mesenchyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162415:Mesenchyme [Embryonic Structure]
   928 E C1513143:Mesenchymal [Qualitative Concept]

Phrase: "during nephrogenesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1171312:nephrogenesis [Organ or Tissue Function]
Processing 00000000.tx.19: BMP7 is also expressed during glomerulogenesis (7). 

Phrase: "BMP7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0083867:BMP-7 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332428:BMP7 [Gene or Genome]

Phrase: "is"

Phrase: "also"

Phrase: "expressed during glomerulogenesis"

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.20: BMP7 null mice die after birth because of early cessation of kidney development (8, 9). 

Phrase: "BMP7 null mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0206745:Null Mouse [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "die"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   944   C0011065:Expired [Organism Function]
   944   C0231800:Expired [Organ or Tissue Function]
   944   C1704631:Expire [Idea or Concept]
   916 E C0184532:dying [Organism Function]
   916 E C1546956:Died [Finding]
   916 E C1553404:terminated [Idea or Concept]
   916 E C2348570:Terminated [Functional Concept]

Phrase: "after birth because of early cessation of kidney development"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   754   C0449407:Origin of kidney [Finding]
   742   C0005615:Birth [Organism Function]
   742   C0231290:After [Temporal Concept]
   742   C0687676:After [Temporal Concept]
   742   C1550722:birth [Idea or Concept]
   742   C3245487:birth [Intellectual Product]
   712   C1820234:genital development [Biologic Function]

Phrase: "(8,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.21: The rudimentary kidneys at birth lack glomeruli, the filtering units, likely due to lack of differentiation of metanephric mesenchymal cells (8). 

Phrase: "The rudimentary kidneys at birth lack glomeruli,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0022646:Kidneys [Body Part, Organ, or Organ Component]
   748   C0227665:kidneys [Body Part, Organ, or Organ Component]
   741   C0022663:Kidney Glomerulus [Body Part, Organ, or Organ Component]
   714 E C1278978:Kidney [Body Part, Organ, or Organ Component]
   714 E C1514845:KIDNEY [Tissue]

Phrase: "the filtering units,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0439148:Units [Quantitative Concept]
   861   C1519795:Units [Quantitative Concept]
   827 E C1704753:Unit [Manufactured Object]
   827 E C1880519:Unit [Quantitative Concept]

Phrase: "likely due to lack of differentiation of metanephric mesenchymal cells"
Meta Candidates (Total=20; Excluded=3; Pruned=0; Remaining=17)
   791   C2755178:metanephric mesenchymal cell differentiation [Cell Function]
   766   C1820192:mesenchymal cell differentiation [Cell Function]
   760   C0678226:Due to [Functional Concept]
           due
   757   C0007589:cells differentiation [Cell Function]
           Differentiation
   757   C1334700:Mesenchymal Differentiation [Finding]
   743   C1257975:Mesenchymal cell [Cell]
   739   C0007634:Cells [Cell]
   739   C0332148:Likely [Qualitative Concept]
   739   C0332268:lack [Qualitative Concept]
   739   C0750492:Likely [Idea or Concept]
   739   C1511938:Differentiation [Clinical Attribute]
   739   C1513143:Mesenchymal [Qualitative Concept]
   739   C2945687:Differentiation [Functional Concept]
   739   C3146286:Due [Idea or Concept]
   739   C3282337:Cells [Cell]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.22: High affinity binding of BMP2, another member of this family, has been identified in a large variety of tissues and cells, including the kidney (10). 

Phrase: "High affinity binding of BMP2,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205250:High [Qualitative Concept]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1299351:High [Qualitative Concept]
   760   C1510827:Affinity [Natural Phenomenon or Process]
   760   C2700149:HIGH [Intellectual Product]

Phrase: "another member of this family,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0086282:Family member [Family Group]
   797   C1611821:Family Member [Intellectual Product]
   760   C0680022:member [Population Group]
   760   C2698041:Member [Professional or Occupational Group]

Phrase: "has"

Phrase: "been"

Phrase: "identified in a large variety of tissues"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0040300:Tissues [Tissue]
   748   C0205396:Identified [Qualitative Concept]
   748   C0549177:Large [Quantitative Concept]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]
   748   C1883525:Variety [Conceptual Entity]
   748   C2346866:Variety [Conceptual Entity]
   714 E C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.23: Similar to TGF-, BMPs exert their effect via type I and type II transmembrane serine-threonine kinase receptors (4-6). 

Phrase: "Similar to TGF-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "BMPs"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0053932:Bone Morphogenetic Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   865   C2610491:bone morphogenesis [Organism Function]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   827   C0391978:Bone [Tissue]
   827   C1266908:Bone [Body Part, Organ, or Organ Component]
   827   C1266909:Bone [Body System]
   755   C0026559:Morphogenesis [Organism Function]
   755 E C0443157:Bony [Functional Concept]

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "their effect via type I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "type II transmembrane serine-threonine kinase receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C0074377:serine receptors [Amino Acid, Peptide, or Protein,Receptor]
   795   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(4-6"

Phrase: ")."
Processing 00000000.tx.24: Binding of BMPs to the receptor induces phosphorylation of the type I receptor in the intracellular GS domain (6). 

Phrase: "Binding of BMPs"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   883   C3271616:bone morphogenetic protein binding [Molecular Function]
   797   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781 E C0033618:Protein Binding [Molecular Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "to the receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "phosphorylation of the type I receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "in the intracellular GS domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.25: Smad1 and Smad5 have been identified recently as downstream targets of the BMP receptor. 

Phrase: "Smad1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1414988:SMAD1 [Gene or Genome]
  1000   C1416962:SMAD1 [Gene or Genome]

Phrase: "and"

Phrase: "Smad5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416963:SMAD5 [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "recently as downstream targets of the BMP receptor."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0289417:Receptor, BMP [Amino Acid, Peptide, or Protein,Receptor]
   744   C0053932:BMP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0279266:BMP [Therapeutic or Preventive Procedure]
   744   C0332185:Recently [Temporal Concept]
   744   C0522506:Downstream [Spatial Concept]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   711   C1521840:Target [Functional Concept]
   711   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.26: Upon BMP receptor activation, these cytoplasmic proteins undergo serine phosphorylation that leads to its translocation to the nucleus (11, 12). 

Phrase: "Upon BMP receptor activation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1514758:Receptor Activation [Cell Function]
   827   C1879547:Activation [Activity]
   734   C0289417:Receptor, BMP [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "these cytoplasmic proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1333198:Cytoplasmic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "undergo"

Phrase: "serine phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "that"

Phrase: "leads to its translocation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0040715:Translocation [Cell or Molecular Dysfunction]
   770   C0181586:leads [Medical Device]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C2987521:Translocation [Activity]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "(11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.27: Furthermore the C-terminal region of Smad1 contains a transcriptional activation domain (11, 13). 

Phrase: "Furthermore"

Phrase: "the C-terminal region of Smad1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707271:C-Terminal [Amino Acid Sequence]
   753   C0017446:Region [Geographic Area]
   753   C0205088:Terminal [Temporal Concept]
   753   C0205147:Region [Spatial Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a transcriptional activation domain"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1519594:Transcriptional Activation Domain [Amino Acid Sequence]
   901   C0162493:Transcriptional Activation [Genetic Function]
   827   C0040649:Transcriptional [Genetic Function]
   827   C1879547:Activation [Activity]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "(11,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.28: BMPs initiate signaling that involves synergistic and antagonistic interplay of different pathways. 

Phrase: "BMPs"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0053932:Bone Morphogenetic Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   865   C2610491:bone morphogenesis [Organism Function]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   827   C0391978:Bone [Tissue]
   827   C1266908:Bone [Body Part, Organ, or Organ Component]
   827   C1266909:Bone [Body System]
   755   C0026559:Morphogenesis [Organism Function]
   755 E C0443157:Bony [Functional Concept]

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "that"

Phrase: "involves"

Phrase: "synergistic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986495:Synergistic [Qualitative Concept]

Phrase: "and"

Phrase: "antagonistic interplay of different pathways."
Processing 00000000.tx.29: It has been reported recently that activation of epidermal growth factor receptor, a tyrosine kinase, leads to phosphorylation of Smad1 in serine residues in a MAPK-dependent manner. 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "that activation of epidermal growth factor receptor,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C2249824:activation of growth [Organism Function]
   774   C1514758:Receptor Activation [Cell Function]
   748   C1879547:Activation [Activity]

Phrase: "a tyrosine kinase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "leads to phosphorylation of Smad1"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0031715:Phosphorylation [Molecular Function]
   760   C0181586:leads [Medical Device]
   760   C1158886:Phosphorylation [Molecular Function]
   760   C1414988:SMAD1 [Gene or Genome]
   760   C1416962:SMAD1 [Gene or Genome]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in serine residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "in a MAPK-dependent manner."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.30: This phosphorylation inhibits localization of Smad1 in the nucleus thus inhibiting its transcriptional function (14). 

Phrase: "This phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "localization of Smad1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0475264:Localisation [Functional Concept]
   790   C1744691:localisation [Biologic Function]

Phrase: "in the nucleus thus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007610:Nucleus [Cell Component]

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "its transcriptional function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.31: It is known that activators of tyrosine kinase receptors, e.g. fibroblast growth factor receptor, oppose the effect of BMP2 during limb bud outgrowth (15). 

Phrase: "It"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that activators of tyrosine kinase receptors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   767   C2247123:kinase activator [Molecular Function]

Phrase: "e.g. fibroblast growth factor receptor,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0060369:Fibroblast Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   923   C0016026:Fibroblast Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0016030:Fibroblast [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "oppose"

Phrase: "the effect of BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "during limb bud outgrowth"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0282505:Limb Bud [Embryonic Structure]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.32: Similarly, epidermal growth factor receptor can block expression of osteogenic differentiation markers induced by BMP2 (16). 

Phrase: "Similarly,"

Phrase: "epidermal growth factor receptor"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0034802:Epidermal Growth Factor Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1414313:EPIDERMAL GROWTH FACTOR RECEPTOR [Gene or Genome]
   923   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   923   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   923   C1323367:epidermal growth factor [Molecular Function]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0014520:Epidermal [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C0221920:Epidermal [Spatial Concept]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "can"

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "expression of osteogenic differentiation markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "induced by BMP2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205263:Induced [Functional Concept]
   790   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1332424:BMP2 [Gene or Genome]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.33: On the contrary, fibroblast growth factor-induced genes essential for tooth development can be blocked by BMP2 (17). 

Phrase: "On the contrary,"

Phrase: "fibroblast growth factor-induced genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   872   C0812325:Growth Factor Gene [Gene or Genome]
   804   C0017337:Genes [Gene or Genome]
   717   C0016026:Fibroblast Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "essential for tooth development"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "blocked by BMP2"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0028778:Blocked [Pathologic Function]
   790   C0332206:Blocked [Functional Concept]
   790   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1332424:BMP2 [Gene or Genome]
   790   C2983591:BLOCKED [Research Activity]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.34: These data indicate that there is cross-talk between BMP receptor serine threonine kinase and its components and the receptor tyrosine kinase cascades. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that there"

Phrase: "is"

Phrase: "cross-talk between BMP receptor serine threonine kinase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   793   C0600513:Receptor Cross-Talk [Molecular Function]
   770   C0010357:Crosstalk [Molecular Function]
   770   C2986468:Cross-talk [Cell Function]
   744   C0037817:Talk [Organism Function]
   744   C0234856:talk [Daily or Recreational Activity]
   744   C0600118:talk [Finding]
   744   C2828360:Cross [Conceptual Entity]

Phrase: "and"

Phrase: "its components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449432:Components [Manufactured Object]
   966 E C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "the receptor tyrosine kinase cascades."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1707310:Cascade [Manufactured Object]
   756   C0206364:Receptor Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
Processing 00000000.tx.35: Platelet-derived growth factor (PDGF) is a potent mitogen for many mesenchymal cells, including mesangial cells, vascular pericytes that occupy the glomerular microvascular bed (18, 19). 

Phrase: "Platelet-derived growth factor"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "(PDGF"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: ")"

Phrase: "is"

Phrase: "a potent mitogen for many mesenchymal cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0026249:Mitogen [Pharmacologic Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "mesangial cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0227651:Mesangial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "vascular pericytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0598800:Pericytes [Cell]

Phrase: "that"

Phrase: "occupy"

Phrase: "the glomerular microvascular bed (18,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1513268:Microvascular Bed [Body Part, Organ, or Organ Component]
   812   C0004916:Bed [Manufactured Object]
   812   C0022663:Glomerular [Body Part, Organ, or Organ Component]
   812   C0268731:GLOMERULAR [Disease or Syndrome]
   812   C0443258:Microvascular [Functional Concept]
   812   C0596170:BED [Mental or Behavioral Dysfunction]

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.36: During embryogenesis activation of PDGF receptor (PDGFR) in multipotent mesenchymal cells is necessary for development, growth, and survival of glomerular mesangial cells (20, 21). 

Phrase: "During embryogenesis activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "of PDGF receptor"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
  1000   C0071253:Platelet-Derived Growth Factor Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   937   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   875   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0005821:Platelet [Cell]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1441547:Derived [Qualitative Concept]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   804   C3245521:derived [Idea or Concept]
   721 E C1963076:Platelets [Finding]

Phrase: "(PDGFR) in multipotent mesenchymal cells"

Phrase: "is"

Phrase: "necessary for development,"

Phrase: "growth,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "survival of glomerular mesangial cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0007620:Cell Survival [Cell Function]
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]

Phrase: "(20,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.37: In the adult kidney, overexpression and activation of PDGFR is associated with proliferative and fibrotic responses (22). 

Phrase: "In the adult kidney,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0022646:Kidney [Body Part, Organ, or Organ Component]
   861   C0227665:kidney [Body Part, Organ, or Organ Component]
   861   C1278978:Kidney [Body Part, Organ, or Organ Component]
   861   C1514845:KIDNEY [Tissue]
   768 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:Overexpression [Genetic Function]

Phrase: "and"

Phrase: "activation of PDGFR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "associated with proliferative"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0334094:Proliferative [Pathologic Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "fibrotic responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.38: One of the major signal transduction pathways initiated by PDGF in target cells is the activation of MAPK (23, 24). 

Phrase: "One of the major signal transduction pathways"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205447:One [Quantitative Concept]

Phrase: "initiated by PDGF"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   882   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   753   C0005821:Platelet [Cell]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1441547:Derived [Qualitative Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   753   C3245521:derived [Idea or Concept]
   719   C1548602:Initiate [Idea or Concept]
   719   C1704686:Initiate [Functional Concept]

Phrase: "in target cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0221284:Target cells [Cell]
  1000   C3272919:Target Cells [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C1521840:Target [Functional Concept]
   861   C2986546:TARGET [Diagnostic Procedure]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "the activation of MAPK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1819041:protein kinase activation [Cell Function]
   774   C0599177:protein activation [Genetic Function]
   748   C1879547:Activation [Activity]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.39: Tyrosine phosphorylation of PDGFR creates binding sites for a number of proteins characterized by the presence of about 100-amino acid residue sequence motifs known as Src homology 2domain (19, 25). 

Phrase: "Tyrosine phosphorylation of PDGFR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1519726:Tyrosine Phosphorylation [Molecular Function]
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "creates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "binding sites for a number of proteins"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   804   C0445108:Number of sites [Quantitative Concept]
   778   C0005456:Binding Sites [Receptor]
   774   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757 E C0033618:Protein Binding [Molecular Function]
   757   C2945843:Site of [Qualitative Concept]
   748   C0205145:Sites [Spatial Concept]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   745 E C0682969:Binding Site [Amino Acid Sequence]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]

Phrase: "characterized by the presence of about 100-amino acid residue sequence motifs"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   783   C0428202:Presence of amino acid [Laboratory or Test Result]
   767   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   767   C0752190:Amino Acid Motifs [Spatial Concept]
   753   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C2917660:Amino Acid [Pharmacologic Substance]
   736   C0001128:Acid [Chemical]
   736   C0004793:Sequence [Nucleotide Sequence]
   736   C0162326:Sequence [Nucleotide Sequence]
   736   C0162327:Sequence [Nucleotide Sequence]
   736   C0202406:Acid [Laboratory Procedure]
   736   C0392148:Presence [Therapeutic or Preventive Procedure]
   736   C1519249:Sequence [Functional Concept]
   736   C1709915:Residue [Conceptual Entity]
   736   C1880022:Characterized [Activity]
   736   C1882936:RESIDUE [Phenomenon or Process]
   703   C1514562:Motif [Amino Acid Sequence]

Phrase: "known as Src homology 2domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205309:Known [Qualitative Concept]
   760   C1334043:Homology [Gene or Genome]
   760   C2697616:Homology [Qualitative Concept]

Phrase: "(19,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.40: Binding of one such Src homology 2domain-containing protein, SHP-2, to the tyrosine-phosphorylated receptor stimulates the guanine nucleotide exchange factor Son of sevenless to activate Ras, an upstream regulator of MAPK cascade (19, 24, 26). 

Phrase: "Binding of one"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "such Src homology 2domain-containing protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "SHP-2,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0656342:SHP-2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335280:SHP-2 [Gene or Genome]
  1000   C1706044:SHP-2 [Gene or Genome]
   861   C1334896:SHP [Gene or Genome]
   861   C1335142:SHP [Amino Acid, Peptide, or Protein,Receptor]
   861   C1705299:SHP [Gene or Genome]

Phrase: "to the tyrosine-phosphorylated receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0255618:tyrosine receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "stimulates"

Phrase: "the guanine nucleotide exchange factor Son of sevenless to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0037683:Son [Family Group]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "Ras,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]

Phrase: "an upstream regulator of MAPK cascade"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0182953:REGULATOR [Medical Device]
   742   C1704734:Regulator [Medical Device]
   742   C1704735:Regulator [Conceptual Entity]

Phrase: "(19,"

Phrase: "24,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.41: We have shown recently that PDGF stimulates PI 3-kinase which in turn regulates MAPK activity in mesangial cells. 

Phrase: "We"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "that PDGF"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "stimulates"

Phrase: "PI 3-kinase"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0044602:PI 3 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0919338:PI-3 kinase [Gene or Genome]
  1000   C2936824:PI-3 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1579194:PI-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0429863:PI [Clinical Attribute]
   827   C3537219:PI [Gene or Genome]
   827   C3539772:PI [Intellectual Product]

Phrase: "which in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "regulates"

Phrase: "MAPK activity in mesangial cells."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   869   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   800   C1150527:protein kinase activity [Molecular Function]
   781 E C2261495:protein phosphokinase activity [Molecular Function]
   770   C1150423:kinase activity [Molecular Function]
   767   C1537044:protein activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]
   731   C1752930:mitogenic activity [Cell Function]
Processing 00000000.tx.42: Thus there is cross-talk between these two pathways that lead to MAPK activation and cell growth (27). 

Phrase: "Thus there"

Phrase: "is"

Phrase: "cross-talk between these two pathways"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0010357:Crosstalk [Molecular Function]
   790   C2986468:Cross-talk [Cell Function]
   753   C0037817:Talk [Organism Function]
   753   C0234856:talk [Daily or Recreational Activity]
   753   C0600118:talk [Finding]
   753   C2828360:Cross [Conceptual Entity]

Phrase: "that"

Phrase: "lead to MAPK activation"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   853   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1819041:protein kinase activation [Cell Function]
   814   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   778   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0599177:protein activation [Genetic Function]
   748   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0026249:Mitogen [Pharmacologic Substance]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522538:Lead [Functional Concept]
   748   C1879547:Activated [Activity]
           Activation
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]
   714 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "cell growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007595:Cell Growth [Cell Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.43: Inhibition of either pathway blocks PDGF-induced mesangial cell proliferation, an important biological response of these cells during glomerular pathology (22). 

Phrase: "Inhibition of either pathway"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "PDGF-induced mesangial cell proliferation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   835   C3278595:Mesangial cell proliferation [Finding]
   822   C0545017:Mesangial proliferation [Cell or Molecular Dysfunction]
   812   C0596290:Cell Proliferation [Cell Function]
   793   C0334094:Proliferation [Pathologic Function]
   793   C1514485:Proliferation [Functional Concept]

Phrase: "an important biological response of these cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0005532:Biological [Biomedical Occupation or Discipline]
   748   C0205460:biological [Qualitative Concept]
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "during glomerular pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.44: Here we show that recombinant BMP2 inhibits PDGF-induced DNA synthesis in mesangial cells in a dose-dependent manner. 

Phrase: "Here"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that recombinant BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1332424:BMP2 [Gene or Genome]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "PDGF-induced DNA synthesis in mesangial cells"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   777   C0016026:DNA Synthesis Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0598312:DNA Synthesis [Genetic Function]
   760   C1328870:DNA synthesis [Laboratory Procedure]
   760   C1817262:DNA synthesis [Genetic Function]
   739   C0220781:synthesis [Biologic Function]
   739   C1883254:Synthesis [Activity]
   722 E C0598279:synthetic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   722   C2936320:Synthetic Cells [Manufactured Object]

Phrase: "in a dose-dependent manner."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]
Processing 00000000.tx.45: The mechanism involves BMP2 inhibition of PDGF-induced MAPK activity resulting in inhibition of Elk-1-dependent transcription of an appropriate reporter gene. 

Phrase: "The mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "involves"

Phrase: "BMP2 inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of PDGF-induced MAPK activity"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   872   C1149472:growth factor activity [Molecular Function]
   861   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   821   C1150527:protein kinase activity [Molecular Function]
   813   C1537044:protein activity [Molecular Function]
   804   C1150423:kinase activity [Molecular Function]
   802 E C2261495:protein phosphokinase activity [Molecular Function]
   799   C1752930:mitogenic activity [Cell Function]
   790   C0205177:Activity [Functional Concept]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1561536:*Activity [Idea or Concept]

Phrase: "resulting in inhibition of Elk-1-dependent transcription"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   770   C0332294:Resulting in [Functional Concept]
   770   C1705455:ELK-1 [Gene or Genome]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C0040649:Transcription [Genetic Function]
   744   C0325228:Elk [Mammal]
   744   C0678226:resulting [Functional Concept]
   744   C0851827:Dependent [Qualitative Concept]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C1701901:Dependent [Qualitative Concept]
   744   C3244310:dependent [Functional Concept]
   744   C3463820:Inhibition [Activity]
   711 E C1274040:Result [Functional Concept]
   711 E C1546471:Result [Idea or Concept]
   711 E C2825142:Result [Finding]

Phrase: "of an appropriate reporter gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0206414:Reporter Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.46: In support of this mechanism, we show that BMP2 inhibits PDGF-mediated c-fos gene transcription in mesangial cells.  

Phrase: "In support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "of this mechanism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "PDGF-mediated c-fos gene transcription"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   807   C0040649:Gene Transcription [Genetic Function]
           Transcription
   734   C1418436:Platelet Derived Growth Factor C Gene [Gene or Genome]
           PLATELET-DERIVED GROWTH FACTOR C
   708   C0916084:platelet-derived growth factor C [Amino Acid, Peptide, or Protein]
   708   C1571527:Platelet-Derived Growth Factor C [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in mesangial cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0227651:Mesangial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789   C0017655:Mesangium [Body Part, Organ, or Organ Component]
Processing 00000000.tx.47: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Materials-- Tissue culture materials and LipofectAMINE were obtained from Life Technologies, Inc. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "--"

Phrase: "Tissue culture materials"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   896   C0457457:Tissue material [Tissue]
   827   C0520510:Materials [Substance]
   734   C0040284:Tissue culture [Laboratory Procedure]

Phrase: "and"

Phrase: "LipofectAMINE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0253711:Lipofectamine [Indicator, Reagent, or Diagnostic Aid,Lipid]

Phrase: "were"

Phrase: "obtained from Life Technologies,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0039421:technologies [Occupation or Discipline]
   770   C0376558:Life [Idea or Concept]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "Inc."
Processing 00000000.tx.48: Nonidet P-40, phenylmethylsulfonyl fluoride and Na3VO4 were purchased from Sigma. 

Phrase: "Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   827   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   827   C0439509:/40 [Temporal Concept]

Phrase: "phenylmethylsulfonyl fluoride"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   861   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "Na3VO4"

Phrase: "were"

Phrase: "purchased from Sigma."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.49: GAL4-Elk-1 fusion plasmid and the GAL-4-luciferase reporter construct were obtained from Stratagene. 

Phrase: "GAL4-Elk-1 fusion plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "the GAL-4-luciferase reporter construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "obtained from Stratagene."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.50: The dual luciferase kit was purchased from Promega. 

Phrase: "The dual luciferase kit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0812225:KIT [Medical Device]
   827   C1150635:KIT [Molecular Function]
   827   C1705212:Kit [Medical Device]
   827   C1705213:KIT [Medical Device]
   827   C3273202:Kit [Manufactured Object]

Phrase: "was"

Phrase: "purchased from Promega."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0072149:Promega [Lipid]
   790   C0869011:purchased [Activity]
Processing 00000000.tx.51: Recombinant PDGF BB was obtained from Amgen. 

Phrase: "Recombinant PDGF BB"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
  1000   C0140908:platelet-derived growth factor BB, recombinant [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   947   C0246681:platelet-derived growth factor BB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   947   C1515387:Recombinant Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   885   C1515377:Recombinant Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   858   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0004739:BB [Geographic Area]
   799   C0005821:Platelet [Cell]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0220844:growth [Physiologic Function]
   799   C0332297:BB [Spatial Concept]
   799   C1441547:Derived [Qualitative Concept]
   799   C1514798:recombinant [Organism]
   799   C1521761:Factor [Functional Concept]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   799   C3245521:derived [Idea or Concept]
   716 E C1963076:Platelets [Finding]

Phrase: "was"

Phrase: "obtained from Amgen."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0331771:Amgen [Health Care Related Organization]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.52: TGF-1 was purchased from R&D Systems. 

Phrase: "TGF-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "purchased from R&D Systems."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205090:R- [Spatial Concept]
   760   C0684010:R. [Professional or Occupational Group]
   760   C0869011:purchased [Activity]
   760   C2603358:R' [Clinical Attribute]
   726   C0449913:System [Functional Concept]
   726   C1553451:System [Manufactured Object]
   726   C1704459:System [Medical Device]
Processing 00000000.tx.53: BMP2 was from the Genetics Institute. 

Phrase: "BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "was from the Genetics"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0017398:Genetics [Biomedical Occupation or Discipline]
   770   C0017399:genetics [Biologic Function]
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1421478:WAS [Gene or Genome]

Phrase: "Institute."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021622:institute [Organization]
  1000   C1272753:Institute [Idea or Concept]
Processing 00000000.tx.54: PDGFR antibody was purchased from Upstate Biotechnology Inc. 

Phrase: "PDGFR antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "purchased from Upstate Biotechnology Inc."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   760   C0869011:purchased [Activity]
Processing 00000000.tx.55: MAPK antibody was from Santa Cruz. 

Phrase: "MAPK antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   771   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]

Phrase: "was from Santa Cruz."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.56: [3H]Thymidine and [-32P]ATP were from Amersham Pharmacia Biotech. 

Phrase: "[3H]Thymidine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040077:Thymidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1442460:3H [Temporal Concept]

Phrase: "and [-"

Phrase: "32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]ATP"

Phrase: "were from Amersham Pharmacia Biotech."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0331955:Pharmacia [Health Care Related Organization]
Processing 00000000.tx.57: Cell Culture-- Rat glomerular mesangial cells (kindly provided by Dr. Jeff Kreisberg) or human mesangial cells were isolated and characterized as described (27, 28). 

Phrase: "Cell Culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "--"

Phrase: "Rat glomerular mesangial cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   923   C1512199:Glomerular Mesangial Cells [Cell]
   890 E C0227651:Glomerular mesangial cell [Cell]
           Mesangial Cells
   825   C0017655:Glomerular Mesangium [Body Part, Organ, or Organ Component]
           Mesangium
   825   C1280212:Glomerular mesangium [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0022663:Glomerular [Body Part, Organ, or Organ Component]
   812   C0268731:GLOMERULAR [Disease or Syndrome]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(kindly"

Phrase: "provided by Dr. Jeff Kreisberg"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0031831:DR [Professional or Occupational Group]
   760   C1707664:DR [Biomedical or Dental Material]
   760   C1999230:Provided [Activity]
   760   C2348314:Dr. [Conceptual Entity]
   760   C3540849:DR [Idea or Concept]

Phrase: ")"

Phrase: "or"

Phrase: "human mesangial cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0427861:Human cells [Laboratory or Test Result]
   901   C0227651:Mesangial Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0086418:Human [Human]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "characterized as described"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1552738:described [Idea or Concept]
   790   C1880022:Characterized [Activity]

Phrase: "(27,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.58: The human and rat cells were used between 6th and 10th passages and 10th and 20th passages, respectively. 

Phrase: "The human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "rat cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "used between 6th"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "10th passages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439799:Passage [Spatial Concept]

Phrase: "and"

Phrase: "10th"

Phrase: "and"

Phrase: "20th passages,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439799:Passage [Spatial Concept]

Phrase: "respectively."
Processing 00000000.tx.59: Cells were maintained in RPMI 1640tissue culture medium supplemented with antibiotic/antifungal solution and 17% fetal bovine serum. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "maintained in RPMI 1640tissue culture medium"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   753   C0009458:Medium [Intellectual Product]
   753   C0010453:Culture [Idea or Concept]
   753   C0220814:culture [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C0439536:Medium [Quantitative Concept]
   753   C1314677:Maintained [Functional Concept]
   753   C1705217:Medium [Substance]
   753   C2242979:Culture [Laboratory Procedure]
   753   C3244283:medium [Intellectual Product]
   719 E C0024501:Maintain [Activity]

Phrase: "supplemented with antibiotic/antifungal solution"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0003235:Antibiotic antifungal [Antibiotic]
   760   C0003232:Antibiotic [Antibiotic]
   760   C0003308:Antifungal [Pharmacologic Substance]
   760   C0037633:Solution [Substance]
   760   C0525069:Solution [Biomedical or Dental Material]
   760   C0718566:Anti-Fungal [Organic Chemical,Pharmacologic Substance]
   726   C0242295:Supplement [Food]
   726   C1947943:Supplement [Intellectual Product]
   726   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "17% fetal bovine serum."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
Processing 00000000.tx.60: Cells were serum-deprived for 48h and treated with BMP2 for 30min before addition of PDGF. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "serum-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "deprived for 48h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1442464:48H [Temporal Concept]

Phrase: "and"

Phrase: "treated with BMP2"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1332424:BMP2 [Gene or Genome]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "for 30min"

Phrase: "before addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of PDGF."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]
Processing 00000000.tx.61: For ease of transfection of rat mesangial cells, biochemical studies and transfections were carried out in these cells. 

Phrase: "For ease"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1331418:Ease [Mental Process]
   928 E C0332219:Easy [Qualitative Concept]

Phrase: "of transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "of rat mesangial cells,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   901   C0227651:Mesangial Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "biochemical studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0205474:Biochemical [Functional Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "transfections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in these cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0439787:Out [Spatial Concept]
   770   C0849355:Out [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.62: Measurement of DNA Synthesis-- DNA synthesis in human mesangial cells was measured as incorporation of [3H]thymidine into trichloroacetic acid-insoluble material as described previously (27, 29). 

Phrase: "Measurement of DNA Synthesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0242485:Measurement [Functional Concept]

Phrase: "--"

Phrase: "DNA synthesis in human mesangial cells"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0598312:DNA Synthesis [Genetic Function]
   790   C1328870:DNA synthesis [Laboratory Procedure]
   790   C1817262:DNA synthesis [Genetic Function]
   753   C0220781:synthesis [Biologic Function]
   753   C1883254:Synthesis [Activity]
   748 E C0598279:synthetic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C2936320:Synthetic Cells [Manufactured Object]

Phrase: "was"

Phrase: "measured as incorporation of [3H]thymidine"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0040077:Thymidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243126:incorporation [Functional Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C1442460:3H [Temporal Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "into trichloroacetic acid-insoluble material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Material [Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(27,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.63: Immunoprecipitation and Tyrosine Kinase Assay-- Cells were lysed in radioimmune precipitation buffer (20mM Tris-HCl, pH 7.5,150mM NaCl, 5mM EDTA, 1mM Na3VO4, 1mM phenylmethylsulfonyl fluoride, 0.1% aprotinin, and 1% Nonidet P-40) at 4C for 30min. 

Phrase: "Immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "Tyrosine Kinase Assay"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "--"

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed in radioimmune precipitation buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0024348:lysed [Pathologic Function]
   760   C0032931:Precipitation [Natural Phenomenon or Process]
   760   C0032932:Precipitation [Molecular Function]
   760   C1642401:% precipitation [Quantitative Concept]
   760   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "(20mM Tris-HCl,"

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "5mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1mM Na3VO4,"

Phrase: "1mM phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   827   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "0.1% aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "1% Nonidet P-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "for 30min."
Processing 00000000.tx.64: The lysates were collected and centrifuged at 10,000g for 30min at 4C. 

Phrase: "The lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "centrifuged at 10,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "000g for 30min"

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.65: Protein was determined in the cleared supernatant using the Bio-Rad reagent. 

Phrase: "Protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "determined in the cleared supernatant"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0521097:cleared [Functional Concept]
   760   C1550101:Supernatant [Body Substance]
   726 E C2963144:Clear [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Bio-Rad reagent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.66: For PDGFR immunoprecipitation, equal amounts of protein were incubated with the PDGFR antibody on ice for 30min. 

Phrase: "For PDGFR immunoprecipitation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "equal amounts of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "incubated with the PDGFR antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "on ice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]

Phrase: "for 30min."
Processing 00000000.tx.67: Protein A-Sepharose beads were added and incubated at 4C for 3h on a rotating device. 

Phrase: "Protein A-Sepharose beads"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0991566:Beads [Biomedical or Dental Material]
   779 E C2346972:Bead [Spatial Concept]
   756   C0075172:protein A-sepharose [Carbohydrate]

Phrase: "were"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "incubated at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450376:4c [Intellectual Product]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 3h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "on a rotating device."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025080:Device [Medical Device]
   861   C0699733:Device [Manufactured Object]
Processing 00000000.tx.68: The beads were washed three times with radioimmune precipitation buffer and twice with buffer A (50mM Tris-HCl, pH 7.4,0.5mM Na3VO4). 

Phrase: "The beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with radioimmune precipitation buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "twice with buffer A (50mM Tris-HCl,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   748   C0450400:50mm [Quantitative Concept]
   748   C0814229:TRI [Intellectual Product]
   748   C1720725:Twice [Intellectual Product]
   748   C1948050:Twice [Quantitative Concept]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "0.5mM Na3VO4"

Phrase: ")."
Processing 00000000.tx.69: Tyrosine kinase activity of PDGFR was measured directly on the Immunobeads as described (30). 

Phrase: "Tyrosine kinase activity of PDGFR"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1150423:kinase activity [Molecular Function]
   797   C1150632:PDGFR activity [Molecular Function]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "directly on the Immunobeads"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1947931:Directly [Qualitative Concept]
   737   C1441615:Immunobead [Laboratory Procedure]

Phrase: "as described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.70: Briefly, the immunobeads were resuspended in kinase assay buffer (50mM HEPES, pH 7.4,and 10mM MnCl2). 

Phrase: "Briefly,"

Phrase: "the immunobeads"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1441615:Immunobead [Laboratory Procedure]

Phrase: "were"

Phrase: "resuspended in kinase assay buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0005507:Assay [Laboratory Procedure]
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0243073:assay [Qualitative Concept]
   760   C1510438:Assay [Laboratory Procedure]

Phrase: "(50mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "10mM MnCl2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0065642:MnCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.71: 20Ci of [-32P]ATP was added, and the reaction was incubated at 30C for 15min. 

Phrase: "20Ci of [-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1553631:32p [Medical Device]

Phrase: "]ATP"

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "incubated at 30C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 15min."
Processing 00000000.tx.72: At the end of the reaction, 2sample buffer was added, and the labeled proteins were separated on 7.5% SDS gel and visualized by autoradiography. 

Phrase: "At the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the reaction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "2sample buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the labeled proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "separated on 7.5% SDS gel"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0086972:Separated [Finding]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]
   753   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "visualized by autoradiography."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004400:Autoradiography [Laboratory Procedure]
   790   C0234621:Visualized [Functional Concept]
Processing 00000000.tx.73: MAPK Assay-- MAPK assay was performed as described earlier (27). 

Phrase: "MAPK Assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0005507:Assay [Laboratory Procedure]
   804   C0243073:assay [Qualitative Concept]
   804   C1510438:Assay [Laboratory Procedure]
   771   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]

Phrase: "--"

Phrase: "MAPK assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0005507:Assay [Laboratory Procedure]
   804   C0243073:assay [Qualitative Concept]
   804   C1510438:Assay [Laboratory Procedure]
   771   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "performed as described earlier"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0884358:Performed [Functional Concept]
   770   C1552738:described [Idea or Concept]
   737   C1279919:Early [Temporal Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.74: Briefly, cleared cell lysates were immunoprecipitated with MAPK-specific antibody. 

Phrase: "Briefly,"

Phrase: "cleared cell lysates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate
   717   C0229473:Clear cell [Cell]

Phrase: "were"

Phrase: "immunoprecipitated with MAPK-specific antibody."
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   833   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   770   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0026249:Mitogen [Pharmacologic Substance]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205369:Specific [Qualitative Concept]
   744   C1552740:specific [Intellectual Product]
   744   C1879547:Activated [Activity]
   711   C0301871:Immunoprecipitate [Immunologic Factor]
   711 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.75: The immunobeads were resuspended in MAPK assay buffer (10mM HEPES, pH 7.4,10mM MgCl2, 0.5mM dithiothreitol, and 0.5mM Na3VO4) in the presence of 0.5mg/ml myelin basic protein (MBP), 0.5M cAMP-dependent protein kinase inhibitor, and 25M cold ATP plus 1Ci of [-32P]ATP. 

Phrase: "The immunobeads"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1441615:Immunobead [Laboratory Procedure]

Phrase: "were"

Phrase: "resuspended in MAPK assay buffer"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   770   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0005507:Assay [Laboratory Procedure]
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0026249:Mitogen [Pharmacologic Substance]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0243073:assay [Qualitative Concept]
   744   C1510438:Assay [Laboratory Procedure]
   744   C1879547:Activated [Activity]
   711 E C1515877:Activate [Functional Concept]

Phrase: "(10mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "10mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "0.5mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.5mM Na3VO4"

Phrase: ")"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 0.5mg/ml myelin basic protein (MBP),"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   861   C0014063:Myelin Basic Protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1417057:MYELIN BASIC PROTEIN [Gene or Genome]
   839   C0026972:Myelin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0026969:Myelin [Tissue]
   799   C0026973:Myelin [Cell Component]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1527178:Basic [Functional Concept]
   727 E C0920750:basicity [Quantitative Concept]

Phrase: "0.5M cAMP-dependent protein kinase inhibitor,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   845   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   818   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   818   C3537023:kinase inhibitor [Molecular Function]
   818   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   795   C1999216:Inhibitor [Qualitative Concept]
   710   C0010531:cAMP-Dependent Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "25M cold ATP plus 1Ci of [-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1553631:32p [Medical Device]

Phrase: "]ATP."
Processing 00000000.tx.76: This reaction was incubated at 30C for 30min. 

Phrase: "This reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "incubated at 30C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 30min."
Processing 00000000.tx.77: The mixture was then incubated on ice for 10min followed by 15% SDS gel analysis. 

Phrase: "The mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated on ice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 10min"

Phrase: "followed by 15% SDS gel analysis."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0936012:Analysis [Research Activity]
   753   C1382104:Gel [Substance]
   753   C1524024:analysis [Functional Concept]
   719 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.78: Phosphorylated MBP was visualized by autoradiography. 

Phrase: "Phosphorylated MBP"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   884   C0014063:Myelin Basic Protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   884   C1417057:MYELIN BASIC PROTEIN [Gene or Genome]
   853   C0026972:Myelin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026969:Myelin [Tissue]
   804   C0026973:Myelin [Cell Component]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1527178:Basic [Functional Concept]
   733 E C0920750:basicity [Quantitative Concept]

Phrase: "was"

Phrase: "visualized by autoradiography."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004400:Autoradiography [Laboratory Procedure]
   790   C0234621:Visualized [Functional Concept]
Processing 00000000.tx.79: The bands were quantitated by densitometry. 

Phrase: "The bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "quantitated by densitometry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0011321:Densitometry [Laboratory Procedure]
Processing 00000000.tx.80: Immunoblotting-- Immunoblotting of MAPK was performed as described previously (29, 31). 

Phrase: "Immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "--"

Phrase: "Immunoblotting of MAPK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0020985:Immunoblotting [Laboratory Procedure]
   716   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(29,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.81: Transient Transfections and Luciferase Assay-- Transient transfection of mesangial cells was performed with LipofectAMINE with a modification of vendor's protocol. 

Phrase: "Transient Transfections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "Luciferase Assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "--"

Phrase: "Transient transfection of mesangial cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "was"

Phrase: "performed with LipofectAMINE"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0253711:Lipofectamine [Indicator, Reagent, or Diagnostic Aid,Lipid]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "with a modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392747:Modification [Functional Concept]
  1000   C1554963:modification [Qualitative Concept]

Phrase: "of vendor's protocol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.82: Briefly, 1g of firefly luciferase reporter plasmid was used. 

Phrase: "Briefly,"

Phrase: "1g of firefly luciferase reporter plasmid"

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.83: In experiments with GAL4 DNA binding domain-Elk-1 transactivation domain fusion protein, 50ng of the fusion construct was used. 

Phrase: "In experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "with GAL4 DNA binding domain-Elk-1 transactivation domain fusion protein,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   883   C0012940:DNA Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   883   C0812382:DNA-binding protein [Gene or Genome]
   868   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   850   C0209089:elk-1 protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   790   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332466:Fusion [Functional Concept]
   790   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "50ng of the fusion construct"

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.84: To standardize for transfection efficiency, 25ng of cytomegalovirus-Renilla luciferase reporter plasmid was included. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "standardize for transfection efficiency,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0013682:Efficiency [Quantitative Concept]
   770   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "25ng of cytomegalovirus-Renilla luciferase reporter plasmid"

Phrase: "was"

Phrase: "included."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]
Processing 00000000.tx.85: These plasmids were mixed with 0.2ml of Opti-MEM medium and 4l of LipofectAMINE. 

Phrase: "These plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "mixed with 0.2ml of Opti-MEM medium"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   744   C0009458:Medium [Intellectual Product]
   744   C0205430:Mixed [Functional Concept]
   744   C0439536:Medium [Quantitative Concept]
   744   C1705217:Medium [Substance]
   744   C3160715:Mixed [Finding]
   744   C3244283:medium [Intellectual Product]
   711 E C1421951:MIX [Gene or Genome]
   711 E C1720722:Mix [Qualitative Concept]

Phrase: "and"

Phrase: "4l of LipofectAMINE."
Processing 00000000.tx.86: The mixture was incubated at room temperature for 45min. 

Phrase: "The mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "incubated at room temperature"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1547703:Room [Spatial Concept]

Phrase: "for 45min."
Processing 00000000.tx.87: To this mixture, 0.8ml of Opti-MEM medium was added. 

Phrase: "To this mixture,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439962:Mixture [Substance]

Phrase: "0.8ml of Opti-MEM medium"

Phrase: "was"

Phrase: "added."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]
Processing 00000000.tx.88: Mesangial cell monolayers in 35-mm culture dishes were washed twice with 2.5ml of serum-free RPMI 1640and washed once with 2ml of Opti-MEM. 

Phrase: "Mesangial cell monolayers in 35-mm culture dishes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C1510803:Monolayer culture [Laboratory Procedure]
   744   C0872351:monolayers [Clinical Drug]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with 2.5ml of serum-free RPMI 1640and"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0229671:Serum [Body Substance]
   742   C0332296:free [Functional Concept]
   742   C1546774:Serum [Intellectual Product]
   742   C1550100:Serum [Body Substance]
   742   C1720725:Twice [Intellectual Product]
   742   C1880497:Free [Qualitative Concept]
   742   C1948050:Twice [Quantitative Concept]
   742   C1996904:Free [Qualitative Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "once with 2ml of Opti-MEM."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1720092:Once [Intellectual Product]
   753   C1948045:Once [Temporal Concept]
Processing 00000000.tx.89: To this monolayer the DNA/LipofectAMINE mix was added. 

Phrase: "To this monolayer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872351:monolayer [Clinical Drug]

Phrase: "the DNA/LipofectAMINE mix"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205430:Mix [Functional Concept]
   827   C1421951:MIX [Gene or Genome]
   827   C1720722:Mix [Qualitative Concept]

Phrase: "was"

Phrase: "added."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]
Processing 00000000.tx.90: The cells were incubated at 37C at 5% CO2 for 5h, after which 1ml of fresh medium with twice the concentration of serum was added. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 5% CO2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "for 5h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442467:5H [Temporal Concept]

Phrase: "after"

Phrase: "which 1ml of fresh medium"

Phrase: "with twice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720725:Twice [Intellectual Product]
  1000   C1948050:Twice [Quantitative Concept]

Phrase: "the concentration of serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0683149:concentration serum [Quantitative Concept]
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "added."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]
Processing 00000000.tx.91: The cells were grown for another 24h. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown for another 24h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456696:/24h [Temporal Concept]
   770   C1442770:24H [Temporal Concept]
Processing 00000000.tx.92: The cells were then made quiescent by incubation in serum free RPMI 1640for 48h. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "quiescent by incubation"

Phrase: "in serum free RPMI 1640for 48h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1442464:48H [Temporal Concept]
Processing 00000000.tx.93: BMP2 at a concentration of 250ng/ml was added for 30min before the addition of 10ng/ml PDGF for 12h. 

Phrase: "BMP2 at a concentration of 250ng/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1332424:BMP2 [Gene or Genome]

Phrase: "was"

Phrase: "added for 30min"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1524062:Added [Functional Concept]
   756 E C1883712:Add [Functional Concept]

Phrase: "before the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of 10ng/ml PDGF"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   901   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   858   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0005821:Platelet [Cell]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0220844:growth [Physiologic Function]
   799   C1441547:Derived [Qualitative Concept]
   799   C1521761:Factor [Functional Concept]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   799   C3245521:derived [Idea or Concept]
   716 E C1963076:Platelets [Finding]

Phrase: "for 12h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456695:/12h [Temporal Concept]
Processing 00000000.tx.94: The cells were lysed in extraction buffer, and the luciferase activity was determined using the dual luciferase assay kit according to the method provided by the manufacturer. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed in extraction buffer,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:lysed [Pathologic Function]
   770   C0185115:Extraction [Therapeutic or Preventive Procedure]
   770   C0684295:extraction [Laboratory Procedure]

Phrase: "and"

Phrase: "the luciferase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1151115:luciferase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the dual luciferase assay kit according to the method"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0812225:KIT [Medical Device]
   742   C1150635:KIT [Molecular Function]
   742   C1705212:Kit [Medical Device]
   742   C1705213:KIT [Medical Device]
   742   C3273202:Kit [Manufactured Object]

Phrase: "provided by the manufacturer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0947322:Manufacturer [Intellectual Product]
   770   C1705426:Manufacturer [Population Group]
   770   C1999230:Provided [Activity]
Processing 00000000.tx.95: Northern Analysis-- Total RNA was isolated from mesangial cells by guanidinium isothiocyanate lysis and centrifugation on cesium chloride gradients (32). 

Phrase: "Northern Analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "--"

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "isolated from mesangial cells"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   833   C0227651:Mesangial Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C0370215:Isolate [Substance]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "by guanidinium isothiocyanate lysis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0024348:Lysis [Pathologic Function]
   827   C1536403:lysis [Cell Function]
   755 E C0439680:Lytic [Qualitative Concept]

Phrase: "and"

Phrase: "centrifugation on cesium chloride gradients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.96: Total RNA was separated on formaldehyde-agarose gels and probed with fibronectin cDNA essentially as described (33). 

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "separated on formaldehyde-agarose gels"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C1706746:Agarose Gel [Research Device]
   760   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   760   C0017243:Gels [Biomedical or Dental Material]
   760   C0036681:Agarose [Carbohydrate]
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   726 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "probed with fibronectin cDNA essentially"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726   C0182400:Probe [Medical Device]
   726   C1704681:Probe [Gene or Genome]
   726   C2347609:Probe [Chemical Viewed Functionally]
   726   C3536729:Probe [Manufactured Object]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.97: Fibronectin cDNA was a kind gift of Dr. 

Phrase: "Fibronectin cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "a kind gift of Dr."
Processing 00000000.tx.98: Jeffrey Barnes. 

Phrase: "Jeffrey Barnes."
Processing 00000000.tx.99: Data Analysis-- Significance of the data was determined by unpaired Student's t test.  

Phrase: "Data Analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0010992:Data Analysis [Occupational Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1511726:Data [Idea or Concept]
   861   C1524024:analysis [Functional Concept]
   861   C3245479:data [Medical Device]

Phrase: "--"

Phrase: "Significance of the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237881:Significance [Quantitative Concept]
   770   C0750502:Significance [Idea or Concept]

Phrase: "was"

Phrase: "determined by unpaired Student's t test."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   820   C1710574:Unpaired t-Test [Intellectual Product]
   753   C0022885:Test [Laboratory Procedure]
   753   C0038492:student [Professional or Occupational Group]
   753   C0039593:Test [Functional Concept]
   753   C0392366:test [Intellectual Product]
   753   C1551041:student [Idea or Concept]
   753   C1552573:student [Intellectual Product]
   753   C2700112:Unpaired [Qualitative Concept]
Processing 00000000.tx.100: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES BMP2 Modulates PDGF-induced DNA Synthesis-- We and others (18, 19, 34) have shown previously that PDGF is a potent mitogen for mesangial cells in culture and that TGF- inhibits PDGF-induced DNA synthesis. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "Modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "PDGF-induced DNA Synthesis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C0598312:DNA Synthesis [Genetic Function]
   818   C1328870:DNA synthesis [Laboratory Procedure]
   818   C1817262:DNA synthesis [Genetic Function]
   795   C0220781:synthesis [Biologic Function]
   795   C1883254:Synthesis [Activity]
   710   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "-"

Phrase: "-"

Phrase: "We"

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "(18,"

Phrase: "19,"

Phrase: "34"

Phrase: ")"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "previously"

Phrase: "that PDGF"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "is"

Phrase: "a potent mitogen for mesangial cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0026249:Mitogen [Pharmacologic Substance]

Phrase: "in culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "that TGF-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "PDGF-induced DNA synthesis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C0598312:DNA Synthesis [Genetic Function]
   818   C1328870:DNA synthesis [Laboratory Procedure]
   818   C1817262:DNA synthesis [Genetic Function]
   795   C0220781:synthesis [Biologic Function]
   795   C1883254:Synthesis [Activity]
   710   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.101: BMP2 falls in the TGF- superfamily of proteins (3, 6). 

Phrase: "BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "falls in the TGF- superfamily of proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0085639:Fall [Finding]
   748   C0238715:Fall [Temporal Concept]
   748   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1883220:Superfamily [Conceptual Entity]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.102: To test the effect of BMP2 in mesangial cells, we first identified the receptor in these cells with total RNA as template in reverse transcriptase polymerase chain reaction using specific primers for BMP receptor type IA (data not shown). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the effect of BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "in mesangial cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0227651:Mesangial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "we first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "the receptor in these cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1514760:Receptor Cell [Cell]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "with total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "as template"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0728990:TEMPLATE [Medical Device]
  1000   C1514575:Template [Conceptual Entity]
  1000   C1705542:Template [Idea or Concept]

Phrase: "in reverse transcriptase polymerase chain reaction"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0599161:Reverse Transcriptase Polymerase Chain Reaction [Molecular Biology Research Technique]
   884   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   840   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0337112:Chain [Manufactured Object]
   804   C0443286:Reaction [Functional Concept]
   804   C1114821:Reaction [Clinical Attribute]
   804   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1524075:Chain [Idea or Concept]
   804   C1555029:Reverse [Idea or Concept]
   804   C2257077:transcriptase [Genetic Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "specific primers for BMP receptor type IA (data"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.103: We then studied the effect of different concentrations of BMP2 on PDGF-induced DNA synthesis. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the effect of different concentrations of BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on PDGF-induced DNA synthesis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C0598312:DNA Synthesis [Genetic Function]
   818   C1328870:DNA synthesis [Laboratory Procedure]
   818   C1817262:DNA synthesis [Genetic Function]
   795   C0220781:synthesis [Biologic Function]
   795   C1883254:Synthesis [Activity]
   710   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.104: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.105: 1, PDGF stimulates DNA synthesis in mesangial cells. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "PDGF"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "stimulates"

Phrase: "DNA synthesis in mesangial cells."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0598312:DNA Synthesis [Genetic Function]
   806   C1328870:DNA synthesis [Laboratory Procedure]
   806   C1817262:DNA synthesis [Genetic Function]
   762 E C0598279:synthetic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   762   C2936320:Synthetic Cells [Manufactured Object]
   760   C0220781:synthesis [Biologic Function]
   760   C1883254:Synthesis [Activity]
Processing 00000000.tx.106: Significant inhibition of DNA synthesis by BMP2 was observed at doses higher than 50ng/ml. 

Phrase: "Significant inhibition of DNA synthesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C1511701:DNA Synthesis Inhibition [Genetic Function]
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "by BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "was"

Phrase: "observed at doses"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0178602:Doses [Quantitative Concept]
   790   C1441672:Observed [Functional Concept]
   756 E C0869039:Dose [Quantitative Concept]
   756 E C1114758:Dose # [Clinical Attribute]
   756 E C1428722:DOS [Gene or Genome]

Phrase: "higher than 50ng/ml."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.107: 50% attenuation of PDGF-mediated DNA synthesis was obtained with 250ng/ml BMP2. 

Phrase: "50% attenuation of PDGF-mediated DNA synthesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0599946:Attenuation [Activity]

Phrase: "was"

Phrase: "obtained with 250ng/ml BMP2."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0439526:/mL [Quantitative Concept]
   760   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1301820:Obtained [Functional Concept]
   760   C1332424:BMP2 [Gene or Genome]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.108: No further inhibition was obtained even at a dose as high as 500ng/ml of BMP2. 

Phrase: "No further inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "was"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "even at a dose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0178602:Dose [Quantitative Concept]
   770   C0869039:Dose [Quantitative Concept]
   770   C1114758:Dose # [Clinical Attribute]

Phrase: "as high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "as 500ng/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "of BMP2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]
Processing 00000000.tx.109: View larger version (16K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.110: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.111: Effect of BMP2 on PDGF-induced DNA synthesis in human mesangial cells. 

Phrase: "Effect of BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on PDGF-induced DNA synthesis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C0598312:DNA Synthesis [Genetic Function]
   818   C1328870:DNA synthesis [Laboratory Procedure]
   818   C1817262:DNA synthesis [Genetic Function]
   795   C0220781:synthesis [Biologic Function]
   795   C1883254:Synthesis [Activity]
   710   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in human mesangial cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0427861:Human cells [Laboratory or Test Result]
   901   C0227651:Mesangial Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0086418:Human [Human]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755   C0017655:Mesangium [Body Part, Organ, or Organ Component]
Processing 00000000.tx.112: Serum-deprived mesangial cells were incubated with different concentration of BMP2 for 30min before addition of 10ng/ml PDGF BB. 

Phrase: "Serum-deprived mesangial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0227651:Mesangial Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "incubated with different concentration of BMP2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0086045:Concentration [Mental Process]
   753   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1332424:BMP2 [Gene or Genome]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1446561:Concentration [Quantitative Concept]
   753   C1705242:Different [Qualitative Concept]

Phrase: "for 30min"

Phrase: "before addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of 10ng/ml PDGF BB."
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   913   C0246681:platelet-derived growth factor BB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   877   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   845   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0004739:BB [Geographic Area]
   795   C0005821:Platelet [Cell]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0220844:growth [Physiologic Function]
   795   C0332297:BB [Spatial Concept]
   795   C1441547:Derived [Qualitative Concept]
   795   C1521761:Factor [Functional Concept]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]
   795   C3245521:derived [Idea or Concept]
   712 E C1963076:Platelets [Finding]
Processing 00000000.tx.113: [3H]Thymidine incorporation was measured as an index of DNA synthesis. 

Phrase: "[3H]Thymidine incorporation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0243126:incorporation [Functional Concept]

Phrase: "was"

Phrase: "measured as an index of DNA synthesis."
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   778   C0598312:DNA Synthesis [Genetic Function]
   778   C1328870:DNA synthesis [Laboratory Procedure]
   778   C1817262:DNA synthesis [Genetic Function]
   774   C0032246:DNA index [Quantitative Concept]
   774   C2919020:DNA Index [Intellectual Product]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0220781:synthesis [Biologic Function]
   748   C0444706:Measured [Qualitative Concept]
   748   C0918012:Index [Intellectual Product]
   748   C1552854:index [Idea or Concept]
   748   C1637833:% index [Quantitative Concept]
   748   C1883254:Synthesis [Activity]
   748   C3541902:MEASURED [Diagnostic Procedure]
   738 E C0598279:synthetic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.114: Results are meanS.E. of three independent experiments, each done in triplicate. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "meanS.E."

Phrase: "of three independent experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "each"

Phrase: "done in triplicate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205174:Triplicate [Quantitative Concept]
   790   C1272695:Done [Qualitative Concept]
   790   C2746065:Done [Temporal Concept]
Processing 00000000.tx.115: *, p<0.05versus PDGF-untreated cells. 

Phrase: "*,"

Phrase: "p<0.05versus PDGF-untreated cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   874   C1179870:P cell [Cell]
   813   C0007595:growth cell [Cell Function]
   791   C0007634:Cells [Cell]
   791   C3282337:Cells [Cell]
   758 E C1269647:Cell [Cell]
   758 E C1704653:Cell [Medical Device]
   758 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.116: @, p<0.05versus PDGF-treated, but BMP2-untreated, cells. 

Phrase: "@,"

Phrase: "p<0.05versus PDGF-treated,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C0332293:treated [Therapeutic or Preventive Procedure]
   793   C1522326:Treated [Functional Concept]
   760 E C1292734:TREAT [Functional Concept]

Phrase: "but"

Phrase: "BMP2-untreated, cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.117: Effect of BMP2 on PDGFR and MAPK Activation-- PDGF exerts its biological effects by stimulating the tyrosine kinase activity of its receptor. 

Phrase: "Effect of BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on PDGFR"

Phrase: "and"

Phrase: "MAPK Activation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C1819041:protein kinase activation [Cell Function]
   853   C0599177:protein activation [Genetic Function]
   804   C1879547:Activation [Activity]
   771   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]

Phrase: "--"

Phrase: "PDGF"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "exerts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "its biological effects by stimulating"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0005532:Biological [Biomedical Occupation or Discipline]
   760   C0205460:biological [Qualitative Concept]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "the tyrosine kinase activity of its receptor."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   804   C0072482:Tyrosine Kinase Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   804   C0206364:Receptor Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   804   C0919487:TYROSINE KINASE RECEPTOR [Gene or Genome]
   778   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1150423:kinase activity [Molecular Function]
   774   C0255618:tyrosine receptor [Amino Acid, Peptide, or Protein,Receptor]
   774   C1152633:receptor activity [Molecular Function]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.118: We have shown recently that inhibition of PDGFR tyrosine kinase activity blocks PDGF-induced DNA synthesis in mesangial cells (31). 

Phrase: "We"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "that inhibition of PDGFR tyrosine kinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   835   C2247121:inhibition of kinase activity [Molecular Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "PDGF-induced DNA synthesis in mesangial cells"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   777   C0016026:DNA Synthesis Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0598312:DNA Synthesis [Genetic Function]
   760   C1328870:DNA synthesis [Laboratory Procedure]
   760   C1817262:DNA synthesis [Genetic Function]
   739   C0220781:synthesis [Biologic Function]
   739   C1883254:Synthesis [Activity]
   722 E C0598279:synthetic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   722   C2936320:Synthetic Cells [Manufactured Object]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.119: Thus the inhibitory effect of BMP2 on PDGF-induced DNA synthesis (Fig. 1) may result from inhibition of tyrosine kinase activity of PDGFR. 

Phrase: "Thus"

Phrase: "the inhibitory effect of BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on PDGF-induced DNA synthesis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C0598312:DNA Synthesis [Genetic Function]
   818   C1328870:DNA synthesis [Laboratory Procedure]
   818   C1817262:DNA synthesis [Genetic Function]
   795   C0220781:synthesis [Biologic Function]
   795   C1883254:Synthesis [Activity]
   710   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "may"

Phrase: "result from inhibition of tyrosine kinase activity of PDGFR."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   807   C2247121:inhibition of kinase activity [Molecular Function]
   764   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C1150423:kinase activity [Molecular Function]
   762   C1150632:PDGFR activity [Molecular Function]
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1274040:Result [Functional Concept]
   742   C1546471:Result [Idea or Concept]
   742   C1561536:*Activity [Idea or Concept]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C2825142:Result [Finding]
   742   C3463820:Inhibition [Activity]
Processing 00000000.tx.120: To test the effect of BMP2 on PDGFR tyrosine kinase activity, we treated mesangial cells with BMP2 followed by stimulation with PDGF. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the effect of BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on PDGFR tyrosine kinase activity,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   902   C1150632:PDGFR activity [Molecular Function]
   861   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1150423:kinase activity [Molecular Function]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "we"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "mesangial cells with BMP2"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0227651:Mesangial Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "followed by stimulation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   790   C1948023:Stimulation [Natural Phenomenon or Process]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with PDGF."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]
Processing 00000000.tx.121: The cell lysate was immunoprecipitated with PDGFR antibody and the receptor-associated tyrosine kinase activity was measured by immune-complex kinase assay. 

Phrase: "The cell lysate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "was"

Phrase: "immunoprecipitated with PDGFR antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   737   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "the receptor-associated tyrosine kinase activity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   897   C1152633:receptor activity [Molecular Function]
   888   C0206364:Receptor Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   840   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C1150423:kinase activity [Molecular Function]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured by immune-complex kinase assay."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   820   C1261356:Immune complex assay [Laboratory Procedure]
   790   C0003313:Immune complex [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0243073:assay [Qualitative Concept]
   753   C0439662:Immune [Functional Concept]
   753   C0439855:Complex [Qualitative Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]
   753   C1704241:Complex [Chemical Viewed Structurally]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.122: The results show that PDGF stimulates PDGFR-associated tyrosine kinase activity (Fig. 2, compare lane 2with lane 1), and incubation of mesangial cells with BMP2 and PDGF does not inhibit PDGF-induced intrinsic tyrosine kinase activity of the PDGFR (Fig. 2, compare lane 4with lane 2). 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that PDGF"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "stimulates"

Phrase: "PDGFR-associated tyrosine kinase activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   897   C1150632:PDGFR activity [Molecular Function]
   840   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C1150423:kinase activity [Molecular Function]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "lane 2with lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "incubation of mesangial cells"

Phrase: "with BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "and"

Phrase: "PDGF"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "PDGF-induced intrinsic tyrosine kinase activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   871   C1149472:growth factor activity [Molecular Function]
   807   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   807   C1150423:kinase activity [Molecular Function]
   791   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   791   C0205177:Activity [Functional Concept]
   791   C0439167:% activity [Quantitative Concept]
   791   C0441655:Activity [Activity]
   791   C1561536:*Activity [Idea or Concept]

Phrase: "of the PDGFR (Fig. 2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0290067:PDGFR-2 [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   827   C0349966:Fig [Food]
   827   C1337208:FIG [Food]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "lane 4with lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.123: These data indicate that BMP2 does not modulate PDGF function at the level of receptor autophosphorylation but may alter downstream signaling molecule(s) of the PDGFR kinase cascade. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "PDGF function at the level of receptor autophosphorylation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   772   C0935587:Level of function [Qualitative Concept]
           function level
   754   C0920267:Platelet Function [Laboratory Procedure]
   754   C0920644:function receptor [Molecular Function]
   754   C1254881:Platelet function [Cell Function]
   738   C0031843:function [Physiologic Function]
   738   C0542341:Function [Functional Concept]
   738   C0700205:FUNCTION [Classification]
   738   C1705273:Function [Intellectual Product]

Phrase: "but"

Phrase: "may"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "downstream signaling molecule"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1519315:Signaling Molecule [Biologically Active Substance]
   827   C0567416:Molecule [Substance]
   755 E C1521991:Molecular [Qualitative Concept]

Phrase: "("

Phrase: "s) of the PDGFR kinase cascade."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1707310:Cascade [Manufactured Object]
   753   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.124: View larger version (39K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(39K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.125: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.126: Effect of BMP2 on PDGFR activation. 

Phrase: "Effect of BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on PDGFR activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]
Processing 00000000.tx.127: Serum-deprived mesangial cells were treated with 250ng/ml BMP2 for 30min before addition of 10ng/ml PDGF for 5min. 

Phrase: "Serum-deprived mesangial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0227651:Mesangial Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "treated with 250ng/ml BMP2"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0439526:/mL [Quantitative Concept]
   760   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1332424:BMP2 [Gene or Genome]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "for 30min"

Phrase: "before addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of 10ng/ml PDGF"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   901   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   858   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0005821:Platelet [Cell]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0220844:growth [Physiologic Function]
   799   C1441547:Derived [Qualitative Concept]
   799   C1521761:Factor [Functional Concept]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   799   C3245521:derived [Idea or Concept]
   716 E C1963076:Platelets [Finding]

Phrase: "for 5min."
Processing 00000000.tx.128: Equal amounts of lysates were immunoprecipitated with PDGFR-specific antibody, and the immunoprecipitates were used in immune complex kinase assay as described under "Experimental Procedures." 

Phrase: "Equal amounts of lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "immunoprecipitated with PDGFR-specific antibody,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "the immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "used in immune complex kinase assay"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   820   C1261356:Immune complex assay [Laboratory Procedure]
   790   C0003313:Immune complex [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0243073:assay [Qualitative Concept]
   753   C0439662:Immune [Functional Concept]
   753   C0439855:Complex [Qualitative Concept]
   753   C1273517:used [Finding]
   753   C1510438:Assay [Laboratory Procedure]
   753   C1704241:Complex [Chemical Viewed Structurally]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.129: The numbers in the left margin indicate molecular mass markers in kilodaltons. 

Phrase: "The numbers in the left margin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "indicate"

Phrase: "molecular mass markers in kilodaltons."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0005516:molecular markers [Clinical Attribute]
           Marker
Processing 00000000.tx.130: We have shown recently that PDGF increases MAPK activity in mesangial cells. 

Phrase: "We"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "that PDGF"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "MAPK activity in mesangial cells."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   869   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   800   C1150527:protein kinase activity [Molecular Function]
   781 E C2261495:protein phosphokinase activity [Molecular Function]
   770   C1150423:kinase activity [Molecular Function]
   767   C1537044:protein activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]
   731   C1752930:mitogenic activity [Cell Function]
Processing 00000000.tx.131: Activation of this kinase cascade is essential for many mitogens, including PDGF (23, 27). 

Phrase: "Activation of this kinase cascade"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "essential for many mitogens,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "PDGF"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.132: To test if the inhibitory effect of BMP2 on PDGF-induced DNA synthesis is via modulation of MAPK activity, we measured the activity of MAPK in MAPK immunoprecipitates after BMP2 and PDGF treatment of mesangial cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "if"

Phrase: "the inhibitory effect of BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on PDGF-induced DNA synthesis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C0598312:DNA Synthesis [Genetic Function]
   818   C1328870:DNA synthesis [Laboratory Procedure]
   818   C1817262:DNA synthesis [Genetic Function]
   795   C0220781:synthesis [Biologic Function]
   795   C1883254:Synthesis [Activity]
   710   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is via modulation of MAPK activity,"
Meta Candidates (Total=21; Excluded=2; Pruned=0; Remaining=19)
   849   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   818   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1150527:protein kinase activity [Molecular Function]
   790   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   771 E C2261495:protein phosphokinase activity [Molecular Function]
   764   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   764   C1150423:kinase activity [Molecular Function]
   762   C1537044:protein activity [Molecular Function]
   742   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0026249:Mitogen [Pharmacologic Substance]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C0443264:Modulation [Spatial Concept]
   742   C1561536:*Activity [Idea or Concept]
   742   C1879547:Activated [Activity]
   726   C1752930:mitogenic activity [Cell Function]
   708 E C1515877:Activate [Functional Concept]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the activity of MAPK"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   879   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   804   C1150527:protein kinase activity [Molecular Function]
   786 E C2261495:protein phosphokinase activity [Molecular Function]
   774   C1150423:kinase activity [Molecular Function]
   774   C1537044:protein activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
   738   C1752930:mitogenic activity [Cell Function]

Phrase: "in MAPK"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "immunoprecipitates after BMP2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0301871:Immunoprecipitate [Immunologic Factor]
   790   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1332424:BMP2 [Gene or Genome]

Phrase: "and"

Phrase: "PDGF treatment of mesangial cells."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0679853:factor treatment [Intellectual Product]
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.133: BMP2 significantly inhibited MAPK activity stimulated by PDGF (Fig. 3A). 

Phrase: "BMP2 significantly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1332424:BMP2 [Gene or Genome]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "MAPK activity"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   884   C1150527:protein kinase activity [Molecular Function]
   865 E C2261495:protein phosphokinase activity [Molecular Function]
   862   C1752930:mitogenic activity [Cell Function]
   853   C1537044:protein activity [Molecular Function]
   840   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]

Phrase: "stimulated by PDGF"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   882   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   753   C0005821:Platelet [Cell]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1441547:Derived [Qualitative Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C1948023:Stimulated [Natural Phenomenon or Process]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   753   C3245521:derived [Idea or Concept]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.134: Quantitation of these data revealed that BMP2 caused approximately 60% inhibition of PDGF-induced MAPK activity (Fig. 3B). 

Phrase: "Quantitation of these data"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantitation [Quantitative Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "approximately 60% inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of PDGF-induced MAPK activity"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   872   C1149472:growth factor activity [Molecular Function]
   861   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   821   C1150527:protein kinase activity [Molecular Function]
   813   C1537044:protein activity [Molecular Function]
   804   C1150423:kinase activity [Molecular Function]
   802 E C2261495:protein phosphokinase activity [Molecular Function]
   799   C1752930:mitogenic activity [Cell Function]
   790   C0205177:Activity [Functional Concept]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.135: These data suggest that BMP2-mediated inhibition of PDGF-induced DNA synthesis may also result from attenuation of MAPK activity. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that BMP2-mediated inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of PDGF-induced DNA synthesis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C0598312:DNA Synthesis [Genetic Function]
   818   C1328870:DNA synthesis [Laboratory Procedure]
   818   C1817262:DNA synthesis [Genetic Function]
   795   C0220781:synthesis [Biologic Function]
   795   C1883254:Synthesis [Activity]
   710   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "also"

Phrase: "result from attenuation of MAPK activity."
Meta Candidates (Total=24; Excluded=2; Pruned=0; Remaining=22)
   849   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   818   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1150527:protein kinase activity [Molecular Function]
   790   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   771 E C2261495:protein phosphokinase activity [Molecular Function]
   764   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   764   C1150423:kinase activity [Molecular Function]
   762   C1537044:protein activity [Molecular Function]
   742   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0026249:Mitogen [Pharmacologic Substance]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C0599946:Attenuation [Activity]
   742   C1274040:Result [Functional Concept]
   742   C1546471:Result [Idea or Concept]
   742   C1561536:*Activity [Idea or Concept]
   742   C1879547:Activated [Activity]
   742   C2825142:Result [Finding]
   726   C1752930:mitogenic activity [Cell Function]
   708 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.136: View larger version (18K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.137: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.138: Effect of BMP2 on PDGF-induced MAPK activity. 

Phrase: "Effect of BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on PDGF-induced MAPK activity."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   872   C1149472:growth factor activity [Molecular Function]
   861   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   821   C1150527:protein kinase activity [Molecular Function]
   813   C1537044:protein activity [Molecular Function]
   804   C1150423:kinase activity [Molecular Function]
   802 E C2261495:protein phosphokinase activity [Molecular Function]
   799   C1752930:mitogenic activity [Cell Function]
   790   C0205177:Activity [Functional Concept]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.139: A, serum-deprived mesangial cells were incubated with BMP2 for 30min. 

Phrase: "A,"

Phrase: "serum-deprived mesangial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0227651:Mesangial Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "incubated with BMP2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1332424:BMP2 [Gene or Genome]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 30min."
Processing 00000000.tx.140: The cells were treated with PDGF for 5min. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with PDGF"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   882   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   783   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   753   C0005821:Platelet [Cell]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1441547:Derived [Qualitative Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1522326:Treated [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   753   C3245521:derived [Idea or Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "for 5min."
Processing 00000000.tx.141: 100g of cell lysate was immunoprecipitated with MAPK-specific antibody, and the immunoprecipitates were used in an in vitro MAPK assay in the presence of MBP as substrate and [-32P]ATP. 

Phrase: "100g of cell lysate"

Phrase: "was"

Phrase: "immunoprecipitated with MAPK-specific antibody,"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   833   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   770   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0026249:Mitogen [Pharmacologic Substance]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205369:Specific [Qualitative Concept]
   744   C1552740:specific [Intellectual Product]
   744   C1879547:Activated [Activity]
   711   C0301871:Immunoprecipitate [Immunologic Factor]
   711 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "the immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "used in an in vitro MAPK assay"
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   806   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   782   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   775   C1515653:In Vitro Assay [Research Activity]
   760   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   757   C0021135:In Vitro [Intellectual Product]
   757   C1533691:in vitro [Qualitative Concept]
           vitro
   757   C2827718:In Vitro [Functional Concept]
   739   C0005507:Assay [Laboratory Procedure]
   739   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0026249:Mitogen [Pharmacologic Substance]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0243073:assay [Qualitative Concept]
   739   C1273517:used [Finding]
   739   C1510438:Assay [Laboratory Procedure]
   739   C1879547:Activated [Activity]
   706 E C0042153:use [Functional Concept]
   706 E C0457083:Use [Functional Concept]
   706 E C1515877:Activate [Functional Concept]
   706 E C1947944:Use [Intellectual Product]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of MBP"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   923   C0014063:Myelin Basic Protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   923   C1417057:MYELIN BASIC PROTEIN [Gene or Genome]
   875   C0026972:Myelin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026969:Myelin [Tissue]
   812   C0026973:Myelin [Cell Component]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1527178:Basic [Functional Concept]
   741 E C0920750:basicity [Quantitative Concept]

Phrase: "as substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "and [-"

Phrase: "32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]ATP."
Processing 00000000.tx.142: Phosphorylated MBP was separated on a 15% SDS gel. 

Phrase: "Phosphorylated MBP"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   884   C0014063:Myelin Basic Protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   884   C1417057:MYELIN BASIC PROTEIN [Gene or Genome]
   853   C0026972:Myelin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026969:Myelin [Tissue]
   804   C0026973:Myelin [Cell Component]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1527178:Basic [Functional Concept]
   733 E C0920750:basicity [Quantitative Concept]

Phrase: "was"

Phrase: "separated on a 15% SDS gel."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0086972:Separated [Finding]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]
   753   C1382104:Gel [Substance]
Processing 00000000.tx.143: Molecular mass markers are shown in kilodaltons in the left margin. 

Phrase: "Molecular mass markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C3152252:Molecular Mass [Quantitative Concept]

Phrase: "are"

Phrase: "shown in kilodaltons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1532717:Kilodalton [Quantitative Concept]
   756   C1547282:Show [Intellectual Product]

Phrase: "in the left margin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0205284:Margin [Spatial Concept]
   861   C0229985:margin [Body Part, Organ, or Organ Component]
   861   C1269830:Margin [Finding]
   789 E C1550517:marginal [Idea or Concept]
   789 E C1947914:Marginal [Qualitative Concept]
Processing 00000000.tx.144: The bottom panel shows the immunoblot analysis of cell lysates with MAPK antibody. 

Phrase: "The bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the immunoblot analysis of cell lysates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "with MAPK antibody."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   771   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.145: B, scanning densitometry of A. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "scanning"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0034606:Scanning [Diagnostic Procedure]
  1000   C0441633:Scanning [Diagnostic Procedure]
   966 E C2826292:SCAN [Finding]

Phrase: "densitometry of A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0011321:Densitometry [Laboratory Procedure]
Processing 00000000.tx.146: Phosphorylated MBP bands were scanned in two dimensions, and the density was corrected for the background present in the lane. 

Phrase: "Phosphorylated MBP bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0175723:Bands [Medical Device]
   766 E C0439645:Band [Spatial Concept]
   766 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "scanned in two dimensions,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205448:Two [Quantitative Concept]
   770   C0439534:Dimensions [Quantitative Concept]
   770   C0441633:scanned [Diagnostic Procedure]
   737 E C0034606:Scan [Diagnostic Procedure]
   737 E C2826292:SCAN [Finding]

Phrase: "and"

Phrase: "the density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:density [Quantitative Concept]
   928 E C0439794:Dense [Qualitative Concept]

Phrase: "was"

Phrase: "corrected for the background present"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   844   C3176809:corrected for background [Qualitative Concept]
   760   C0150312:Present [Quantitative Concept]
   760   C0205202:Corrected [Qualitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C1706907:Background [Conceptual Entity]
   726 E C2349182:Correct [Qualitative Concept]

Phrase: "in the lane."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]
Processing 00000000.tx.147: Data represent corrected densities and are expressed as arbitrary units. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "corrected densities"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0178587:densities [Quantitative Concept]
   777 E C0439794:Dense [Qualitative Concept]

Phrase: "and"

Phrase: "are"

Phrase: "expressed as arbitrary units."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   799   C0439183:Arbitrary unit [Quantitative Concept]
   770   C0439148:Units [Quantitative Concept]
   770   C1264693:*Arbitrary [Quantitative Concept]
   770   C1519795:Units [Quantitative Concept]
   737 E C1704753:Unit [Manufactured Object]
   737 E C1880519:Unit [Quantitative Concept]
Processing 00000000.tx.148: TGF-, another member of this family, is known to inhibit DNA synthesis in a variety of cells, including mesangial cells (34). 

Phrase: "TGF-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "another member of this family,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0086282:Family member [Family Group]
   797   C1611821:Family Member [Intellectual Product]
   760   C0680022:member [Population Group]
   760   C2698041:Member [Professional or Occupational Group]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "DNA synthesis in a variety of cells,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0598312:DNA Synthesis [Genetic Function]
   778   C1328870:DNA synthesis [Laboratory Procedure]
   778   C1817262:DNA synthesis [Genetic Function]
   748   C0220781:synthesis [Biologic Function]
   748   C1883254:Synthesis [Activity]
   738 E C0598279:synthetic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   738   C2936320:Synthetic Cells [Manufactured Object]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "mesangial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0227651:Mesangial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.149: Since we demonstrated in Fig. 

Phrase: "Since"

Phrase: "we"

Phrase: "demonstrated in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.150: 3 that one of the mechanism of BMP2-induced inhibition of DNA synthesis may involve inhibition of MAPK, we studied the effect of TGF- on PDGF-induced MAPK activity. 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "that one of the mechanism of BMP2-induced inhibition of DNA synthesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0205447:One [Quantitative Concept]

Phrase: "may"

Phrase: "involve"

Phrase: "inhibition of MAPK,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]
   716   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the effect of TGF-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on PDGF-induced MAPK activity."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   872   C1149472:growth factor activity [Molecular Function]
   861   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   821   C1150527:protein kinase activity [Molecular Function]
   813   C1537044:protein activity [Molecular Function]
   804   C1150423:kinase activity [Molecular Function]
   802 E C2261495:protein phosphokinase activity [Molecular Function]
   799   C1752930:mitogenic activity [Cell Function]
   790   C0205177:Activity [Functional Concept]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.151: Mesangial cells were treated with TGF- and PDGF. 

Phrase: "Mesangial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0227651:Mesangial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "treated with TGF-"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1522326:Treated [Functional Concept]
   790   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "PDGF."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]
Processing 00000000.tx.152: MAPK was immunoprecipitated from the cell lysate, and its activity was assayed. 

Phrase: "MAPK"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "was"

Phrase: "immunoprecipitated from the cell lysate,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1881488:Cell Lysate [Physical Object]
           Lysate
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "its activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "assayed."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.153: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.154: 4, similar to BMP2, TGF- also inhibited PDGF-induced MAPK activity in mesangial cells. 

Phrase: "4,"

Phrase: "similar to BMP2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "TGF- also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "PDGF-induced MAPK activity"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   872   C1149472:growth factor activity [Molecular Function]
   861   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   821   C1150527:protein kinase activity [Molecular Function]
   813   C1537044:protein activity [Molecular Function]
   804   C1150423:kinase activity [Molecular Function]
   802 E C2261495:protein phosphokinase activity [Molecular Function]
   799   C1752930:mitogenic activity [Cell Function]
   790   C0205177:Activity [Functional Concept]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1561536:*Activity [Idea or Concept]

Phrase: "in mesangial cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0227651:Mesangial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789   C0017655:Mesangium [Body Part, Organ, or Organ Component]
Processing 00000000.tx.155: Therefore, TGF- intercepts an early signal transduction pathway to elicit its inhibitory effect on DNA synthesis. 

Phrase: "Therefore,"

Phrase: "TGF-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "intercepts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0598981:Intercept [Organic Chemical,Pharmacologic Substance]
  1000   C3146232:Intercept [Quantitative Concept]

Phrase: "an early signal transduction pathway to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0086982:Signal Transduction Pathway [Molecular Function]
   853   C0037080:Signal Pathway [Molecular Function]
   840   C0037083:Signal Transduction [Cell Function]
   804   C1160185:transduction [Organism Function]
   804   C1704259:Pathway [Molecular Function]
   804   C1705987:Pathway [Conceptual Entity]
   804   C1710082:Signal [Phenomenon or Process]

Phrase: "elicit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "its inhibitory effect on DNA synthesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.156: View larger version (46K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(46K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.157: 4.  

Phrase: "4."
Processing 00000000.tx.158: Effect of TGF- on PDGF-induced MAPK activity. 

Phrase: "Effect of TGF-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on PDGF-induced MAPK activity."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   872   C1149472:growth factor activity [Molecular Function]
   861   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   821   C1150527:protein kinase activity [Molecular Function]
   813   C1537044:protein activity [Molecular Function]
   804   C1150423:kinase activity [Molecular Function]
   802 E C2261495:protein phosphokinase activity [Molecular Function]
   799   C1752930:mitogenic activity [Cell Function]
   790   C0205177:Activity [Functional Concept]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.159: Serum-deprived mesangial cells were incubated with 2ng/ml TGF-1 for 30min followed by stimulation with 10ng/ml PDGF for 5min. 

Phrase: "Serum-deprived mesangial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0227651:Mesangial Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "incubated with 2ng/ml TGF-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439526:/mL [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "for 30min"

Phrase: "followed by stimulation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   790   C1948023:Stimulation [Natural Phenomenon or Process]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with 10ng/ml PDGF"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   901   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   858   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0005821:Platelet [Cell]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0220844:growth [Physiologic Function]
   799   C1441547:Derived [Qualitative Concept]
   799   C1521761:Factor [Functional Concept]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   799   C3245521:derived [Idea or Concept]
   716 E C1963076:Platelets [Finding]

Phrase: "for 5min."
Processing 00000000.tx.160: MAPK was immunoprecipitated and assayed by immune complex kinase assay using MBP as substrate as described in the legend to Fig. 

Phrase: "MAPK"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "was"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "assayed by immune complex kinase assay"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   804   C1261356:Immune complex assay [Laboratory Procedure]
   790   C0003313:Immune complex [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0439662:Immune [Functional Concept]
   753   C0439855:Complex [Qualitative Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]
   719   C0005507:Assay [Laboratory Procedure]
   719   C0243073:assay [Qualitative Concept]
   719   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "MBP as substrate"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0014063:Myelin Basic Protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   833   C1417057:MYELIN BASIC PROTEIN [Gene or Genome]
   783   C0026972:Myelin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0026969:Myelin [Tissue]
   753   C0026973:Myelin [Cell Component]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1527178:Basic [Functional Concept]

Phrase: "as"

Phrase: "described in the legend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   770   C2729544:Legend [Pharmacologic Substance]

Phrase: "to Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.161: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.162: Molecular mass markers are shown in kilodaltons in the left margin. 

Phrase: "Molecular mass markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C3152252:Molecular Mass [Quantitative Concept]

Phrase: "are"

Phrase: "shown in kilodaltons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1532717:Kilodalton [Quantitative Concept]
   756   C1547282:Show [Intellectual Product]

Phrase: "in the left margin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0205284:Margin [Spatial Concept]
   861   C0229985:margin [Body Part, Organ, or Organ Component]
   861   C1269830:Margin [Finding]
   789 E C1550517:marginal [Idea or Concept]
   789 E C1947914:Marginal [Qualitative Concept]
Processing 00000000.tx.163: The bottom panel shows the immunoblot analysis of cell lysates with MAPK antibody. 

Phrase: "The bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the immunoblot analysis of cell lysates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "with MAPK antibody."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   771   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.164: BMP2 Inhibits MAPK-mediated Transcription-- Activation of MAPK stimulates transcription of a variety of target genes that are necessary for the mitogenic effect of growth factors (23, 24). 

Phrase: "BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "Inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "MAPK-mediated Transcription"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0040649:Transcription [Genetic Function]
   734   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "--"

Phrase: "Activation of MAPK"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C1819041:protein kinase activation [Cell Function]
   783   C0599177:protein activation [Genetic Function]
   753   C1879547:Activation [Activity]
   716   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "stimulates"

Phrase: "transcription of a variety of target genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0040649:genes transcription [Genetic Function]
           Transcription

Phrase: "that"

Phrase: "are"

Phrase: "necessary for the mitogenic effect of growth factors"

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.165: Part of this transcriptional activation is mediated by direct phosphorylation of certain substrate transcription factor(s) by MAPK. 

Phrase: "Part of this transcriptional activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1292711:Part of [Spatial Concept]
   760   C0449719:Part [Spatial Concept]
   760   C1709471:Part [Quantitative Concept]

Phrase: "is"

Phrase: "mediated by direct phosphorylation of certain substrate transcription factor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0031715:Phosphorylation [Molecular Function]
   742   C0040649:Transcription [Genetic Function]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C0439851:Direct [Qualitative Concept]
   742   C1158886:Phosphorylation [Molecular Function]
   742   C1521761:Factor [Functional Concept]
   742   C1710236:Substrate [Manufactured Object]
   742   C1947931:Direct [Qualitative Concept]
   742   C2827422:Factor [Conceptual Entity]

Phrase: "("

Phrase: "s) by MAPK."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   882   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   790   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   783   C0072393:Protein S [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1418948:PROTEIN S [Gene or Genome]
   753   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0026249:Mitogen [Pharmacologic Substance]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1879547:Activated [Activity]
   753   C2603362:S' [Clinical Attribute]
   719 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.166: One target protein of MAPK is the ternary complex factor Elk-1. 

Phrase: "One target protein of MAPK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "the ternary complex factor Elk-1."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C1705455:ELK-1 [Gene or Genome]
   804   C0325228:Elk [Mammal]
   804   C0439855:Complex [Qualitative Concept]
   804   C1521761:Factor [Functional Concept]
   804   C1704241:Complex [Chemical Viewed Structurally]
   804   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.167: Elk-1 belongs to a subgroup of ETS domain family of transcription factors (35). 

Phrase: "Elk-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705455:ELK-1 [Gene or Genome]
   861   C0325228:Elk [Mammal]

Phrase: "belongs to a subgroup of ETS domain family of transcription factors"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   779   C0919488:ETS-Domain Transcription Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   772   C0072461:ets Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1512142:ETS Domain [Amino Acid Sequence]
   738   C0015576:Family [Family Group]
   738   C0040649:Transcription [Genetic Function]
   738   C1079230:subgroup [Virus]
   738   C1515021:Subgroup [Classification]
   738   C1704727:Family [Conceptual Entity]
   738   C1880389:Domain [Functional Concept]
   738   C1883221:Domain [Conceptual Entity]
   738   C3541951:Domain [Intellectual Product]
   737   C0960756:factor A [Organic Chemical]
   704   C1521761:Factor [Functional Concept]
   704   C2827422:Factor [Conceptual Entity]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.168: Addition of mitogens to cells stimulates serine phosphorylation of the C-terminal domain of Elk-1 by MAPK. 

Phrase: "Addition of mitogens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1883712:Addition [Functional Concept]
   718 E C1524062:Additional [Functional Concept]

Phrase: "to cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "stimulates"

Phrase: "serine phosphorylation of the C-terminal domain of Elk-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0031715:Phosphorylation [Molecular Function]
   739   C1158886:Phosphorylation [Molecular Function]

Phrase: "by MAPK."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.169: This phosphorylation of Elk-1 is necessary for its ability to transactivate target genes (36, 37). 

Phrase: "This phosphorylation of Elk-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "necessary for its ability to"

Phrase: "transactivate"

Phrase: "target genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1332838:Target Gene [Gene or Genome]
   861   C0017337:Genes [Gene or Genome]

Phrase: "(36,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.170: To test whether the regulation of MAPK by BMP2 in mesangial cells results in Elk-1-mediated transcriptional activation, we performed cotransfection assays with an expression vector encoding the Elk-1 C-terminal transactivation domain fused to the GAL4 DNA binding domain and a reporter plasmid under the control of GAL4 DNA element. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "the regulation of MAPK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "by BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "in mesangial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0227651:Mesangial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "results in Elk-1-mediated transcriptional activation,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0162493:Transcriptional Activation [Genetic Function]
   778   C1705455:ELK-1 [Gene or Genome]
   748   C0040649:Transcriptional [Genetic Function]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0325228:Elk [Mammal]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1879547:Activation [Activity]
   748   C2825142:Result [Finding]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "cotransfection assays with an expression vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0005507:Assay [Laboratory Procedure]
   719   C0243073:assay [Qualitative Concept]
   719   C1510438:Assay [Laboratory Procedure]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the Elk-1 C-terminal transactivation domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0040624:Transactivation [Genetic Function]
   799   C1880389:Domain [Functional Concept]
   799   C1883221:Domain [Conceptual Entity]
   799   C3541951:Domain [Intellectual Product]

Phrase: "fused to the GAL4 DNA binding domain"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   814   C1511662:DNA Binding Domain [Amino Acid Sequence]
   778   C1148673:DNA Binding [Genetic Function]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0243122:binding [Functional Concept]
   748   C0699952:Fused [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1416832:GAL4 [Gene or Genome]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]
   714 E C1414861:FUSE [Gene or Genome]
   714 E C1708111:Fuse [Manufactured Object]

Phrase: "and"

Phrase: "a reporter plasmid under the control of GAL4 DNA element."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.171: This is a sensitive assay for Elk-1 phosphorylation and activation. 

Phrase: "This"

Phrase: "is"

Phrase: "a sensitive assay for Elk-1 phosphorylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0005507:Assay [Laboratory Procedure]
   748   C0243073:assay [Qualitative Concept]
   748   C0332324:Sensitive [Functional Concept]
   748   C1510438:Assay [Laboratory Procedure]
   748   C1550474:sensitive [Idea or Concept]

Phrase: "and"

Phrase: "activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]
Processing 00000000.tx.172: As expected, PDGF increases GAL4-dependent reporter gene expression in mesangial cells transfected with GAL4-ElK-1 fusion plasmid, suggesting activation of Elk-1 transcription factor (Fig. 5A). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "PDGF"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "GAL4-dependent reporter gene expression in mesangial cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0017262:Gene Expression [Genetic Function]
   770   C0206414:Reporter Gene [Gene or Genome]
   750   C1861886:CELL Gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "transfected with GAL4-ElK-1 fusion plasmid,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1705455:ELK-1 [Gene or Genome]
   748   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0325228:Elk [Mammal]
   748   C0332466:Fusion [Functional Concept]
   748   C1293131:Fusion [Therapeutic or Preventive Procedure]
   748   C1416832:GAL4 [Gene or Genome]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "activation of Elk-1 transcription factor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0162493:Transcription Activation [Genetic Function]
   753   C1879547:Activation [Activity]
   716   C0209089:Elk-1 Transcription Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.173: Prior exposure of mesangial cells to BMP2 inhibited PDGF-induced reporter gene expression in the Elk-1-dependent promoter. 

Phrase: "Prior exposure of mesangial cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0274281:Exposure, NOS [Injury or Poisoning]
   760   C0332157:Exposure [Clinical Attribute]

Phrase: "to BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "PDGF-induced reporter gene expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   855   C0812325:Growth Factor Gene [Gene or Genome]
   812   C0017262:Gene Expression [Genetic Function]
   812   C0206414:Reporter Gene [Gene or Genome]
   793   C0017337:Gene [Gene or Genome]
   793   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the Elk-1-dependent promoter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.174: Many mitogens, including PDGF, are potent activators of c-fos mRNA expression (38, 39). 

Phrase: "Many mitogens,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026249:Mitogens [Pharmacologic Substance]
   966 E C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "PDGF,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "are"

Phrase: "potent activators of c-fos mRNA expression"

Phrase: "(38,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.175: Elk-1 forms a ternary complex with serum response factor and the serum response element (SRE) that is present in many genes (35). 

Phrase: "Elk-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705455:ELK-1 [Gene or Genome]
   861   C0325228:Elk [Mammal]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a ternary complex with serum response factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439855:Complex [Qualitative Concept]
   748   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "the serum response element (SRE)"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0969709:Serum Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0229671:Serum [Body Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "that"

Phrase: "is"

Phrase: "present in many genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.176: Thus SRE present in the c-fos gene promoter is a target of Elk-1 in mitogen-stimulated cells (39). 

Phrase: "Thus SRE present in the c-fos gene promoter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0150312:Present [Quantitative Concept]
   738   C0449450:Present [Idea or Concept]

Phrase: "is"

Phrase: "a target of Elk-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1521840:Target [Functional Concept]
   760   C2986546:TARGET [Diagnostic Procedure]

Phrase: "in mitogen-stimulated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.177: Regulation of Elk-1 activity modulates the transcription of the c-fos gene. 

Phrase: "Regulation of Elk-1 activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the transcription of the c-fos gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0040649:Gene Transcription [Genetic Function]
           Transcription
Processing 00000000.tx.178: We performed transient transfection assays in mesangial cells with a reporter gene under the control of c-fos promoter that includes SRE. 

Phrase: "We"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "transient transfection assays in mesangial cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   753   C0040704:Transient [Population Group]
   753   C0205374:Transient [Temporal Concept]
   719   C0005507:Assay [Laboratory Procedure]
   719   C0243073:assay [Qualitative Concept]
   719   C1510438:Assay [Laboratory Procedure]

Phrase: "with a reporter gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206414:Reporter Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "under the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of c-fos promoter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0085301:c fos [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0085940:c fos [Gene or Genome]
   734   C0087140:c-fos [Gene or Genome]

Phrase: "that"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "SRE."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0969709:Serum Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0229671:Serum [Body Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
Processing 00000000.tx.179: PDGF stimulates c-fos gene transcription (Fig. 5B). 

Phrase: "PDGF"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "stimulates"

Phrase: "c-fos gene transcription"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0040649:Gene Transcription [Genetic Function]
           Transcription
   756   C0085940:c Fos gene [Gene or Genome]
   756   C1706383:c-FOS Gene [Gene or Genome]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.180: Exposure of mesangial cells to BMP2 inhibits both basal as well as PDGF-induced c-fos transcription (Fig. 5B). 

Phrase: "Exposure of mesangial cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0274281:Exposure, NOS [Injury or Poisoning]
   770   C0332157:Exposure [Clinical Attribute]

Phrase: "to BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "both basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "as well as"

Phrase: "PDGF-induced c-fos transcription"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0040649:Transcription [Genetic Function]
   723   C0916084:platelet-derived growth factor C [Amino Acid, Peptide, or Protein]
   723   C1418436:PLATELET-DERIVED GROWTH FACTOR C [Gene or Genome]
   723   C1571527:Platelet-Derived Growth Factor C [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.181: Collectively these data indicate that BMP2 blocks transcriptional events that result from activation of MAPK by PDGF. 

Phrase: "Collectively"

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "transcriptional events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]

Phrase: "that"

Phrase: "result from activation of MAPK"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   833   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   793   C1819041:protein kinase activation [Cell Function]
   770   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0599177:protein activation [Genetic Function]
   744   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0026249:Mitogen [Pharmacologic Substance]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C1879547:Activated [Activity]
           Activation
   744   C2825142:Result [Finding]
   711 E C1515877:Activate [Functional Concept]

Phrase: "by PDGF."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]
Processing 00000000.tx.182: View larger version (10K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(10K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.183: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.184: BMP2 inhibits PDGF-induced transcription. 

Phrase: "BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "PDGF-induced transcription."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0040649:Transcription [Genetic Function]
   734   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.185: A, effect of BMP2 on PDGF-induced Elk-1-mediated transcription of reporter gene. 

Phrase: "A,"

Phrase: "effect of BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on PDGF-induced Elk-1-mediated transcription"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0040649:Transcription [Genetic Function]
   701   C0071241:platelet factor 1 [Amino Acid, Peptide, or Protein]

Phrase: "of reporter gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206414:Reporter Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.186: Mesangial cells were transfected with 1g of GAL4-luciferase reporter plasmid, 50ng of GAL4-Elk-1 fusion plasmid, and 25ng of cytomegalovirus-Renilla plasmid as described under "Experimental Procedures." 

Phrase: "Mesangial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0227651:Mesangial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "transfected with 1g of GAL4-luciferase reporter plasmid,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   744   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0335038:Reporter [Professional or Occupational Group]
   744   C1416832:GAL4 [Gene or Genome]
   744   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   744   C1705915:Reporter [Conceptual Entity]
   744   C1709908:Reporter [Group]

Phrase: "50ng of GAL4-Elk-1 fusion plasmid,"

Phrase: "and"

Phrase: "25ng of cytomegalovirus-Renilla plasmid"

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.187: Serum-starved transfected cells were treated with BMP2 for 30min followed by PDGF, and the luciferase activity was measured in the cell lysate as described under "Experimental Procedures." 

Phrase: "Serum-starved transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with BMP2"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1332424:BMP2 [Gene or Genome]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "for 30min"

Phrase: "followed by PDGF,"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   882   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332283:Followed by [Temporal Concept]
           followed
   783   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   753   C0005821:Platelet [Cell]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1441547:Derived [Qualitative Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   753   C3245521:derived [Idea or Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "the luciferase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1151115:luciferase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured in the cell lysate"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C1881488:Cell Lysate [Physical Object]
           Lysate
   760   C0007634:Cell [Cell]
   760   C0444706:Measured [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.188: B, effect of BMP2 on PDGF-induced c-fos transcription. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "effect of BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on PDGF-induced c-fos transcription."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0040649:Transcription [Genetic Function]
   723   C0916084:platelet-derived growth factor C [Amino Acid, Peptide, or Protein]
   723   C1418436:PLATELET-DERIVED GROWTH FACTOR C [Gene or Genome]
   723   C1571527:Platelet-Derived Growth Factor C [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.189: A reporter construct in which the luciferase cDNA is driven by a 550-bp fragment of c-fos promoter was transiently transfected with cytomegalovirus-Renilla plasmid into mesangial cells. 

Phrase: "A reporter construct in which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2827421:Construct [Classification]

Phrase: "the luciferase cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "driven by a 550-bp fragment of c-fos promoter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0332255:fragment [Functional Concept]
   739   C1708096:Fragment [Qualitative Concept]
   706   C0013126:Drive [Mental Process]

Phrase: "was"

Phrase: "transiently"

Phrase: "transfected with cytomegalovirus-Renilla plasmid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0010825:Cytomegalovirus [Virus]
   760   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1093003:Renilla [Eukaryote]

Phrase: "into mesangial cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0227651:Mesangial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789   C0017655:Mesangium [Body Part, Organ, or Organ Component]
Processing 00000000.tx.190: Serum-starved transfected cells were treated with BMP2 and PDGF, and the luciferase activity was determined in the cell lysate as described in A. 

Phrase: "Serum-starved transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with BMP2"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1332424:BMP2 [Gene or Genome]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "PDGF,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "and"

Phrase: "the luciferase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1151115:luciferase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "determined in the cell lysate"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1881488:Cell Lysate [Physical Object]
           Lysate
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "described in A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.191: Effects of BMP2 and TGF- on Fibronectin mRNA Expression in Mesangial Cells-- Increased extracellular matrix production is one of the feature of mesangial proliferative glomerulonephritis that includes fibrosis (40). 

Phrase: "Effects of BMP2"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "TGF-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "on Fibronectin mRNA Expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1515670:mRNA Expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in Mesangial Cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0227651:Mesangial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "--"

Phrase: "Increased extracellular matrix production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033268:production [Occupational Activity]

Phrase: "is"

Phrase: "one of the feature of mesangial proliferative glomerulonephritis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205447:One [Quantitative Concept]

Phrase: "that"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "fibrosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016059:Fibrosis [Pathologic Function]
   928 E C0334129:Fibrotic [Functional Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.192: One major biological activity of TGF-, besides inhibition of DNA synthesis, is stimulation of matrix production in many cells, including mesangial cells (41). 

Phrase: "One major biological activity of TGF-,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0005532:Biological [Biomedical Occupation or Discipline]
   753   C0205177:Activity [Functional Concept]
   753   C0205460:biological [Qualitative Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "besides inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of DNA synthesis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0598312:DNA Synthesis [Genetic Function]
  1000   C1328870:DNA synthesis [Laboratory Procedure]
  1000   C1817262:DNA synthesis [Genetic Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "is"

Phrase: "stimulation of matrix production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "in many cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "mesangial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0227651:Mesangial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.193: In these cells, TGF- increases the formation of collagen type I and fibronectin (42). 

Phrase: "In these cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "TGF-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the formation of collagen type I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C2246343:collagen formation [Molecular Function]
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "fibronectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.194: The increase in fibronectin production in response to TGF- is mediated at least partially at the transcriptional level (43). 

Phrase: "The increase in fibronectin production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to TGF-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "mediated at least partially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "at the transcriptional level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.195: However, the effect of BMP2, a member of the TGF- family, on matrix gene expression has not been studied in mesangial cells. 

Phrase: "However,"

Phrase: "the effect of BMP2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "a member of the TGF- family,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0086282:Family member [Family Group]
   783   C1611821:Family Member [Intellectual Product]
   753   C0680022:member [Population Group]
   753   C2698041:Member [Professional or Occupational Group]

Phrase: "on matrix gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0017262:Gene Expression [Genetic Function]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "studied in mesangial cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0227651:Mesangial Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737   C0557651:Study [Manufactured Object]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737   C2603343:Study [Research Activity]
Processing 00000000.tx.196: Mesangial cells were treated with either TGF- or BMP2 for different periods of time. 

Phrase: "Mesangial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0227651:Mesangial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "treated with either TGF-"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1522326:Treated [Functional Concept]
   770   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "BMP2 for different periods of time."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1332424:BMP2 [Gene or Genome]
Processing 00000000.tx.197: Total RNAs were analyzed by Northern blotting using a cellular fibronectin cDNA probe. 

Phrase: "Total RNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:rnas [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "analyzed by Northern blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005861:Northern Blotting [Molecular Biology Research Technique]
   816 E C1621557:Northern Blot [Research Device]
   770   C0936012:Analyzed [Research Activity]
   770   C1709269:Northern [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a cellular fibronectin cDNA probe."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0182400:Probe [Medical Device]
   812   C1704681:Probe [Gene or Genome]
   812   C2347609:Probe [Chemical Viewed Functionally]
   812   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.198: The data show that after both 8and 16h of stimulation, TGF- increases fibronectin mRNA expression (Fig. 6, lanes 3and 6). 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "after"

Phrase: "both 8and 16h of stimulation,"

Phrase: "TGF-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "fibronectin mRNA expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1515670:mRNA Expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lanes 3and 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.199: Unlike TGF-, BMP2 does not increase fibronectin mRNA expression in mesangial cells. 

Phrase: "Unlike TGF-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "fibronectin mRNA expression in mesangial cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1515670:mRNA Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.200: This finding may have broader implication to the potential use of BMP2 as antimitotic agent in proliferative and fibrotic disorders. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "may"

Phrase: "have"

Phrase: "broader implication to the potential use of BMP2"

Phrase: "as antimitotic agent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003379:Antimitotic agent [Pharmacologic Substance]
   861   C0450442:Agent [Chemical Viewed Functionally]
   861   C1254351:Agent [Pharmacologic Substance]
   861   C1521826:Agent [Intellectual Product]

Phrase: "in proliferative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0334094:Proliferative [Pathologic Function]

Phrase: "and"

Phrase: "fibrotic disorders."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.201: View larger version (58K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(58K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.202: 6.  

Phrase: "6."
Processing 00000000.tx.203: Effect of TGF- and BMP2 on fibronectin gene expression. 

Phrase: "Effect of TGF-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "BMP2 on fibronectin gene expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1332424:BMP2 gene [Gene or Genome]
           BMP2
   760   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.204: Mesangial cells were incubated with either TGF-1 or BMP2 for the indicated time periods. 

Phrase: "Mesangial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0227651:Mesangial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "incubated with either TGF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "BMP2 for the indicated time periods."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1332424:BMP2 [Gene or Genome]
Processing 00000000.tx.205: 10g of total RNA was separated electrophoretically in formaldehyde-agarose gel and transferred to gene screen membrane. 

Phrase: "10g of total RNA"

Phrase: "was"

Phrase: "separated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086972:Separated [Finding]
  1000   C0443299:separated [Spatial Concept]
  1000   C0687118:Separated [Functional Concept]

Phrase: "electrophoretically in formaldehyde-agarose gel"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1706746:Agarose Gel [Research Device]
   760   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0036681:Agarose [Carbohydrate]
   760   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "transferred to gene screen membrane."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   781   C1517499:Gene Transfer [Molecular Biology Research Technique]
   760   C0017337:Gene [Gene or Genome]
   760   C0025255:Membrane [Tissue]
   760   C0220908:screen [Health Care Activity]
   760   C0348011:transferred [Functional Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1305399:screen [Functional Concept]
   760   C1705053:Screen [Medical Device]
   760   C1706182:Membrane [Manufactured Object]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]
Processing 00000000.tx.206: Upper panel, transferred RNAs were hybridized with fibronectin cDNA. 

Phrase: "Upper panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "transferred RNAs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0035711:Transfer RNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0035668:rnas [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "hybridized with fibronectin cDNA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.207: The lower panel shows the ethidium bromide staining of the same blot.  

Phrase: "The lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the ethidium bromide staining of the same blot."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0487602:Staining [Laboratory Procedure]
   744   C1704680:Staining [Finding]
Processing 00000000.tx.208: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES These studies demonstrate that BMP2 inhibits PDGF-induced DNA synthesis in mesangial cells by blocking PDGF-stimulated MAPK activity that leads to inhibition of Elk-1-dependent transcriptional events and c-fos gene expression. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "demonstrate"

Phrase: "that BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "PDGF-induced DNA synthesis in mesangial cells"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   777   C0016026:DNA Synthesis Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0598312:DNA Synthesis [Genetic Function]
   760   C1328870:DNA synthesis [Laboratory Procedure]
   760   C1817262:DNA synthesis [Genetic Function]
   739   C0220781:synthesis [Biologic Function]
   739   C1883254:Synthesis [Activity]
   722 E C0598279:synthetic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   722   C2936320:Synthetic Cells [Manufactured Object]

Phrase: "by blocking PDGF-stimulated MAPK activity"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   863   C1149472:growth factor activity [Molecular Function]
   851   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   816   C1150527:protein kinase activity [Molecular Function]
   809   C1537044:protein activity [Molecular Function]
   801   C1150423:kinase activity [Molecular Function]
   797 E C2261495:protein phosphokinase activity [Molecular Function]
   794   C1752930:mitogenic activity [Cell Function]
   788   C0205177:Activity [Functional Concept]
   788   C0439167:% activity [Quantitative Concept]
   788   C0441655:Activity [Activity]
   788   C1561536:*Activity [Idea or Concept]

Phrase: "that"

Phrase: "leads to inhibition of Elk-1-dependent transcriptional events"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   764   C1705455:ELK-1 [Gene or Genome]
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   742   C0040649:Transcriptional [Genetic Function]
   742   C0181586:leads [Medical Device]
   742   C0325228:Elk [Mammal]
   742   C0441471:Events [Event]
   742   C0851827:Dependent [Qualitative Concept]
   742   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   742   C1522538:Lead [Functional Concept]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C1701901:Dependent [Qualitative Concept]
   742   C2348269:Lead [Element, Ion, or Isotope]
   742   C3244310:dependent [Functional Concept]
   742   C3275067:LEAD [Therapeutic or Preventive Procedure]
   742   C3463820:Inhibition [Activity]
   742   C3541888:Events [Classification]

Phrase: "and"

Phrase: "c-fos gene expression."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0085940:c Fos gene [Gene or Genome]
           fos gene
   923   C1706383:c-FOS Gene [Gene or Genome]
   861   C0017262:Gene Expression [Genetic Function]
   861   C0085303:FOS Gene [Gene or Genome]
   861   C0087140:FOS gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.209: BMP2 had no inhibitory effect on PDGFR activation. 

Phrase: "BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "had"

Phrase: "no inhibitory effect on PDGFR activation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.210: These data provide the first evidence that BMP2 blocks DNA synthesis in mammalian cells by blocking MAPK-mediated signal transduction. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "the first evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "DNA synthesis in mammalian cells"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0598312:DNA Synthesis [Genetic Function]
   806   C1328870:DNA synthesis [Laboratory Procedure]
   806   C1817262:DNA synthesis [Genetic Function]
   762 E C0598279:synthetic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   762   C2936320:Synthetic Cells [Manufactured Object]
   760   C0220781:synthesis [Biologic Function]
   760   C1883254:Synthesis [Activity]

Phrase: "by blocking MAPK-mediated signal transduction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0037083:Signal Transduction [Cell Function]
   793   C1160185:transduction [Organism Function]
   793   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.211: We have shown previously that PDGF-mediated signal transduction in mesangial cells is initiated in the plasma membrane by tyrosine phosphorylation of the dimerized PDGF receptor (29, 31, 32). 

Phrase: "We"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "previously"

Phrase: "that PDGF-mediated signal transduction in mesangial cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0037083:Signal Transduction [Cell Function]
           signal cell
   738   C1160185:transduction [Organism Function]
   738   C1710082:Signal [Phenomenon or Process]

Phrase: "is"

Phrase: "initiated in the plasma membrane"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0007603:Plasma membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0596901:Membrane [Cell Component]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1706182:Membrane [Manufactured Object]
   726   C1548602:Initiate [Idea or Concept]
   726   C1704686:Initiate [Functional Concept]

Phrase: "by tyrosine phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1519726:Tyrosine Phosphorylation [Molecular Function]
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "of the dimerized PDGF receptor"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   947   C0071253:Platelet-Derived Growth Factor Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   901   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   858   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0005821:Platelet [Cell]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0220844:growth [Physiologic Function]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C1441547:Derived [Qualitative Concept]
   799   C1521761:Factor [Functional Concept]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   799   C3245521:derived [Idea or Concept]
   716 E C1963076:Platelets [Finding]

Phrase: "(29,"

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.212: Three major signal transduction pathways are activated by PDGFR. 

Phrase: "Three major signal transduction pathways"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0086982:Signal Transduction Pathways [Molecular Function]
   853   C0037080:Signal Pathways [Molecular Function]
   840   C0037083:Signal Transduction [Cell Function]
   804   C1160185:transduction [Organism Function]
   804   C1704259:Pathways [Molecular Function]
   804   C1705987:Pathways [Conceptual Entity]
   804   C1710082:Signal [Phenomenon or Process]

Phrase: "are"

Phrase: "activated by PDGFR."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.213: These are phospholipase C, phosphatidylinositol 3-kinase and MAPK (19, 24, 25). 

Phrase: "These"

Phrase: "are"

Phrase: "phospholipase C,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031669:Phospholipase C [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phosphatidylinositol 3-kinase"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "MAPK"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "(19,"

Phrase: "24,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.214: Present evidence indicates that each of these signaling molecules contributes to mitogenic effect of PDGF. 

Phrase: "Present evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "indicates"

Phrase: "that"

Phrase: "each of these signaling molecules"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C1519315:Signaling Molecule [Biologically Active Substance]
   760   C0037083:Signaling [Cell Function]
   760   C0567416:molecules [Substance]
   760   C1457900:Each [Quantitative Concept]
   760   C3537152:signaling [Biologic Function]
   726 E C1710082:Signal [Phenomenon or Process]

Phrase: "contributes to mitogenic effect of PDGF."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   818   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0021756:Mitogenic Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C1522405:Mitogenic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   762   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   742   C0005821:Platelet [Cell]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0220844:growth [Physiologic Function]
   742   C1280500:Effect [Qualitative Concept]
   742   C1441547:Derived [Qualitative Concept]
   742   C1521761:Factor [Functional Concept]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C1880177:Contribute [Activity]
   742   C2348382:Effect [Qualitative Concept]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]
   742   C3245521:derived [Idea or Concept]
Processing 00000000.tx.215: There is evidence of cross-talk among these signaling pathways. 

Phrase: "There"

Phrase: "is"

Phrase: "evidence of cross-talk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "among these signaling pathways."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C0037080:Signal Pathways [Molecular Function]
   983   C0037083:signaling pathway [Cell Function]
   983   C0086982:Signaling Pathway [Molecular Function]
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.216: For example, we have recently shown that inhibition of PI 3-kinase blocks PDGF-induced DNA synthesis and that PI 3-kinase is an upstream regulator of MAPK in mesangial cells (27). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "we"

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that inhibition of PI 3-kinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "PDGF-induced DNA synthesis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C0598312:DNA Synthesis [Genetic Function]
   818   C1328870:DNA synthesis [Laboratory Procedure]
   818   C1817262:DNA synthesis [Genetic Function]
   795   C0220781:synthesis [Biologic Function]
   795   C1883254:Synthesis [Activity]
   710   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "that PI 3-kinase"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0044602:PI 3 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0919338:PI-3 kinase [Gene or Genome]
  1000   C2936824:PI-3 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1579194:PI-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0429863:PI [Clinical Attribute]
   827   C3537219:PI [Gene or Genome]
   827   C3539772:PI [Intellectual Product]

Phrase: "is"

Phrase: "an upstream regulator of MAPK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0182953:REGULATOR [Medical Device]
   744   C1704734:Regulator [Medical Device]
   744   C1704735:Regulator [Conceptual Entity]

Phrase: "in mesangial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0227651:Mesangial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.217: BMP2 is a member of the TGF- superfamily of proteins, although they differ from the TGF- family in several features. 

Phrase: "BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "is"

Phrase: "a member of the TGF- superfamily of proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0680022:member [Population Group]
   744   C2698041:Member [Professional or Occupational Group]

Phrase: "although"

Phrase: "they"

Phrase: "differ from the TGF- family"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0015576:Family [Family Group]
   760   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1704727:Family [Conceptual Entity]

Phrase: "in several features."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.218: They contain seven conserved cysteines instead of nine present in TGF-. 

Phrase: "They"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "seven conserved cysteines instead of nine present"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0010654:cysteines [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in TGF-."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.219: Unlike TGF-, each BMP family member is glycosylated (3). 

Phrase: "Unlike TGF-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "each BMP family member"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0086282:Family member [Family Group]
   901   C1611821:Family Member [Intellectual Product]
   827   C0015576:Family [Family Group]
   827   C0680022:member [Population Group]
   827   C1704727:Family [Conceptual Entity]
   827   C2698041:Member [Professional or Occupational Group]
   755 E C0241888:Familial [Functional Concept]

Phrase: "is"

Phrase: "glycosylated"

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.220: Both TGF- and BMPs function through distinct type I and type II receptors (5, 6). 

Phrase: "Both TGF-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "BMPs"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0053932:Bone Morphogenetic Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   865   C2610491:bone morphogenesis [Organism Function]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   827   C0391978:Bone [Tissue]
   827   C1266908:Bone [Body Part, Organ, or Organ Component]
   827   C1266909:Bone [Body System]
   755   C0026559:Morphogenesis [Organism Function]
   755 E C0443157:Bony [Functional Concept]

Phrase: "function through distinct type I"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0441729:Type I [Classification]
   760   C0021966:I- [Inorganic Chemical]
   760   C0031843:function [Physiologic Function]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0332307:Type [Qualitative Concept]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1547052:*Type [Quantitative Concept]
   760   C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "type II receptors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0441730:Type II [Classification]
   827   C0332307:Type [Qualitative Concept]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.221: TGF- binds to type II receptor and then recruits the type I protein to undergo oligomerization (5). 

Phrase: "TGF-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "binds to type II receptor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0441730:Type II [Classification]
   760   C0332307:Type [Qualitative Concept]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "recruits"

Phrase: "the type I protein to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "undergo"

Phrase: "oligomerization"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.222: In the absence of type II receptor TGF- cannot interact with type I receptor alone. 

Phrase: "In the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of type II receptor TGF-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "cannot"

Phrase: "interact with type I receptor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0441729:Type I [Classification]
   760   C0021966:I- [Inorganic Chemical]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0332307:Type [Qualitative Concept]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.223: BMPs can interact with both receptors independently with low affinity; 

Phrase: "BMPs"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0053932:Bone Morphogenetic Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   865   C2610491:bone morphogenesis [Organism Function]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   827   C0391978:Bone [Tissue]
   827   C1266908:Bone [Body Part, Organ, or Organ Component]
   827   C1266909:Bone [Body System]
   755   C0026559:Morphogenesis [Organism Function]
   755 E C0443157:Bony [Functional Concept]

Phrase: "can"

Phrase: "interact with both receptors independently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "with low affinity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205251:low [Qualitative Concept]
   861   C1299352:Low [Qualitative Concept]
   861   C1510827:Affinity [Natural Phenomenon or Process]
   861   C1550472:low [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.224: however, in the presence of both receptors, BMPs bind with a very high affinity and can signal to induce appropriate genes. 

Phrase: "however,"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of both receptors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "BMPs"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0053932:Bone Morphogenetic Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   865   C2610491:bone morphogenesis [Organism Function]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   827   C0391978:Bone [Tissue]
   827   C1266908:Bone [Body Part, Organ, or Organ Component]
   827   C1266909:Bone [Body System]
   755   C0026559:Morphogenesis [Organism Function]
   755 E C0443157:Bony [Functional Concept]

Phrase: "bind with a very high affinity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0442804:Very high [Finding]
   753   C0205250:High [Qualitative Concept]
   753   C0442824:Very [Qualitative Concept]
   753   C1145667:Bind [Activity]
   753   C1167622:bind [Molecular Function]
   753   C1299351:High [Qualitative Concept]
   753   C1510827:Affinity [Natural Phenomenon or Process]
   753   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "can"

Phrase: "signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "appropriate genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.225: We have shown previously that TGF- inhibits PDGF-induced mesangial cell proliferation (34). 

Phrase: "We"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "previously"

Phrase: "that TGF-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "PDGF-induced mesangial cell proliferation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   835   C3278595:Mesangial cell proliferation [Finding]
   822   C0545017:Mesangial proliferation [Cell or Molecular Dysfunction]
   812   C0596290:Cell Proliferation [Cell Function]
   793   C0334094:Proliferation [Pathologic Function]
   793   C1514485:Proliferation [Functional Concept]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.226: It is known that TGF- exerts its inhibitory effect by increasing the expression of p27, leading to the inhibition of cyclin-dependent kinases, a point of convergence of many mitogenic signaling pathways (44). 

Phrase: "It"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that TGF-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "exerts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "its inhibitory effect by increasing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
   751   C0595938:EFFECT INCREASED [Pathologic Function]

Phrase: "the expression of p27,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "leading to the inhibition of cyclin-dependent kinases,"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   800   C0243045:Cyclin-Dependent Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0332152:Leading [Temporal Concept]
   744   C0851827:Dependent [Qualitative Concept]
   744   C1150565:cyclin [Molecular Function]
   744   C1522538:Leading [Functional Concept]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C1701901:Dependent [Qualitative Concept]
   744   C3244310:dependent [Functional Concept]
   744   C3463820:Inhibition [Activity]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "a point of convergence of many mitogenic signaling pathways"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C2924612:A point [Body Location or Region]
   742   C1552961:Point [Quantitative Concept]
   742   C2347617:point [Quantitative Concept]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.227: Thus inhibition of cyclin-dependent kinases causes cells to arrest in G1 and prevents their entry into S phase. 

Phrase: "Thus inhibition of cyclin-dependent kinases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "cells to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "arrest in G1"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   858   C1517342:G1 Arrest [Molecular Function]
   790   C0237477:Arrest [Temporal Concept]
   790   C0392351:arrest [Governmental or Regulatory Activity]
   734 E C0311403:Inhibited [Qualitative Concept]
   734 E C3463820:Inhibiting [Activity]
   706 E C0018790:arrested [Disease or Syndrome]
   706 E C0521111:Retarded [Qualitative Concept]

Phrase: "and"

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "their entry into S phase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705654:Entry [Intellectual Product]
Processing 00000000.tx.228: Whether BMP2 regulates any cyclin-dependent kinase inhibitors is not known. 

Phrase: "Whether"

Phrase: "BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "regulates"

Phrase: "any cyclin-dependent kinase inhibitors"
Meta Candidates (Total=19; Excluded=6; Pruned=0; Remaining=13)
  1000   C0919418:Cyclin-Dependent Kinase Inhibitors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cyclin Kinase Inhibitor
   966 E C1152568:cyclin dependent kinase inhibitor [Molecular Function]
   966 E C1511576:Cyclin-Dependent Kinase Inhibitor [Pharmacologic Substance]
   923   C0243045:Cyclin-Dependent Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   912   C0292198:Cyclin-Dependent Inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1152564:Kinase Inhibitors [Molecular Function]
   844 E C1171350:Kinase Inhibitor [Pharmacologic Substance]
   844 E C3537023:kinase inhibitor [Molecular Function]
   844 E C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243077:inhibitors [Chemical Viewed Functionally]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1150565:cyclin [Molecular Function]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]
   779 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]
Processing 00000000.tx.229: It should be emphasized that the concentration of PDGF that was used in our studies elicits maximum stimulation of DNA synthesis in mesangial cells similar to that observed with serum (data not shown). 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "emphasized"

Phrase: "that"

Phrase: "the concentration of PDGF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "that"

Phrase: "was"

Phrase: "used in our studies"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   802   C0869040:Use studies [Research Activity]
   770   C0947630:studies [Laboratory Procedure]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C1947944:Use [Intellectual Product]
   737 E C2603343:Study [Research Activity]

Phrase: "elicits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "maximum stimulation of DNA synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "in mesangial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0227651:Mesangial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "observed with serum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0229671:Serum [Body Substance]
   790   C1441672:Observed [Functional Concept]
   790   C1546774:Serum [Intellectual Product]
   790   C1550100:Serum [Body Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.230: In this report, we show that 100ng/ml BMP2, which is rather a high concentration, significantly inhibits PDGF-induced DNA synthesis in mesangial cells (Fig. 1). 

Phrase: "In this report,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that 100ng/ml BMP2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1332424:BMP2 [Gene or Genome]

Phrase: "which"

Phrase: "is"

Phrase: "rather"

Phrase: "a high concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "significantly"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "PDGF-induced DNA synthesis in mesangial cells"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   777   C0016026:DNA Synthesis Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0598312:DNA Synthesis [Genetic Function]
   760   C1328870:DNA synthesis [Laboratory Procedure]
   760   C1817262:DNA synthesis [Genetic Function]
   739   C0220781:synthesis [Biologic Function]
   739   C1883254:Synthesis [Activity]
   722 E C0598279:synthetic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   722   C2936320:Synthetic Cells [Manufactured Object]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.231: There is a wide variability among various cell types in threshold doses of BMP2 that result in inhibition of DNA synthesis. 

Phrase: "There"

Phrase: "is"

Phrase: "a wide variability among various cell types"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2827666:Variability [Conceptual Entity]

Phrase: "in threshold doses"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0178602:Doses [Quantitative Concept]
   861   C0449864:Threshold [Qualitative Concept]
   827 E C0869039:Dose [Quantitative Concept]
   827 E C1114758:Dose # [Clinical Attribute]
   827 E C1428722:DOS [Gene or Genome]

Phrase: "of BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "that result in inhibition of DNA synthesis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]
Processing 00000000.tx.232: In a recent report, Ide et al. 

Phrase: "In a recent report,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "Ide et al."
Processing 00000000.tx.233: (45) demonstrated that BMP2 at a dose of 100ng/ml significantly inhibited the growth of human prostate cancer cells stimulated by serum and androgen. 

Phrase: "(45"

Phrase: ")"

Phrase: "demonstrated"

Phrase: "that BMP2 at a dose of 100ng/ml significantly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1332424:BMP2 [Gene or Genome]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the growth of human prostate cancer cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   793   C0007595:growth of cell [Cell Function]
           cells growth
   788   C1516170:Cancer Cell Growth [Neoplastic Process]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2911660:Growth [Activity]

Phrase: "stimulated by serum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0229671:Serum [Body Substance]
   790   C1546774:Serum [Intellectual Product]
   790   C1550100:Serum [Body Substance]
   790   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "androgen."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002844:Androgen [Hormone,Pharmacologic Substance]
  1000   C3536949:Androgen [Pharmacologic Substance]
Processing 00000000.tx.234: It remains to be determined if such requirement of high concentration of BMP2 reflects number or affinity of BMP2 receptors on the target cells. 

Phrase: "It"

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined"

Phrase: "if"

Phrase: "such requirement of high concentration of BMP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1514873:Requirement [Functional Concept]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "or"

Phrase: "affinity of BMP2 receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "on the target cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0221284:Target cells [Cell]
  1000   C3272919:Target Cells [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C1521840:Target [Functional Concept]
   861   C2986546:TARGET [Diagnostic Procedure]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.235: Moreover, the pathophysiologic relevance of these concentrations of BMP2 to concentrations achieved locally in cell or tissue microenvironment remains to be determined. 

Phrase: "Moreover,"

Phrase: "the pathophysiologic relevance of these concentrations of BMP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2347946:Relevance [Qualitative Concept]

Phrase: "to concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "achieved"

Phrase: "locally in cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "tissue microenvironment"

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined."
Processing 00000000.tx.236: Receptor tyrosine kinases are known to be phosphorylated at serine and threonine residues by downstream signaling kinases, and this phosphorylation inactivates receptor function (46, 47). 

Phrase: "Receptor tyrosine kinases"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0206364:Receptor Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   867   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "phosphorylated at serine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "threonine residues by downstream signaling kinases,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "this phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "inactivates"

Phrase: "receptor function"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0920644:receptor function [Molecular Function]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "(46,"

Phrase: "47"

Phrase: ")."
Processing 00000000.tx.237: PDGFR may also be negatively modulated by serine phosphorylation directly via BMP receptor signaling upon exposure of mesangial cells to BMP2. 

Phrase: "PDGFR"

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "negatively"

Phrase: "modulated by serine phosphorylation directly"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0443264:Modulated [Spatial Concept]
   760   C1158886:Phosphorylation [Molecular Function]
   760   C1947931:Directly [Qualitative Concept]

Phrase: "via BMP receptor signaling"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1155364:BMP receptor signaling [Molecular Function]
   901   C1514762:Receptor Signaling [Molecular Function]
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]
   734   C0289417:Receptor, BMP [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "upon exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "of mesangial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0227651:Mesangial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "to BMP2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]
Processing 00000000.tx.238: However, our results argue against this possibility, since BMP2 does not inhibit ligand-induced PDGFR-associated tyrosine kinase activity (Fig. 2). 

Phrase: "However,"

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "argue against this possibility,"

Phrase: "since"

Phrase: "BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "ligand-induced PDGFR-associated tyrosine kinase activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C1150632:PDGFR activity [Molecular Function]
   818   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   818   C1150423:kinase activity [Molecular Function]
   795   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   795   C0205177:Activity [Functional Concept]
   795   C0439167:% activity [Quantitative Concept]
   795   C0441655:Activity [Activity]
   795   C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.239: As discussed earlier, attenuation of PI 3-kinase and MAPK results in inhibition of PDGF-induced DNA synthesis (27). 

Phrase: "As"

Phrase: "discussed"

Phrase: "earlier,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: "attenuation of PI 3-kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0599946:Attenuation [Activity]

Phrase: "and"

Phrase: "MAPK"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "results in inhibition of PDGF-induced DNA synthesis"
Meta Candidates (Total=31; Excluded=1; Pruned=0; Remaining=30)
   797   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   772   C0016026:DNA Synthesis Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   772   C1511701:DNA Synthesis Inhibition [Genetic Function]
   772   C1512280:Growth Factor Inhibition [Physiologic Function]
   772   C2249823:inhibition of growth [Organism Function]
   756   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0598312:DNA Synthesis [Genetic Function]
   756   C1328870:DNA synthesis [Laboratory Procedure]
   756   C1817262:DNA synthesis [Genetic Function]
   754   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   738   C0005821:Platelet [Cell]
   738   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0018270:'growth' NOS [Organism Function]
   738   C0021467:Inhibition [Mental Process]
   738   C0021469:Inhibition [Molecular Function]
   738   C0205263:Induced [Functional Concept]
   738   C0220781:synthesis [Biologic Function]
   738   C0220844:growth [Physiologic Function]
   738   C1274040:Result [Functional Concept]
   738   C1441547:Derived [Qualitative Concept]
   738   C1521761:Factor [Functional Concept]
   738   C1546471:Result [Idea or Concept]
   738   C1621966:Growth [Organ or Tissue Function]
   738   C1628982:% inhibition [Quantitative Concept]
   738   C1883254:Synthesis [Activity]
   738   C2825142:Result [Finding]
   738   C2827422:Factor [Conceptual Entity]
   738   C2911660:Growth [Activity]
   738   C3245521:derived [Idea or Concept]
   738   C3463820:Inhibition [Activity]
   718 E C0598279:synthetic DNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.240: However the inhibitory effect of BMP2 on PDGF-mediated DNA synthesis was only 50% (Fig. 1), suggesting that BMP2 does not completely block all the parallel early mitogenic signal transduction pathways. 

Phrase: "However"

Phrase: "the inhibitory effect of BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on PDGF-mediated DNA synthesis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C0598312:DNA Synthesis [Genetic Function]
   818   C1328870:DNA synthesis [Laboratory Procedure]
   818   C1817262:DNA synthesis [Genetic Function]
   795   C0220781:synthesis [Biologic Function]
   795   C1883254:Synthesis [Activity]
   710   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "only 50%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "does"

Phrase: "not completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205197:Completely [Qualitative Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "all the parallel early mitogenic signal transduction pathways."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0086982:Signal Transduction Pathways [Molecular Function]
   839   C0037080:Signal Pathways [Molecular Function]
   827   C0037083:Signal Transduction [Cell Function]
   799   C1160185:transduction [Organism Function]
   799   C1704259:Pathways [Molecular Function]
   799   C1705987:Pathways [Conceptual Entity]
   799   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.241: Indeed little inhibitory effect of BMP2 was observed on PDGF-induced PI 3-kinase activity (data not shown). 

Phrase: "Indeed little inhibitory effect of BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "observed on PDGF-induced PI 3-kinase activity"
Meta Candidates (Total=31; Excluded=0; Pruned=0; Remaining=31)
   797   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   775   C0044602:PI 3 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   775   C0919338:PI-3 kinase [Gene or Genome]
   775   C2936824:PI-3 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   772   C1149472:growth factor activity [Molecular Function]
   772   C2260371:PI kinase activity [Molecular Function]
   770   C0032182:Platelet Factor 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1150423:kinase activity [Molecular Function]
   756   C1579194:PI-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C0015498:Factor Pi [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   738   C0005821:Platelet [Cell]
   738   C0018270:'growth' NOS [Organism Function]
   738   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0205177:Activity [Functional Concept]
   738   C0205263:Induced [Functional Concept]
   738   C0220844:growth [Physiologic Function]
   738   C0429863:PI [Clinical Attribute]
   738   C0439167:% activity [Quantitative Concept]
   738   C0441655:Activity [Activity]
   738   C1441547:Derived [Qualitative Concept]
   738   C1441672:Observed [Functional Concept]
   738   C1521761:Factor [Functional Concept]
   738   C1561536:*Activity [Idea or Concept]
   738   C1621966:Growth [Organ or Tissue Function]
   738   C2827422:Factor [Conceptual Entity]
   738   C2911660:Growth [Activity]
   738   C3245521:derived [Idea or Concept]
   738   C3537219:PI [Gene or Genome]
   738   C3539772:PI [Intellectual Product]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.242: Although BMP2 inhibits PDGF-stimulated MAPK activity significantly (Fig. 3), it also was not sufficient to completely block PDGF-induced DNA synthesis. 

Phrase: "Although"

Phrase: "BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "PDGF-stimulated MAPK activity significantly"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   863   C1149472:growth factor activity [Molecular Function]
   851   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   816   C1150527:protein kinase activity [Molecular Function]
   809   C1537044:protein activity [Molecular Function]
   801   C1150423:kinase activity [Molecular Function]
   797 E C2261495:protein phosphokinase activity [Molecular Function]
   794   C1752930:mitogenic activity [Cell Function]
   788   C0205177:Activity [Functional Concept]
   788   C0439167:% activity [Quantitative Concept]
   788   C0441655:Activity [Activity]
   788   C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "it also"

Phrase: "was"

Phrase: "not sufficient to completely"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205197:Completely [Qualitative Concept]
   812   C0205410:Sufficient [Qualitative Concept]
   812   C1518422:Not [Functional Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "PDGF-induced DNA synthesis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C0598312:DNA Synthesis [Genetic Function]
   818   C1328870:DNA synthesis [Laboratory Procedure]
   818   C1817262:DNA synthesis [Genetic Function]
   795   C0220781:synthesis [Biologic Function]
   795   C1883254:Synthesis [Activity]
   710   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.243: In fact, BMP2 alone stimulates MAPK activity very weakly (e.g. Fig. 3A, compare lane 3with lane 1and Fig. 3B). 

Phrase: "In fact,"

Phrase: "BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "stimulates"

Phrase: "MAPK activity very weakly"
Meta Candidates (Total=21; Excluded=2; Pruned=0; Remaining=19)
   913   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   877   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   845   C1150527:protein kinase activity [Molecular Function]
   845   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   829   C1537044:protein activity [Molecular Function]
   827 E C2261495:protein phosphokinase activity [Molecular Function]
   825   C1752930:mitogenic activity [Cell Function]
   818   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   818   C1150423:kinase activity [Molecular Function]
   795   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0026249:Mitogen [Pharmacologic Substance]
   795   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0205177:Activity [Functional Concept]
   795   C0439167:% activity [Quantitative Concept]
   795   C0441655:Activity [Activity]
   795   C0442824:Very [Qualitative Concept]
   795   C1561536:*Activity [Idea or Concept]
   795   C1879547:Activated [Activity]
   762 E C1515877:Activate [Functional Concept]

Phrase: "("

Phrase: "e.g. Fig. 3A,"

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "lane 3with lane 1and Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0450365:3b [Intellectual Product]
   799   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.244: These data indicate that MAPK is regulated in a positive manner by BMP2 alone, while in the presence of PDGF stimulation, it exerts a negative regulatory signal. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that MAPK"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "is"

Phrase: "regulated in a positive manner"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0439178:% Positive [Quantitative Concept]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C2825490:Positive [Qualitative Concept]

Phrase: "by BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "alone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "while in the presence of PDGF stimulation,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   806   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   775   C2249825:stimulation of growth [Organism Function]
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   739   C0005821:Platelet [Cell]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0220844:growth [Physiologic Function]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   739   C0750519:while [Idea or Concept]
   739   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   739   C1441547:Derived [Qualitative Concept]
   739   C1521761:Factor [Functional Concept]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C1948023:Stimulation [Natural Phenomenon or Process]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]
   739   C3245521:derived [Idea or Concept]

Phrase: "it"

Phrase: "exerts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "a negative regulatory signal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.245: The signal initiated by BMP2 in the presence of PDGF is not sufficient to completely inhibit MAPK activity induced by PDGF (Fig. 3). 

Phrase: "The signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "initiated by BMP2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1332424:BMP2 [Gene or Genome]
   756   C1548602:Initiate [Idea or Concept]
   756   C1704686:Initiate [Functional Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of PDGF"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "is"

Phrase: "not sufficient to completely"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205197:Completely [Qualitative Concept]
   812   C0205410:Sufficient [Qualitative Concept]
   812   C1518422:Not [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "MAPK activity"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   884   C1150527:protein kinase activity [Molecular Function]
   865 E C2261495:protein phosphokinase activity [Molecular Function]
   862   C1752930:mitogenic activity [Cell Function]
   853   C1537044:protein activity [Molecular Function]
   840   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]

Phrase: "induced by PDGF"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   882   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   753   C0005821:Platelet [Cell]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0205263:Induced [Functional Concept]
   753   C0220844:growth [Physiologic Function]
   753   C1441547:Derived [Qualitative Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   753   C3245521:derived [Idea or Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.246: It should be emphasized that TGF- also inhibits PDGF-induced MAPK activity in mesangial cells (Fig. 4). 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "emphasized"

Phrase: "that TGF- also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "PDGF-induced MAPK activity"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   872   C1149472:growth factor activity [Molecular Function]
   861   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   821   C1150527:protein kinase activity [Molecular Function]
   813   C1537044:protein activity [Molecular Function]
   804   C1150423:kinase activity [Molecular Function]
   802 E C2261495:protein phosphokinase activity [Molecular Function]
   799   C1752930:mitogenic activity [Cell Function]
   790   C0205177:Activity [Functional Concept]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1561536:*Activity [Idea or Concept]

Phrase: "in mesangial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0227651:Mesangial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.247: This action of TGF- demonstrates that along with its late effects on cell cycle proteins, it also blocks early mitogenic signal transduction pathways. 

Phrase: "This action of TGF-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441472:Action [Functional Concept]
   770   C3266814:Action [Activity]

Phrase: "demonstrates"

Phrase: "that along with its late effects"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0543419:late effects [Finding]
   790   C1368999:late effects [Pathologic Function]
   753   C0205087:Late [Temporal Concept]
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on cell cycle proteins,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0243021:Cell Cycle Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0007586:Cell Cycle [Cell Function]
   734   C1155839:Cell Cycle [Cell Function]

Phrase: "it also"

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "early mitogenic signal transduction pathways."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0086982:Signal Transduction Pathways [Molecular Function]
   853   C0037080:Signal Pathways [Molecular Function]
   840   C0037083:Signal Transduction [Cell Function]
   804   C1160185:transduction [Organism Function]
   804   C1704259:Pathways [Molecular Function]
   804   C1705987:Pathways [Conceptual Entity]
   804   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.248: MAPK is primarily regulated by activation of Ras, Raf1, and MEK (23, 24). 

Phrase: "MAPK"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "is"

Phrase: "primarily"

Phrase: "regulated by activation of Ras,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0034678:RAS [Gene or Genome]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1879547:Activation [Activity]

Phrase: "Raf1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0139905:RAF1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812215:RAF1 [Gene or Genome]

Phrase: "and"

Phrase: "MEK (23,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450348:23 [Quantitative Concept]
   861   C0752313:mek [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.249: Also protein kinase C can stimulate MAPK activity in cells via direct phosphorylation of Raf1 (48). 

Phrase: "Also protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   875   C1168438:Protein C [Laboratory Procedure]
   875   C1418943:PROTEIN C [Gene or Genome]
   875   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "stimulate"

Phrase: "MAPK activity in cells"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   897   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   814   C1150527:protein kinase activity [Molecular Function]
   795 E C2261495:protein phosphokinase activity [Molecular Function]
   778   C1150423:kinase activity [Molecular Function]
   774   C1537044:protein activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
   738   C1752930:mitogenic activity [Cell Function]

Phrase: "via direct phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "of Raf1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0139905:RAF1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812215:RAF1 [Gene or Genome]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.250: PDGF is known to activate all these enzymes (27, 29, 32). 

Phrase: "PDGF"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "all these enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "(27,"

Phrase: "29,"

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.251: Which of these proteins is targeted by BMP2 or TGF- to exert their inhibitory effect is not yet known. 

Phrase: "Which of these proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "targeted by BMP2"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1332424:BMP2 [Gene or Genome]
   790   C1521840:Targeted [Functional Concept]
   756 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "or"

Phrase: "TGF- to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "their inhibitory effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "known."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]
Processing 00000000.tx.252: Early PDGF growth signals are amplified and eventually integrate into the nucleus to initiate de novo transcription of genes and synthesis of proteins that are necessary for their biological function. 

Phrase: "Early PDGF growth signals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1710082:Signal [Phenomenon or Process]
   710   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "amplified"

Phrase: "and"

Phrase: "eventually"

Phrase: "integrate into the nucleus to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0007610:Nucleus [Cell Component]

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "de novo transcription of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0040649:genes transcription [Genetic Function]
           Transcription

Phrase: "and"

Phrase: "synthesis of proteins"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   841   C0597295:Protein Synthesis [Molecular Function]
   805 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]
   790   C0220781:synthesis [Biologic Function]
   790   C1883254:Synthesis [Activity]

Phrase: "that"

Phrase: "are"

Phrase: "necessary for their biological function."
Processing 00000000.tx.253: There is evidence that MAPK can positively regulate activities of several transcription factors. 

Phrase: "There"

Phrase: "is"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that MAPK"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "can"

Phrase: "positively"

Phrase: "regulate"

Phrase: "activities of several transcription factors."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   811   C1148759:transcription factor activity [Genetic Function]
   811   C3537021:Transcription Factor Activity [Molecular Function]
   760   C0441655:Activities [Activity]
   726 E C0205177:Activity [Functional Concept]
   726 E C0439167:% activity [Quantitative Concept]
   726 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.254: MAPK activity is also involved in the post-transcriptional control of gene expression (23). 

Phrase: "MAPK activity"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   884   C1150527:protein kinase activity [Molecular Function]
   865 E C2261495:protein phosphokinase activity [Molecular Function]
   862   C1752930:mitogenic activity [Cell Function]
   853   C1537044:protein activity [Molecular Function]
   840   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "also"

Phrase: "involved in the post-transcriptional control of gene expression"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   790   C1514248:Post-Transcriptional Control [Genetic Function]
   764   C0017262:Gene Expression [Genetic Function]
   764   C1158770:Transcriptional Control [Genetic Function]
   742   C0017337:Gene [Gene or Genome]
   742   C0040649:Transcriptional [Genetic Function]
           Gene Transcription
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0243148:control [Qualitative Concept]
   742   C0687676:Post [Temporal Concept]
   742   C1314939:Involved [Functional Concept]
   742   C1550141:Control [Substance]
   742   C1704687:Post [Manufactured Object]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.255: In Drosophila, the ETS domain containing transcription factor, PointedP2, is phosphorylated by Rolled/ERKA at a single conserved threonine-proline residue that is essential for R7 photoreceptor cell differentiation (49, 50). 

Phrase: "In Drosophila,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013138:Drosophila [Eukaryote]
  1000   C1028876:Drosophila [Fungus]
  1000   C1504613:Drosophila [Eukaryote]

Phrase: "the ETS domain containing transcription factor,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   924   C0919488:ETS-Domain Transcription Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0040649:Transcription [Genetic Function]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]

Phrase: "PointedP2,"

Phrase: "is"

Phrase: "phosphorylated by Rolled/ERKA"

Phrase: "at a single conserved threonine-proline residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C1709915:Residue [Conceptual Entity]
   804   C1882936:RESIDUE [Phenomenon or Process]
   733 E C1609982:Residual [Qualitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "essential for R7 photoreceptor cell differentiation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205224:Essential [Qualitative Concept]

Phrase: "(49,"

Phrase: "50"

Phrase: ")."
Processing 00000000.tx.256: In mammalian cells, MAPK directly phosphorylates the ETS domain transcription factors Elk-1 in at least three serine residues in the C-terminal C-box (23, 36). 

Phrase: "In mammalian cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "MAPK directly"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "phosphorylates"

Phrase: "the ETS domain transcription factors Elk-1 in"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   822   C0919488:ETS-Domain Transcription Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   808   C0209089:Elk-1 Transcription Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0377914:Ets-1 Transcription Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0072461:ets Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   776   C0209278:Transcription Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   776   C1420631:TRANSCRIPTION FACTOR 1 [Gene or Genome]
   770   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1512142:ETS Domain [Amino Acid Sequence]
   770   C1705455:ELK-1 [Gene or Genome]
   767   C0812201:ETS-1 [Gene or Genome]
   744   C0040649:Transcription [Genetic Function]
   744   C0325228:Elk [Mammal]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]
   711   C1521761:Factor [Functional Concept]
   711   C2827422:Factor [Conceptual Entity]

Phrase: "at least three serine residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "in the C-terminal C-box"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0179400:Box [Manufactured Object]
   812   C1533124:Box [Medical Device]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "36"

Phrase: ")."
Processing 00000000.tx.257: Mutation of the MAPK phosphorylation sites in Elk-1 reduced serum-induced transcriptional activation by a GAL4-Elk-1 fusion protein-GAL4 reporter assay (35, 51). 

Phrase: "Mutation of the MAPK phosphorylation sites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0026882:Mutation [Genetic Function]
   742   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in Elk-1 reduced serum-induced transcriptional activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   818   C0162493:Transcriptional Activation [Genetic Function]
   795   C1879547:Activation [Activity]

Phrase: "by a GAL4-Elk-1 fusion protein-GAL4 reporter assay"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C0335038:Reporter [Professional or Occupational Group]
   793   C1510438:Assay [Laboratory Procedure]
   793   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   793   C1705915:Reporter [Conceptual Entity]
   793   C1709908:Reporter [Group]

Phrase: "(35,"

Phrase: "51"

Phrase: ")."
Processing 00000000.tx.258: We now provide evidence that inhibition of PDGF-induced MAPK activity by BMP2 blocks GAL4-Elk-1-mediated transcription (Fig. 5A). 

Phrase: "We now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of PDGF-induced MAPK activity"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   872   C1149472:growth factor activity [Molecular Function]
   861   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   821   C1150527:protein kinase activity [Molecular Function]
   813   C1537044:protein activity [Molecular Function]
   804   C1150423:kinase activity [Molecular Function]
   802 E C2261495:protein phosphokinase activity [Molecular Function]
   799   C1752930:mitogenic activity [Cell Function]
   790   C0205177:Activity [Functional Concept]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1561536:*Activity [Idea or Concept]

Phrase: "by BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "GAL4-Elk-1-mediated transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0040649:Transcription [Genetic Function]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.259: These data indicate that Elk-1-mediated transcription is a necessary component of the mitogenic effect of PDGF. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that Elk-1-mediated transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0040649:Transcription [Genetic Function]

Phrase: "is"

Phrase: "a necessary component of the mitogenic effect of PDGF."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0449432:Component [Manufactured Object]
   736   C1705248:Component [Conceptual Entity]
Processing 00000000.tx.260: c-fos expression is regulated by SRE present in its promoter. 

Phrase: "c-fos expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0085301:c fos [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0085940:c fos [Gene or Genome]
   734   C0087140:c-fos [Gene or Genome]

Phrase: "is"

Phrase: "regulated by SRE present"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   833   C0969709:Serum Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0013879:Element [Element, Ion, or Isotope]
   753   C0150312:Present [Quantitative Concept]
   753   C0229671:Serum [Body Substance]
   753   C0449450:Present [Idea or Concept]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C0871261:Response [Organism Attribute]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C1704632:Response [Finding]
   753   C1705248:Element [Conceptual Entity]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "in its promoter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.261: The SRE has been shown to be sufficient for rapid transcriptional induction of this gene in response to many growth factors (38, 39). 

Phrase: "The SRE"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0969709:Serum Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0229671:Serum [Body Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "sufficient for rapid transcriptional induction of this gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205410:Sufficient [Qualitative Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to many growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "(38,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.262: The serum response factor is a 64-kDa protein with DNA binding and transactivation properties. 

Phrase: "The serum response factor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0074398:Serum Response Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420400:SERUM RESPONSE FACTOR [Gene or Genome]
   827   C0229671:Serum [Body Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1521761:Factor [Functional Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "a 64-kDa protein with DNA binding"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   831   C1413746:DNA-BINDING PROTEIN A [Gene or Genome]
   804   C0012940:DNA Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0812382:DNA-binding protein [Gene or Genome]
   774   C0033618:Protein Binding [Molecular Function]
   774   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   774   C0058610:protein dna [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "transactivation properties."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]
Processing 00000000.tx.263: After binding to its cognate core sequence in the SRE, it recruits Elk-1 to the 5' end of the core sequence. 

Phrase: "After binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "to its cognate core sequence"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C0444669:Core [Spatial Concept]
   827   C1167518:core [Cell Component]
   827   C1519249:Sequence [Functional Concept]
   827   C1706352:Core [Medical Device]
   827   C1882467:Core [Manufactured Object]
   827   C3274653:Core [Body Substance]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "in the SRE,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0969709:Serum Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0229671:Serum [Body Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "it"

Phrase: "recruits"

Phrase: "Elk-1 to the 5' end of the core sequence."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   760   C1705455:ELK-1 [Gene or Genome]
   739   C0004793:Sequence [Nucleotide Sequence]
   739   C0162326:Sequence [Nucleotide Sequence]
   739   C0162327:Sequence [Nucleotide Sequence]
   739   C0325228:Elk [Mammal]
   739   C0444669:Core [Spatial Concept]
   739   C0444930:End [Spatial Concept]
   739   C1167518:core [Cell Component]
   739   C1519249:Sequence [Functional Concept]
   739   C1706352:Core [Medical Device]
   739   C1882467:Core [Manufactured Object]
   739   C2746065:End [Temporal Concept]
   739   C3274653:Core [Body Substance]
Processing 00000000.tx.264: The recruitment of Elk-1 in the ternary complex involving SRF and DNA depends upon the phosphorylation of its C-terminal domain by MAPK (23, 35, 36). 

Phrase: "The recruitment of Elk-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2949735:Recruitment [Activity]

Phrase: "in the ternary complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "SRF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037668:SRF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C0074398:SRF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420400:SRF [Gene or Genome]

Phrase: "and"

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "depends upon the phosphorylation of its C-terminal domain"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C1707271:C-Terminal [Amino Acid Sequence]
   742   C0031715:Phosphorylation [Molecular Function]
   742   C0205088:Terminal [Temporal Concept]
   742   C0725813:depend [Medical Device]
   742   C1158886:Phosphorylation [Molecular Function]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C3541951:Domain [Intellectual Product]

Phrase: "by MAPK"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "35,"

Phrase: "36"

Phrase: ")."
Processing 00000000.tx.265: Mutation of these phosphorylation sites inhibits c-fos gene expression (51). 

Phrase: "Mutation of these phosphorylation sites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "c-fos gene expression"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0085940:c Fos gene [Gene or Genome]
           fos gene
   923   C1706383:c-FOS Gene [Gene or Genome]
   861   C0017262:Gene Expression [Genetic Function]
   861   C0085303:FOS Gene [Gene or Genome]
   861   C0087140:FOS gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(51"

Phrase: ")."
Processing 00000000.tx.266: Our data show a linear relation of MAPK activation and c-fos transcription by PDGF (Fig. 5B). 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a linear relation of MAPK activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   758   C0027120:Kinase-Related Protein [Amino Acid, Peptide, or Protein,Enzyme]
   758   C1833135:KINASE-RELATED PROTEIN [Gene or Genome]
   742   C0080103:Relation [Family Group]
   742   C0869014:relation [Social Behavior]

Phrase: "and"

Phrase: "c-fos transcription by PDGF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0040649:Transcription [Genetic Function]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.267: Furthermore, inhibition of PDGF-induced MAPK by BMP2 inhibits c-fos gene expression (Fig. 5B). 

Phrase: "Furthermore,"

Phrase: "inhibition of PDGF-induced MAPK"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   772   C1512280:Growth Factor Inhibition [Physiologic Function]
   772   C2249823:inhibition of growth [Organism Function]
   738   C0021467:Inhibition [Mental Process]
   738   C0021469:Inhibition [Molecular Function]
   738   C1628982:% inhibition [Quantitative Concept]
   738   C3463820:Inhibition [Activity]

Phrase: "by BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "c-fos gene expression"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0085940:c Fos gene [Gene or Genome]
           fos gene
   923   C1706383:c-FOS Gene [Gene or Genome]
   861   C0017262:Gene Expression [Genetic Function]
   861   C0085303:FOS Gene [Gene or Genome]
   861   C0087140:FOS gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.268: We should emphasize that treatment of mesangial cells with BMP2 also inhibits the basal transcription of the c-fos gene (Fig. 5B). 

Phrase: "We"

Phrase: "should"

Phrase: "emphasize"

Phrase: "that treatment of mesangial cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "with BMP2 also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1332424:BMP2 [Gene or Genome]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the basal transcription of the c-fos gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0040649:Gene Transcription [Genetic Function]
           Transcription

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.269: These data indicate that apart from the effect of BMP2 on MAPK that leads to inhibition of PDGF-induced c-fos expression, BMP2 modulates other pathways that regulate basal transcription of this gene. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that apart from the effect of BMP2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1280500:Effect [Qualitative Concept]
   748   C1332424:BMP2 [Gene or Genome]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on MAPK"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "that"

Phrase: "leads to inhibition"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C0181586:leads [Medical Device]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]
   790   C3463820:Inhibition [Activity]
   718 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of PDGF-induced c-fos expression,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0185117:Expression [Therapeutic or Preventive Procedure]
   723   C0916084:platelet-derived growth factor C [Amino Acid, Peptide, or Protein]
   723   C1418436:PLATELET-DERIVED GROWTH FACTOR C [Gene or Genome]
   723   C1571527:Platelet-Derived Growth Factor C [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "other pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]

Phrase: "that"

Phrase: "regulate"

Phrase: "basal transcription of this gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0040649:Gene Transcription [Genetic Function]
           Transcription
Processing 00000000.tx.270: The role of BMP2 in the biology of mesangial and other kidney cells remains to be determined. 

Phrase: "The role of BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in the biology"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0005532:Biology [Biomedical Occupation or Discipline]
   928 E C0205460:Biologic [Qualitative Concept]
   928 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "of mesangial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "other kidney cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0553257:kidney cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined."
Processing 00000000.tx.271: TGF- plays a major role in fibrotic disorders, including glomerulosclerosis (41). 

Phrase: "TGF-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a major role in fibrotic disorders,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "glomerulosclerosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0178664:Glomerulosclerosis [Disease or Syndrome]
  1000   C1417247:glomerulosclerosis [Gene or Genome]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.272: This deleterious action of TGF- is due to its effect on matrix accumulation in glomerular cells, including mesangial cells (41). 

Phrase: "This deleterious action of TGF-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441472:Action [Functional Concept]
   760   C3266814:Action [Activity]

Phrase: "is due to its effect"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0678226:Due to [Functional Concept]
           due
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
   760   C3146286:Due [Idea or Concept]

Phrase: "on matrix accumulation"

Phrase: "in glomerular cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0007634:Cells [Cell]
   861   C0022663:Glomerular [Body Part, Organ, or Organ Component]
   861   C0268731:GLOMERULAR [Disease or Syndrome]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "mesangial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0227651:Mesangial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.273: However, unlike TGF-, BMP2 at doses that inhibit DNA synthesis does not stimulate fibronectin gene expression in mesangial cells (Fig. 6). 

Phrase: "However,"

Phrase: "unlike TGF-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "BMP2 at doses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1332424:BMP2 [Gene or Genome]

Phrase: "that"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "DNA synthesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0598312:DNA Synthesis [Genetic Function]
  1000   C1328870:DNA synthesis [Laboratory Procedure]
  1000   C1817262:DNA synthesis [Genetic Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "stimulate"

Phrase: "fibronectin gene expression in mesangial cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0017262:Gene Expression [Genetic Function]
   767   C1861886:CELL Gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.274: Nakaoka et al. 

Phrase: "Nakaoka et al."
Processing 00000000.tx.275: (52) have demonstrated recently that in vascular smooth muscle cells, TGF-, but not BMP2, stimulates collagen synthesis. 

Phrase: "(52"

Phrase: ")"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "that in vascular smooth muscle cells,"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   833   C0026844:Muscle, Smooth, Vascular [Tissue]
   833   C1135918:Smooth Muscle Cells [Cell]
   790   C0596981:Muscle Cells [Cell]
   790   C1267092:Muscle, Smooth [Tissue]
   753   C0005847:vascular [Body Part, Organ, or Organ Component]
   753   C0007634:Cells [Cell]
   753   C0026845:Muscle [Tissue]
   753   C0205357:Smooth [Qualitative Concept]
   753   C1558950:VASCULAR [Finding]
   753   C1801960:Vascular [Qualitative Concept]
   753   C3282337:Cells [Cell]
   733   C0005773:Blood Cells [Cell]
   725 E C2328697:Hemal cell [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "TGF-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "but"

Phrase: "not BMP2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1332424:BMP2 [Gene or Genome]

Phrase: "stimulates"

Phrase: "collagen synthesis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2246343:collagen synthesis [Molecular Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]
Processing 00000000.tx.276: These findings may have important therapeutic implication in proliferative and fibrotic disorders. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "may"

Phrase: "have"

Phrase: "important therapeutic implication in proliferative"

Phrase: "and"

Phrase: "fibrotic disorders."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.277: Mesangial cell proliferation and matrix synthesis are prominent features of inflammatory glomerular diseases. 

Phrase: "Mesangial cell proliferation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C3278595:Mesangial cell proliferation [Finding]
   913   C0545017:Mesangial proliferation [Cell or Molecular Dysfunction]
   901   C0596290:Cell Proliferation [Cell Function]
   827   C0334094:Proliferation [Pathologic Function]
   827   C1514485:Proliferation [Functional Concept]
   734   C0227651:Mesangial cell [Cell]

Phrase: "and"

Phrase: "matrix synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "are"

Phrase: "prominent features of inflammatory glomerular diseases."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   719   C1521970:Feature [Qualitative Concept]
   719   C1706388:Feature [Conceptual Entity]
   719   C2346469:Feature [Qualitative Concept]
   719   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.278: BMP2 may prove to be an effective antiproliferative agent for mesangioproliferative disorders without matrix expansion.  

Phrase: "BMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0527443:BMP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332424:BMP2 [Gene or Genome]

Phrase: "may"

Phrase: "prove"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "an effective antiproliferative agent for mesangioproliferative disorders"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0450442:Agent [Chemical Viewed Functionally]
   748   C1254351:Agent [Pharmacologic Substance]
   748   C1521826:Agent [Intellectual Product]

Phrase: "without matrix expansion."
Processing 00000000.tx.279: ACKNOWLEDGEMENT We thank Sergio Garcia for help with the cell culture.  

Phrase: "ACKNOWLEDGEMENT"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Sergio Garcia for"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442999:Garcia [Intellectual Product]
   790   C1621797:Garcia [Plant]

Phrase: "help with the cell culture."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0007585:Cell Culture [Laboratory Procedure]
   760   C0007634:Cell [Cell]
   760   C0010453:Culture [Idea or Concept]
   760   C0018896:Help [Social Behavior]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C1269647:Cell [Cell]
   760   C1552861:help [Idea or Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.280: FOOTNOTES * This work was supported in part by a Veterans Administration Medical Research Service grant and National Institutes of Health Grants DK 50190(both to G.G.C.), DK43988 (to H.E.A.), and AR 44728(to S.H.).

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by a Veterans Administration Medical Research Service grant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C0260206:research grant [Research Activity]
   799   C0018173:Grant [Quantitative Concept]
   799   C1548284:Grant [Idea or Concept]

Phrase: "and"

Phrase: "National Institutes of Health Grants DK 50190"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   877   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   795   C0011318:DK [Geographic Area]
   795   C0018173:Grants [Quantitative Concept]
   795   C0018684:Health [Idea or Concept]
   795   C0021622:Institutes [Organization]
   795   C3245503:national [Intellectual Product]
   762 E C1272753:Institute [Idea or Concept]
   762 E C1548284:Grant [Idea or Concept]

Phrase: "("

Phrase: "both to G.G."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1319635:g/g [Quantitative Concept]
   770   C0238767:Both [Spatial Concept]
   770   C0439267:g% [Quantitative Concept]
   770   C1706086:Both [Qualitative Concept]

Phrase: "C."

Phrase: ")"

Phrase: ","

Phrase: "DK43988"

Phrase: "("

Phrase: "to H.E.A."

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "AR 44728"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986463:AR+ [Finding]

Phrase: "(to S.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.281: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.282: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.283: Section 1734solely to indicate this fact.  

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.284: To whom all correspondence should be addressed: Dept. of Medicine, The University of Texas Health Science Center, 7703Floyd Curl Dr., San Antonio, TX 78284-7882.E-mail: choundhuryg{at}uthscsa.edu .  Supported by a Research Fellowship from the German Research Foundation and by a fellowship award from the National Kidney Foundation. 

Phrase: "To whom"

Phrase: "all correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Dept."

Phrase: "of Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013227:Medicine, NOS [Pharmacologic Substance]
  1000   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "The University of Texas Health Science Center,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   839   C0475309:Health center [Health Care Related Organization,Manufactured Object]
   799   C0018684:Health [Idea or Concept]
   799   C0036397:Science [Occupation or Discipline]
   799   C0039711:Texas [Geographic Area]
   799   C0041740:University [Manufactured Object,Organization]
   799   C0205099:Center [Spatial Concept]

Phrase: "7703Floyd Curl Dr., San Antonio,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1826357:San [Gene or Genome]

Phrase: "TX 78284-7882.E-mail"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0024492:Mail [Manufactured Object]
   804   C1538057:MAIL [Gene or Genome]
   804   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "choundhuryg{at}uthscsa.edu ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "Supported by a Research Fellowship"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   797   C0035176:research supported [Quantitative Concept]
   760   C0015770:Fellowship [Educational Activity]
   760   C0035168:research [Research Activity]
   760   C0242481:Research [Research Activity]
   760   C1521721:Supported [Conceptual Entity]
   726 E C0183683:Support [Medical Device]

Phrase: "from the German Research Foundation"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   859   C2986512:Research Base [Organization]
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "and by a fellowship award"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0004446:Award [Manufactured Object]
   760   C0015770:Fellowship [Educational Activity]
   760   C1515981:And [Idea or Concept]

Phrase: "from the National Kidney Foundation."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]
Processing 00000000.tx.285: Supported by an institutional American Cancer Society grant.  

Phrase: "Supported by an institutional American Cancer Society grant."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   800   C0002455:American Cancer Society [Professional Society]
   744   C0006826:Cancer [Neoplastic Process]
   744   C0018173:Grant [Quantitative Concept]
   744   C0037455:society [Organization]
   744   C0596070:American [Population Group]
   744   C0998265:Cancer [Eukaryote]
   744   C1306459:Cancer [Finding]
   744   C1521721:Supported [Conceptual Entity]
   744   C1548284:Grant [Idea or Concept]
   711 E C0183683:Support [Medical Device]
Processing 00000000.tx.286: ABBREVIATIONS The abbreviations used are: TGF-, transforming growth factor-; 

Phrase: "ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "TGF-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "transforming growth factor-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: ";"
Processing 00000000.tx.287: BMP, bone morphogenetic protein; 

Phrase: "BMP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0053932:BMP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0279266:BMP [Therapeutic or Preventive Procedure]

Phrase: "bone morphogenetic protein"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0053932:Bone Morphogenetic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   865   C2610491:bone morphogenesis [Organism Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   827   C0391978:Bone [Tissue]
   827   C1266908:Bone [Body Part, Organ, or Organ Component]
   827   C1266909:Bone [Body System]
   755   C0026559:Morphogenesis [Organism Function]
   755 E C0443157:Bony [Functional Concept]

Phrase: ";"
Processing 00000000.tx.288: MAPK, mitogen-activated protein kinase; 

Phrase: "MAPK,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "mitogen-activated protein kinase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: ";"
Processing 00000000.tx.289: PDGF, platelet-derived growth factor; 

Phrase: "PDGF,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "platelet-derived growth factor"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: ";"
Processing 00000000.tx.290: PDGFR, PDGF receptor; 

Phrase: "PDGFR,"

Phrase: "PDGF receptor"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
  1000   C0071253:Platelet-Derived Growth Factor Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   937   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   875   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0005821:Platelet [Cell]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1441547:Derived [Qualitative Concept]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   804   C3245521:derived [Idea or Concept]
   721 E C1963076:Platelets [Finding]

Phrase: ";"
Processing 00000000.tx.291: PI, phosphatidylinositol; 

Phrase: "PI,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0429863:PI [Clinical Attribute]
  1000   C3537219:PI [Gene or Genome]
  1000   C3539772:PI [Intellectual Product]

Phrase: "phosphatidylinositol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
  1000   C2348046:Phosphatidylinositol [Lipid]

Phrase: ";"
Processing 00000000.tx.292: MBP, myelin basic protein; 

Phrase: "MBP,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   923   C0014063:Myelin Basic Protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   923   C1417057:MYELIN BASIC PROTEIN [Gene or Genome]
   875   C0026972:Myelin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026969:Myelin [Tissue]
   812   C0026973:Myelin [Cell Component]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1527178:Basic [Functional Concept]
   741 E C0920750:basicity [Quantitative Concept]

Phrase: "myelin basic protein"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0014063:Myelin Basic Protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417057:MYELIN BASIC PROTEIN [Gene or Genome]
   913   C0026972:Myelin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0026969:Myelin [Tissue]
   827   C0026973:Myelin [Cell Component]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1527178:Basic [Functional Concept]
   755 E C0920750:basicity [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.293: SRE, serum response element.  

Phrase: "SRE,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0969709:Serum Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0229671:Serum [Body Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "serum response element."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0969709:Serum Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0229671:Serum [Body Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
Processing 00000000.tx.294: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Urist, M. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Urist,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.295: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.296: (1965) Science 150, 893-899[Medline] [OrderarticleviaInfotrieve] Reddi, A. 

Phrase: "(1965"

Phrase: ")"

Phrase: "Science 150,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "893-899"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Reddi,"

Phrase: "A."
Processing 00000000.tx.297: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.298: (1994) Curr. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.299: Opin. 

Phrase: "Opin."
Processing 00000000.tx.300: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.301: Dev. 

Phrase: "Dev."
Processing 00000000.tx.302: 4, 737-744[Medline] [OrderarticleviaInfotrieve] Wozney, J. 

Phrase: "4,"

Phrase: "737-744"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wozney,"

Phrase: "J."
Processing 00000000.tx.303: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.304: (1992) Mol. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.305: Reprod. 

Phrase: "Reprod."
Processing 00000000.tx.306: Dev. 

Phrase: "Dev."
Processing 00000000.tx.307: 32, 160-167[Medline] [OrderarticleviaInfotrieve] Hogan, B. 

Phrase: "32,"

Phrase: "160-167"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hogan,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.308: L.M. 

Phrase: "L.M."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.309: (1996) Genes Dev. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.310: 10, 1580-1594[CrossRef][Medline] [OrderarticleviaInfotrieve] Heldin, C.-H., Miyazono, K., and ten Dijke, P. 

Phrase: "10,"

Phrase: "1580-1594"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Heldin,"

Phrase: "C.-H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Miyazono,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "ten Dijke,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014518:TEN [Disease or Syndrome]
   861   C0205456:Ten [Quantitative Concept]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.311: (1997) Nature 390, 465-471[CrossRef][Medline] [OrderarticleviaInfotrieve] Massague, J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nature 390,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "465-471"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Massague,"

Phrase: "J."
Processing 00000000.tx.312: (1996) Cell 85, 947-950[Medline] [OrderarticleviaInfotrieve] Vukicevic, S., Koff, J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Cell 85,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "947-950"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Vukicevic,"

Phrase: "S."

Phrase: ","

Phrase: "Koff,"

Phrase: "J."
Processing 00000000.tx.313: B., Luyten, F. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Luyten,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.314: P., and Sampath, T. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Sampath,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.315: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.316: (1996) Proc. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.317: Natl. 

Phrase: "Natl."
Processing 00000000.tx.318: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.319: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.320: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.321: 93, 9021-9026[Abstract/Free FullText] Luo, G., Hofmann, C., Bronckers, A. 

Phrase: "93,"

Phrase: "9021-9026"

Phrase: "[Abstract/Free FullText"

Phrase: "] Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337841:Luo [Population Group]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hofmann,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Bronckers,"

Phrase: "A."
Processing 00000000.tx.322: L.J.J., Sohocki, M., Bradley, A., and Karsenty, G. 

Phrase: "L.J.J.,"

Phrase: "Sohocki,"

Phrase: "M."

Phrase: ","

Phrase: "Bradley,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Karsenty,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.323: (1995) Genes Dev. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.324: 9, 2808-2820[Abstract] Dudley, T. 

Phrase: "9,"

Phrase: "2808-2820"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Dudley,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.325: A., Lyons, K. 

Phrase: "A.,"

Phrase: "Lyons,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.326: M., and Robertson, E. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Robertson,"

Phrase: "E."
Processing 00000000.tx.327: J. 

Phrase: "J."
Processing 00000000.tx.328: (1995) Genes Dev. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.329: 9, 2795-2807[Abstract] Iwasaki, S., Tsuruoka, N., Hattori, A., Sato, M., Tsujimoto, M., and Kohno, M. 

Phrase: "9,"

Phrase: "2795-2807"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Iwasaki,"

Phrase: "S."

Phrase: ","

Phrase: "Tsuruoka,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Hattori,"

Phrase: "A.,"

Phrase: "Sato,"

Phrase: "M."

Phrase: ","

Phrase: "Tsujimoto,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Kohno,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.330: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.331: Biol. 

Phrase: "Biol."
Processing 00000000.tx.332: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.333: 270, 5476-5482[Abstract/Free FullText] Niehrs, C. 

Phrase: "270,"

Phrase: "5476-5482"

Phrase: "[Abstract/Free FullText"

Phrase: "] Niehrs,"

Phrase: "C."
Processing 00000000.tx.334: (1996) Nature 381, 561-562[CrossRef][Medline] [OrderarticleviaInfotrieve] Kretzschmar, M., Liu, F., Hata, A., Doody, J., and Massague, J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nature 381,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "561-562"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kretzschmar,"

Phrase: "M."

Phrase: ","

Phrase: "Liu,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Hata,"

Phrase: "A.,"

Phrase: "Doody,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Massague,"

Phrase: "J."
Processing 00000000.tx.335: (1997) Genes Dev. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.336: 11, 984-995[Abstract] Liu, F., Hata, A., Baker, J. 

Phrase: "11,"

Phrase: "984-995"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Liu,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Hata,"

Phrase: "A.,"

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.337: C., Doody, J., Carcamo, J., Harland, R. 

Phrase: "C., Doody,"

Phrase: "J.,"

Phrase: "Carcamo,"

Phrase: "J.,"

Phrase: "Harland,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.338: M., and Massague, J. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Massague,"

Phrase: "J."
Processing 00000000.tx.339: (1996) Nature 381, 620-623[CrossRef][Medline] [OrderarticleviaInfotrieve] Kretzschmar, M., Doody, J., and Massague, J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nature 381,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "620-623"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kretzschmar,"

Phrase: "M."

Phrase: ","

Phrase: "Doody,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Massague,"

Phrase: "J."
Processing 00000000.tx.340: (1997) Nature 389, 618-622[CrossRef][Medline] [OrderarticleviaInfotrieve] Niswander, L., and Martin, G. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nature 389,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "618-622"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Niswander,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Martin,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.341: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.342: (1993) Nature 361, 68-71[CrossRef][Medline] [OrderarticleviaInfotrieve] Bernier, S. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Nature 361,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "68-71"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450387:68 [Intellectual Product]
   861   C0450389:71 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bernier,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.343: M., and Goltzman, D. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Goltzman,"

Phrase: "D."
Processing 00000000.tx.344: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.345: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.346: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.347: 152, 317-327[Medline] [OrderarticleviaInfotrieve] Neubuser, A., Peters, H., Balling, R., and Martin, G. 

Phrase: "152,"

Phrase: "317-327"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Neubuser,"

Phrase: "A.,"

Phrase: "Peters,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Balling,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706910:Ball [Manufactured Object]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Martin,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.348: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.349: (1997) Cell 90, 247-255[Medline] [OrderarticleviaInfotrieve] Abboud, H. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Cell 90,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0007634:Cell [Cell]
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "247-255"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Abboud,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.350: E. 

Phrase: "E."
Processing 00000000.tx.351: (1995) Annu. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.352: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.353: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.354: 57, 297-309[CrossRef][Medline] [OrderarticleviaInfotrieve] Abboud, H. 

Phrase: "57,"

Phrase: "297-309"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Abboud,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.355: E., Bhandari, B., and Ghosh Choudhury, G. 

Phrase: "E.,"

Phrase: "Bhandari,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Ghosh Choudhury,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.356: (1995) in Molecular Nephrology. 

Phrase: "(1995"

Phrase: ")"

Phrase: "in Molecular Nephrology."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027712:Nephrology [Biomedical Occupation or Discipline]
Processing 00000000.tx.357: Kidney Function in Health and Disease (Bonvetre, J., and Schlondorf, D., eds), pp. 

Phrase: "Kidney Function in Health"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0232804:kidney function [Organ or Tissue Function]
   783   C2984555:Functional Health [Functional Concept]
   770   C0022646:Kidney [Body Part, Organ, or Organ Component]
   770   C0031843:function [Physiologic Function]
   770   C0227665:kidney [Body Part, Organ, or Organ Component]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1278978:Kidney [Body Part, Organ, or Organ Component]
   770   C1514845:KIDNEY [Tissue]
   770   C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "Disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "(Bonvetre,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Schlondorf,"

Phrase: "D."

Phrase: ","

Phrase: "eds"

Phrase: ")"

Phrase: ","

Phrase: "pp."
Processing 00000000.tx.358: 573-590, Marcel Dekker, Inc., New York Leveen, P., Pekny, M., Gebre-Medhin, S., Swolin, B., Larsson, E., and Betsholtz, C. 

Phrase: "573-590,"

Phrase: "Marcel Dekker,"

Phrase: "Inc.,"

Phrase: "New York Leveen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027976:New York [Geographic Area]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Pekny,"

Phrase: "M."

Phrase: ","

Phrase: "Gebre-Medhin,"

Phrase: "S."

Phrase: ","

Phrase: "Swolin,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Larsson,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Betsholtz,"

Phrase: "C."
Processing 00000000.tx.359: (1994) Genes Dev. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.360: 8, 1875-1887[Abstract] Soriano, P. 

Phrase: "8,"

Phrase: "1875-1887"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Soriano,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.361: (1994) Genes Dev. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.362: 8, 1888-1896[Abstract] Johnson, R. 

Phrase: "8,"

Phrase: "1888-1896"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Johnson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.363: J. 

Phrase: "J."
Processing 00000000.tx.364: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.365: Lab. 

Phrase: "Lab."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0022877:Lab [Manufactured Object,Organization]
   944 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   916 E C0587081:Labs [Finding]
Processing 00000000.tx.366: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.367: Med. 

Phrase: "Med."
Processing 00000000.tx.368: 121, 190-192[Medline] [OrderarticleviaInfotrieve] Su, B., and Karin, M. 

Phrase: "121,"

Phrase: "190-192"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Su,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705534:SU [Idea or Concept]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Karin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.369: (1996) Curr. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.370: Opin. 

Phrase: "Opin."
Processing 00000000.tx.371: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.372: 8, 402-411[CrossRef][Medline] [OrderarticleviaInfotrieve] Margolis, B., and Skolnik, E. 

Phrase: "8,"

Phrase: "402-411"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Margolis,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Skolnik,"

Phrase: "E."
Processing 00000000.tx.373: Y. 

Phrase: "Y."
Processing 00000000.tx.374: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.375: Am. 

Phrase: "Am."
Processing 00000000.tx.376: Soc. 

Phrase: "Soc."
Processing 00000000.tx.377: Nephrol. 

Phrase: "Nephrol."
Processing 00000000.tx.378: 5, 1288-1299[Abstract] Kazlauskas, A. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "1288-1299"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kazlauskas,"

Phrase: "A."
Processing 00000000.tx.379: (1994) Curr. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.380: Opin. 

Phrase: "Opin."
Processing 00000000.tx.381: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.382: Dev. 

Phrase: "Dev."
Processing 00000000.tx.383: 4, 5-14[Medline] [OrderarticleviaInfotrieve] Li, W., Nishimura, R., Kashiahian, A., Batzer, A. 

Phrase: "4,"

Phrase: "5-14"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "W.,"

Phrase: "Nishimura,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kashiahian,"

Phrase: "A.,"

Phrase: "Batzer,"

Phrase: "A."
Processing 00000000.tx.384: G., Kim, W. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Kim,"

Phrase: "W."
Processing 00000000.tx.385: J.H., Cooper, J. 

Phrase: "J.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.386: A., and Schlessinger, J. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Schlessinger,"

Phrase: "J."
Processing 00000000.tx.387: (1994) Mol. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.388: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.389: Biol. 

Phrase: "Biol."
Processing 00000000.tx.390: 14, 509-517[Abstract] Ghosh Choudhury, G., Karamitsos, C., Hernandez, J., Gentilini, A., Bardgette, J., and Abboud, H. 

Phrase: "14,"

Phrase: "509-517"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ghosh Choudhury,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Karamitsos,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Hernandez,"

Phrase: "J.,"

Phrase: "Gentilini,"

Phrase: "A.,"

Phrase: "Bardgette,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Abboud,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.391: E. 

Phrase: "E."
Processing 00000000.tx.392: (1997) Am. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.393: J.

Phrase: "J."
Processing 00000000.tx.394: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.395: Renal Physiol. 

Phrase: "Renal Physiol."
Processing 00000000.tx.396: 273, F931-F938[Abstract/Free FullText] Glass, W. 

Phrase: "273,"

Phrase: "F931-F938"

Phrase: "[Abstract/Free FullText"

Phrase: "] Glass,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017596:Glass [Manufactured Object]
  1000   C1947936:Glass [Medical Device]
   928 E C0074759:Glassy [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   928 E C0522500:Glassy [Qualitative Concept]

Phrase: "W."
Processing 00000000.tx.397: F., Rampt, E., Garoni, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Rampt,"

Phrase: "E.,"

Phrase: "Garoni,"

Phrase: "J."
Processing 00000000.tx.398: A., Fenton, J. 

Phrase: "A.,"

Phrase: "Fenton,"

Phrase: "J."
Processing 00000000.tx.399: W., and Kreisberg, J. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Kreisberg,"

Phrase: "J."
Processing 00000000.tx.400: (1991) Am. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.401: J.

Phrase: "J."
Processing 00000000.tx.402: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.403: 261, F336-F344[Abstract/Free FullText] Ghosh Choudhury, G., Biswas, P., Grandaliano, G., Fouqueray, B., Harvey, S. 

Phrase: "261,"

Phrase: "F336-F344"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034703:F344 [Mammal]

Phrase: "[Abstract/Free FullText"

Phrase: "] Ghosh Choudhury,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Biswas,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Grandaliano,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Fouqueray,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Harvey,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.404: A., and Abboud, H. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Abboud,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.405: E. 

Phrase: "E."
Processing 00000000.tx.406: (1994) Kidney Int. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Kidney Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063789:INT [Organic Chemical]
   861   C3272375:INT [Intellectual Product]
Processing 00000000.tx.407: 46, 37-47[Medline] [OrderarticleviaInfotrieve] Ghosh Choudhury, G., Wang, L.-M., Pierce, J., Harvey, S. 

Phrase: "46,"

Phrase: "37-47"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ghosh Choudhury,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Wang,"

Phrase: "L.-M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Pierce,"

Phrase: "J.,"

Phrase: "Harvey,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.408: A., and Sakaguchi, A. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Sakaguchi,"

Phrase: "A."
Processing 00000000.tx.409: Y. 

Phrase: "Y."
Processing 00000000.tx.410: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.411: Biol. 

Phrase: "Biol."
Processing 00000000.tx.412: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.413: 266, 8068-8072[Abstract/Free FullText] Grandaliano, G., Ghosh Choudhury, G., Biswas, P., and Abboud, H. 

Phrase: "266,"

Phrase: "8068-8072"

Phrase: "[Abstract/Free FullText"

Phrase: "] Grandaliano,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ghosh Choudhury,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Biswas,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Abboud,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.414: E. 

Phrase: "E."
Processing 00000000.tx.415: (1994) Am. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.416: J.

Phrase: "J."
Processing 00000000.tx.417: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.418: 267, F528-F536[Abstract/Free FullText] Ghosh Choudhury, G., Biswas, P., Grandaliano, G., and Abboud, H. 

Phrase: "267,"

Phrase: "F528-F536"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ghosh Choudhury,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Biswas,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Grandaliano,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Abboud,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.419: E. 

Phrase: "E."
Processing 00000000.tx.420: (1993) Am. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.421: J.

Phrase: "J."
Processing 00000000.tx.422: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.423: 265, F634-F642[Abstract/Free FullText] Knauss, T. 

Phrase: "265,"

Phrase: "F634-F642"

Phrase: "[Abstract/Free FullText"

Phrase: "] Knauss,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.424: C., Jaffer, F. 

Phrase: "C., Jaffer,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.425: E., and Abboud, H. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Abboud,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.426: E. 

Phrase: "E."
Processing 00000000.tx.427: (1990) J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.428: Biol. 

Phrase: "Biol."
Processing 00000000.tx.429: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.430: 265, 14457-14463[Abstract/Free FullText] Jaffer, F., Saunders, C., Shultz, P., Throckmorton, D., Weinshell, and Abboud, H. 

Phrase: "265,"

Phrase: "14457-14463"

Phrase: "[Abstract/Free FullText"

Phrase: "] Jaffer,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Saunders,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Shultz,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Throckmorton,"

Phrase: "D."

Phrase: ","

Phrase: "Weinshell,"

Phrase: "and"

Phrase: "Abboud,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.431: E. 

Phrase: "E."
Processing 00000000.tx.432: (1989) Am. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.433: J.Pathol. 

Phrase: "J.Pathol."
Processing 00000000.tx.434: 135, 261-269[Abstract] Johansen, F.-E., and Prywes, R. 

Phrase: "135,"

Phrase: "261-269"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Johansen,"

Phrase: "F.-E.,"

Phrase: "and"

Phrase: "Prywes,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.435: (1995) Biochim. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.436: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.437: Acta 1242, 1-10[CrossRef][Medline] [OrderarticleviaInfotrieve] Hill, C. 

Phrase: "Acta 1242,"

Phrase: "1-10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442532:Hill [Spatial Concept]

Phrase: "C."
Processing 00000000.tx.438: S., Marais, R., John, S., Wynne, J., Dalton, S., and Treisman, R. 

Phrase: "S."

Phrase: ","

Phrase: "Marais,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "John,"

Phrase: "S."

Phrase: ","

Phrase: "Wynne,"

Phrase: "J.,"

Phrase: "Dalton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678223:dalton [Quantitative Concept]

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Treisman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.439: (1993) Cell 73, 395-406[Medline] [OrderarticleviaInfotrieve] Whitmarsh, Q. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Cell 73,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "395-406"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Whitmarsh,"

Phrase: "Q."
Processing 00000000.tx.440: J., Shore, P., Sharrocks, A. 

Phrase: "J.,"

Phrase: "Shore,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sharrocks,"

Phrase: "A."
Processing 00000000.tx.441: D., and Davis, R. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Davis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.442: J. 

Phrase: "J."
Processing 00000000.tx.443: (1995) Science 269, 403-407[Medline] [OrderarticleviaInfotrieve] Greenberg, M. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Science 269,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "403-407"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Greenberg,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.444: E., and Zeff, E. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Zeff,"

Phrase: "E."
Processing 00000000.tx.445: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.446: (1984) Nature 311, 433-438[Medline] [OrderarticleviaInfotrieve] Treisman, R. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Nature 311,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "433-438"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Treisman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.447: (1990) Semin. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Semin."
Processing 00000000.tx.448: Cancer Biol. 

Phrase: "Cancer Biol."
Processing 00000000.tx.449: 1, 47-58[Medline] [OrderarticleviaInfotrieve] Bruijn, J. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "47-58"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bruijn,"

Phrase: "J."
Processing 00000000.tx.450: A., Roos, A., Gues, B., and Heer, E. 

Phrase: "A.,"

Phrase: "Roos,"

Phrase: "A.,"

Phrase: "Gues,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Heer,"

Phrase: "E."
Processing 00000000.tx.451: D.E. 

Phrase: "D."

Phrase: "E."
Processing 00000000.tx.452: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.453: Lab. 

Phrase: "Lab."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0022877:Lab [Manufactured Object,Organization]
   944 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   916 E C0587081:Labs [Finding]
Processing 00000000.tx.454: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.455: Med. 

Phrase: "Med."
Processing 00000000.tx.456: 123, 34-47[Medline] [OrderarticleviaInfotrieve] Border, W. 

Phrase: "123,"

Phrase: "34-47"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Border,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205284:Border [Spatial Concept]
  1000   C1522411:Border [Body Location or Region]
  1000   C2828371:Border [Classification]

Phrase: "W."
Processing 00000000.tx.457: A., and Noble, N. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Noble,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.458: A. 

Phrase: "A."
Processing 00000000.tx.459: (1997) Kidney Int. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Kidney Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063789:INT [Organic Chemical]
   861   C3272375:INT [Intellectual Product]
Processing 00000000.tx.460: 51, 1388-1396[Medline] [OrderarticleviaInfotrieve] McKay, K., Striker, L. 

Phrase: "51,"

Phrase: "1388-1396"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] McKay,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Striker,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.461: J., Stauffer, J. 

Phrase: "J.,"

Phrase: "Stauffer,"

Phrase: "J."
Processing 00000000.tx.462: W., Doi, T., Agodo, L. 

Phrase: "W., Doi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2348291:DOI [Classification]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Agodo,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.463: Y., and Striker, G. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Striker,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.464: E. 

Phrase: "E."
Processing 00000000.tx.465: (1989) J. 

Phrase: "(1989"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.466: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.467: Invest. 

Phrase: "Invest."
Processing 00000000.tx.468: 83, 1160-1167[Medline] [OrderarticleviaInfotrieve] Mackay, N. 

Phrase: "83,"

Phrase: "1160-1167"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mackay,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.469: G., Haites, N. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Haites,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.470: E., and Power, D. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Power,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "D."
Processing 00000000.tx.471: A. 

Phrase: "A."
Processing 00000000.tx.472: (1992) Abstr. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Abstr."
Processing 00000000.tx.473: Kidney Int. 

Phrase: "Kidney Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063789:INT [Organic Chemical]
   861   C3272375:INT [Intellectual Product]
Processing 00000000.tx.474: 41, 703 Toyoshima, H., and Hunter, T. 

Phrase: "41,"

Phrase: "703 Toyoshima,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Hunter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239971:HUNTER [Professional or Occupational Group]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.475: (1994) Cell 78, 67-74[Medline] [OrderarticleviaInfotrieve] Ide, H., Yoshida, T., Matsumoto, N., Aoki, K., Osada, Y., Sugimura, T., and Terada, M. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Cell 78,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "67-74"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yoshida,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Matsumoto,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Aoki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Osada,"

Phrase: "Y.,"

Phrase: "Sugimura,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Terada,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.476: (1997) Cancer Res. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.477: 57, 5022-5027[Abstract] White, M. 

Phrase: "57,"

Phrase: "5022-5027"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.478: F., and Kahn, C. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Kahn,"

Phrase: "C."
Processing 00000000.tx.479: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.480: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.481: Biol. 

Phrase: "Biol."
Processing 00000000.tx.482: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.483: 269, 1-4[Free FullText] Hsuan, J. 

Phrase: "269,"

Phrase: "1-4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[Free FullText"

Phrase: "] Hsuan,"

Phrase: "J."
Processing 00000000.tx.484: J., Panayotou, G., and Waterfield, M. 

Phrase: "J.,"

Phrase: "Panayotou,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Waterfield,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.485: D. 

Phrase: "D."
Processing 00000000.tx.486: (1989) Prog. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Prog."
Processing 00000000.tx.487: Growth Factor Res. 

Phrase: "Growth Factor Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.488: 1, 23-32[Medline] [OrderarticleviaInfotrieve] Koch, W., Heidecker, G., Kochs, G., Hummel, R., Vahidi, H., Mischak, H., Finkenzeller, G., Marme, D., and Rapp, U. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "23-32"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Koch,"

Phrase: "W.,"

Phrase: "Heidecker,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Kochs,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hummel,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Vahidi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mischak,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Finkenzeller,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Marme,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Rapp,"

Phrase: "U."
Processing 00000000.tx.489: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.490: (1993) Nature 364, 249-252[CrossRef][Medline] [OrderarticleviaInfotrieve] Bruner, D., Ducker, K., Oellers, N., Hafen, E., Scholz, H., and Klambt, C. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Nature 364,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "249-252"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bruner,"

Phrase: "D."

Phrase: ","

Phrase: "Ducker,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Oellers,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Hafen,"

Phrase: "E.,"

Phrase: "Scholz,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Klambt,"

Phrase: "C."
Processing 00000000.tx.491: (1994) Nature 370, 386-389[CrossRef][Medline] [OrderarticleviaInfotrieve] O'Neil, E. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Nature 370,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "386-389"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] O'Neil,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "E."
Processing 00000000.tx.492: M., Rebay, I., Tjian, R., and Rubin, G. 

Phrase: "M."

Phrase: ","

Phrase: "Rebay,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Tjian,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Rubin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0252873:rubin's [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.493: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.494: (1994) Cell 78, 137-147[Medline] [OrderarticleviaInfotrieve] Marais, R., Wynne, J., and Treisman, R. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Cell 78,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "137-147"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Marais,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wynne,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Treisman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.495: (1993) Cell 73, 381-393[Medline] [OrderarticleviaInfotrieve] Nakaoka, T., Gonda, K., Ogita, T., Otawara-Hamamoto, Y., Okabe, F., Kira, Y., Harii, K., Miyazono, K., Takuwa, Y., and Fujita, T. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Cell 73,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "381-393"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Nakaoka,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Gonda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ogita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Otawara-Hamamoto,"

Phrase: "Y.,"

Phrase: "Okabe,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Kira,"

Phrase: "Y.,"

Phrase: "Harii,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Miyazono,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Takuwa,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Fujita,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.496: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.497: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.498: Invest. 

Phrase: "Invest."
Processing 00000000.tx.499: 100, 2824-2832[Abstract/Free FullText] Copyright  1999 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "100,"

Phrase: "2824-2832"

Phrase: "[Abstract/Free FullText"

Phrase: "] Copyright  1999 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

